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Abstract 
Current approaches to drug discovery tends to involve the rapid analogue synthesis and 
testing of small, focused libraries of low molecular weight, structurally similar "drug-
like" molecules, often based around heterocyclic core scaffolds. If some desired activity 
is shown by a compound, elaboration can give higher activity and more favourable 
pharrnokinetic properties. As this "lead generation" stage of drug development has been 
identified as a major bottleneck in the drug pipeline process, there is a great demand for 
methodology detailing the synthesis of highly functionalised heterocyclic compounds. 
Our approach involves the sequential nucleophilic aromatic substitution of highly 
fluorinated pyridines, in an efficient and flexible manner, to furnish a range of novel, 
functionalised polycyclic systems. 
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Chapter 1 
Introduction 
1.1 The Pharmaceutical Industry 
1.1.1 Development 
The evolution of the pharmaceutical industry has been an interesting one. Emerging 
from the synthetic dye industry in Germany and following the watershed discovery and 
sale of aspirin, companies such as Bayer set about finding new drugs to market. The 
source of novel pharmaceuticals was generally through the extraction of natural 
products from plants and microorganisms and from the exploration of the chemicals 
making up coal tar, 1 which had previously yielded the collection of compounds 
constituting the first synthetic dye, mauve, discovered by the then teenage William 
Perkin. The chemical knowledge gleaned from this work, along with the drive to find 
drugs that could combat the serious health problems that had existed in mankind up 
until then, eventually led to the modern drug discovery process (and synthetic organic 
chemistry) that we know today. 
1.1.2 Modern Drug Discovery 
The approach to finding "lead compounds" by the systematic synthesis and testing of 
novel chemicals remained relatively unchanged until the development of combinatorial 
chemistry, that is, the science of creating and testing, en masse, large libraries of 
structurally diverse compounds with the aim of discovering lead compounds more 
quickly and inexpensively than previously possible2 However, since its inception in the 
1980s, there has been an acknowledgement that this concept is not necessarily the most 
efficient way of generating lead compounds due to the fact that, through an attempt to 
maximise structural variation, a proportion of the structures making up a library will not 
be "drug-like" and hence are unlikely to have useful biological activity. 3• 4 As such, the 
current approach to lead generation and optimisation is to synthesise small, polar, 
"drug-like" molecules which, if shown to have some affinity against a selected target, 
can be elaborated in such way as to give improved activities and pharmokinetic 
.·· 
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properties.5 Concepts such as "privileged structures",6 which describes the ability of a 
pharmacophore to exhibit varied biological activity through the judicious modification 
of the functional groups attached/ and Lipinski's "rules of 5",8 which help to identify 
and improve favourable physico-chemical properties in potential lead compounds, have 
added weight to this approach. Given that this early stage of the drug discovery pipeline 
has been identified as a major bottleneck, it is largely down to chemists to provide new 
biologically relevant substances. 3• 9 
1.1.3 Heterocyclic Systems 
The ability to vary the properties of heterocycles by manipulating their structures makes 
such systems highly amenable to drug discovery and accounts for the widespread 
occurrence of active compounds containing a heterocyclic core. However, the 
elaboration of heterocycles is often difficult due to their sometimes low reactivity and 
selectivity. There are various approaches that have been adopted, often in combination 
with one another, to circumvent these inherent disadvantages such as multi-
component, 10 metal-catalysed coupling11 and cycloaddition reactions, annulation of 
alkynes and their equivalents,12• 13 and sequential nucleophilic aromatic substitution.14' 15 
It is this last approach that is the basis for the work submitted in this thesis, that is the 
perhalogenation of a suitable heterocycle followed by the sequential displacement of 
halide, in a selective fashion, to build in functionality around a parent scaffold. 
1.1.4 [5,6] Fused Systems 
The [5,6] fused-ring motif has been shown to be in the top eight most frequently 
occumng frameworks in drugsi 6 This is, of course, largely due to the relatively 
commonly employed pharmacophores indole, benzimidazole and purine. However, the 
ability to vary the heteroatoms present in these scaffolds gives systems with differing 
electronic properties and, potentially, improved activities. For example, in the 
development of vasorelaxants and using adenosine as a low affinity lead, scientists 
developed the following imidazopyridine based bioactive molecule (Figure 1.1 ). 17 As 
well as elaboration of the amino group, modification of the fused ring was also 
explored. 
2 
Figure 1.1 
1 r~ H~~ Nn Cl 
<'; I ~0,/ N"' 
EIHN H 
HO OH 
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Adenosine (I) and imidazopyridine based vasorelaxant (r) 
As a further example, conversion of indole A, a potentially novel antipsychotic agent, 
into pyrrolo-pyridine B resulted in a dramatic improvement in selectivity towards the 
desired dopamine 0 4 receptor: 18 
X 
A CH 
B N 
Figure 1.2 Indole and pyrrolo-pyridine based antipsychotic agents 
l.l.S (5,6] Pyridine Ring-Fused Synthesis 
As can be seen from above, pyridine ring-fused heterocycles are potentially invaluable 
scaffolds for drug discovery. However, their synthesis is often non-trivial and can be 
convoluted because they are often derived from pyridine, a compound frequently 
difficult to functionalise in a selective and high yielding manner. 19• 20 This is no more 
true than in the case of the synthesis of [5,6] pyridine ring fused heterocycle synthesis 
of the type shown in Figure 1.3, where there exists a variety of approaches to access 
fused-compounds. In light of this thesis reporting new approaches to the synthesis of 
fused-ring systems, the following section will highlight the most common methods for 
3 
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their synthesis, starting with imidazopyridines due to this motifs recurring nature in this 
thesis. 
Ccz ''y ' N X 
X, Y, Z = CH, NR, N, S, 0 
Figure 1.3 Possible pyridine ring-fused heterocycles 
Imidazopyridines are most commonly synthesised by the reaction of an ortho-
diaminopyridine precursor with a suitable electrophilic reagent/ 1 as shown in the 
scheme below: 
•cR = RCHO, 
RCOCI etc 
A--~ 
ll..A ,)---R N N 
Figure 1.4 General approach to imidazopyridine synthesis 
As well as the obvious challenges of forming the ortho-diaminopyridine intermediates, 
the annulation step often requires forcing conditions, such as high temperatures and the 
presence of an oxidising agent, as shown below in the following example, where 
imidazopyridine C was obtained via the condensation of 2,3-diamino-pyridine with 
benzaldehyde, in the presence of sulfur22 
Figure 1.5 
0 
Ph)J_._H , Sulfur 
165- 170 °C 
- H20,- H2S 
Cc}-0 
N H 
C,93% 
Phenyl-imidazopyridine synthesis via the condensation of pyridine-2,3-
diamine with benzaldehyde 
4 
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An interesting reaction reported, and one that illustrates the difficulty of synthesising 
(5,6] pyridine ring-fused structures, is the reaction of the following triamine with acetic 
anhydride: 23 
0 0 )loA_ 
----'"-----l .. 
AcOH, Reflux, 2 h 
Figure 1.6 
The formation of the benzimidazole fused ring, in excellent yield, rather than the 
pyridine ring-fused analogue, shows the ease of formation of the former compared with 
the latter. 
A slightly different approach to imidazopyridine synthesis is shown in figure 1.7:24•25 
R1 R2 
\...-:y._ 
0 ~'J ~NH2-~~~H~R~--~ 
N Cl POCI3, reflux 
R =Me, Ph, R1 = H, 3-0Me, 3-0H 
R2 = H, 4-0Me, 4-SMe 
Figure 1.7 
Reaction of 2-chloro-3-aminopyridine with a range of benzamides, in POCb, gave a 
series of tethered amidines, which in tum were cyclised by nucleophilic aromatic 
substitution of the carbon-chlorine bond to give the corresponding imidazopyridines, 
albeit in low yields. 
2-0xo (hydroxyl) and 2-thio (thioxy) substituted imidazopyridines are the most 
accessible compounds of this type and, like the majority of syntheses reported, proceed 
via an ortho-diaminopyridine precursor as discussed above:21 
5 
X 
HN4 
~NH 
tJ 
N 
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Figure 1.8 General approach to oxo- and thio-substituted imidazopyridines 
Pyrazolopyridines have received interest due not only to their structural similarity to 
indoles and imidazopyridines but also due to their proven biological activity, as 
exemplified in the following two lead compounds: 
" 
N~NH2 
F 0 cf.~ ;?' HN~ """ "" ~,N "' N N N N ~ H 
E ~ ,; D 
Figure 1.9 Pyrazolopyridine-based lead compounds 
A series of pyridine ring-fused heterocycles, exemplified by compound D, were shown 
to be potent glycogen synthase kinase-3 inhibitors,26 an enzyme thought to be involved 
in the regulation of several physiological processes, while compound E was shown to 
have a blood pressure lowering effect in rats.27 The synthesis of pyrazolopyridines has 
been achieved through a range of synthetic strategies28 including cycloaddition 
reactions,29 the thermal decomposition of vinyl azides,30 cyclisation of N-acyl-N-nitroso 
compounds,31 and the reaction of an ortho-chloro-cyanopyridine with hydrazine (Figure 
1.10).32 
Lei 
)L . .J 
el N 
PhB(OH)2 
Na2e03, 
DME, H20, 
EtOH, reflux 
Lei 
)L . .J 
Ph N 
60% 
Figure 1.10 
N2H4 .H20• 
EtOH, reflux 
59% 
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The synthesis of oxazolopyridines and thiazolopyridines can be achieved in an 
analogous manner to imidazopyridines, as shown below in the following examples of 
the formation of a bromo-substituted oxazolopyridine, an intermediate in the synthesis 
of a potential glycoprotein antagonist (Figure !.II )33 and the unsubstituted thiazolo[5,4-
c)pyridine (Figure 1.12).34 
BryyOH HO\___/\__ 
t_.,J.._ + f~ CN 
N NH2 0 
PPSE 
200 °C, 3 h 
----'--: .... 
Figure 1.11 
93% 
Reaction of 2-amino-5-bromo-pyridin-3-ol, obtained in 5 steps from furfural, with 4-
cyano-bemoic acid and in the presence of polyphosphoric acid trimethylsilyl ester 
(PPSE), a dehydrating agent, gave the corresponding oxazolopyridine in excellent yield. 
In the second example (Figure 1.12), once the desired heteroatoms have been positioned 
on the pyridine ring, cyclisation gave 2-methyl-thiazolo[5,4-c]pyridine, whilst 
subsequent hydrolysis and condensation with formic acid gave the parent heterocycle in 
poor yield. 
>!NH A i) nBuLi 
N~ 
l) ii) > 
rN}---s ~_/ 
s 's-{ 
s 
0 
28% 
CHa 
N=( ers H)lH &SH N2H4, EtOH ers 
"' 
RT, 20 h N N N 
25% 62% 
NaOH, 
EtOH 
36% 
0 0 j )l_ )l_ HCI04 
H3C 0 CH3 
62% 
Figure 1.12 Synthesis ofthiazolo[5,4-c)pyridine 
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The synthesis of triazolopyridines have been reviewed35 and, as with the other pyridine-
ring fused heterocycles involves various approaches, such as diazotization of ortho-
diaminopyridines36 and base induced pyridine annulation into a preformed triazole ring 
(Figure 1.13):37 
General approach to triazolopyridine synthesis 
HN-N 
Diazotize ~~ "" 'N 
.... t..J or 
Base-induced pyridine annulation 
e 
OEt 
N 
44% 
Figure 1.13 Examples oftriazolopyridine synthesis 
[C, X] centred [5,6] pyridine-ring fused heterocycles (where X = NH, NR, 0, S) have 
been reported in the literature and the synthesis of these compounds will be briefly 
outlined below. 
r 1_) 
tJX t:r 
N N 
~ [!__NJ-/ 
X= NH, NR, 0, S 
Figure 1.14 
Pyrrolopyridines (X = NH, NR) are generally synthesised vta the annulation of a 
suitable aminopyridine precursor to form the 5-membered pyrrole ring and are of 
interest as a potential bioisostere for indole. 38 
Furopyridines (X = 0) are most frequently formed either by annulation onto a 
preformed pyridine or oxazole ring and have attracted interest from both medicinal 
chemists, due to their potentially useful biological activity and from theoretical 
8 
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chemists, as a system containing both an electron deficient (pyridine) and rich (furan) 
ring.J9 
Thienopyridines (X = S) have been investigated as potential molecular switches and 
wires,'0 and as monomer units making up optoelectronic polymers.41 In both cases, the 
fused rings have been derived from suitably substituted thiophenes. 
1.1.6 Conclusions 
As can be seen from the examples given, there is no general approach to the synthesis of 
[5,6] pyridine-fused rings and, furthermore, little functionality remains once the desired 
annulation is achieved, rendering further derivatisation difficult. The following section 
on fluorine chemistry, after outlining some basic principles, will show how highly 
fluorinated heterocycles can be excellent scaffolds for functionalised heterocycle 
synthesis. 
1.2 Organofluorine Chemistry 
In light of the central concept of the work submitted in this thesis, that is of using highly 
fluorinated pyridines as building blocks for the synthesis of functionalised pyridine 
ring-fused heterocycles, the following section will introduce the area of organofluorine 
chemistry. After a brief introduction, the review will focus on the effect fluorine has 
upon inclusion into molecules in general and, more specifically, drug-like molecules; 
the synthetic aspect of C-F bond formation will be reviewed, followed by the synthesis 
and reactivity of pentafluoropyridine, a key starting material for the research herein, and 
finally a comprehensive review of literature over the last decade that details chemistry 
involving this compound. 
1.2.1 Background 
Organofluorine chemistry has undergone a sporadic but continual growth since Henri 
Moisson's isolation of fluorine in 1886, resulting in its ubiquitous status in several areas 
of chemistry and materials science, from drug design and the development of 
anaesthetics, to polymer science and liquid crystal display technology.42 The 
9 
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incorporation of one or more fluorine atoms into an orgamc molecule can have a 
profound effect on properties such as reactivity, polarity and physical properties. This is 
due to the unique characteristics covalently bound fluorine exhibits: 
• Fluorine is the most electronegative element (4.0 on the Pauling scale),43 and is 
far more electron withdrawing than carbon (2.5). The consequence of this is that 
a C-F bond is highly polarised. Carbanions can be stabilised by this effect, and 
surrounding groups' electronic environments are different to those in the 
hydrocarbon equivalent. 
• C-F bonds are the strongest single bonds to carbon. The consequence of this is 
the high thermal stability of some perfluorinated systems. 
• Though the Vander Waals radius of fluorine is inbetween that for hydrogen and 
hydroxyl, its steric requirement is more akin the former, thus allowing a 
hydrogen atom to be replaced by a fluorine atom with the minimal of disruption 
to steric requirement. 
• The electronic configuration: 
ls1 ls2, 2s2, 2p5 
Figure 1.15 Electronic configuration of hydrogen and fluorine 
Fluorine will preferentially leave as F·, as this completes the octet for the outer 
(second) shell. Hydrogen's preference is as W, though it can leave as H" 
(hydride ion) as this has a full shell. Also, the existence of three tightly bound 
non bonding electron pairs makes for electron pair repulsions that do not exist in 
hydrocarbon systems. 
Perfluorination, the replacement of all the hydrogens in a molecule by fluorine atoms, 
can have a pronounced effect on the physical and chemical properties that a molecule 
displays. Chemistry that is taken for granted in hydrocarbon systems is turned on its 
head when applied to the fluorocarbon equivalents, hence the regular use of the term 
10 
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"mirror-image chemistry" to describe some of the chemistry of these man-made species 
(fluorinated compounds rarely exist in nature).'4 Take aromatic substitution, for 
example. Under standard reaction conditions, aromatic hydrocarbons readily undergo 
electrophilic substitution (figure 1.16) but not nucleophilic substitution whereas, in 
fluoroaromatic compounds, nucleophilic substitution tends to occur due to the presence 
of highly electronegative fluorine atoms (figure 1.17): 
__ .,_ 
_.,_ 
Carbocation 
intermediate 
Figure 1.16 Electrophilic substitution of benzene 
F*l:'"" F I + 
F h F 
F 
Nuc _:~F-F*:c F+ F-F~F F h F 
F F 
Carbanion intermediate 
Figure 1.17 Nucleophilic aromatic substitution ofhexafluorobenzene 
1.2.2 Fluorine in Drugs 
Although the effects of incorporating fluorine atoms into drug-like molecules I drugs 
was first investigated more than fifty years ago in the pioneering work by Fried,45 it 
wasn't until the 1970s that this approach found a more common role in the drug 
discovery process. Indeed, nowadays, fluorinated molecules are often seen in research 
concerning the search for novel bioactive agents, whilst a recent review on the synthesis 
of fluorine-containing drug target molecules attests to their relevance and importance in 
the pharmaceutical industry.46 In the United States of America in 2002, nine of the 
thirty-one drugs approved by the Food and Drug Administration (FDA) contained one 
or more fluorine,47 while perusal of Forbes.com's list of the top ten selling drugs in 
America reveals four out of ten contain either one or more fluorine atoms or a 
trifluoromethyl group.48 The exchange of a functional group (e.g. hydroxyl, methyl), or 
hydrogen, with a fluorine atom can not only have an effect on the chemical properties of 
11 
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that molecule but it can limit its metabolism, increase biological activity against a 
desired target and increase cell penetration.49• 50 
5-Fiuorouracil 
(chemotherapy drug) 
0 
FroCOOH ~6NHMe I"' I  /'N ~N 
F3C :I H~~ ~ 
Prozac 
(Antidepressant) 
Ciprofloxacin 
(Antibiotic) 
Figure 1.18 Examples ofFluoine-containing drugs 
In the case of ciprofloxacin (figure 1.18), the effect of the presence of fluorine in the C-
6 position of the quinolone ring has been investigated, 51 and has been shown to increase 
binding affinity, reduce plasma protein binding leading to a higher bioavailability and 
increase cell penetration. 
1.2.3 Fluorination Methods 
Of course, to access these unnatural halogenated species, carbon-fluorine bonds must be 
made at some point in the synthetic strategy of a target molecule. The following section 
will outline some useful approaches to this. 
There are two distinct types of fluorination; selective and perfluorination. Selective 
fluorination is the introduction of one or two fluorine atoms into a molecule e.g. 
Q ~ F2 Formic acid F 
CH3 CH3 
50% 
Figure 1.19 
Fluorine gas, carried in a stream of inert nitrogen gas, is made susceptible to attack by a 
nucleophile through interaction with an acid and is hence an electrophilic fluorinating 
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agent. Nucleophilic fluorinating agents ("F"), such as potassium fluoride52 and 
tetramethylammonium fluoride (TMAF),53 may be employed to displace either another 
halogen (Halex reaction) or a suitable leaving group, such as N02. Alternatively, a Balz-
Schiemann reaction involving HBF4 or pyridine-HF as a source of fluoride ion is 
possible: 54 
5 5 Me3NF ~ N02 DMSO F 
70% 
UNH2 UF NaN02 ~ 
..< pyridine-HF ..< N N 
93% 
Figure 1.20 Fluorodenitration of 1,3-dinitrobenzene by TMAF (top) and pyridine-HF 
mediated Balz-Schiemann reaction (bottom) 
The highly hygroscopic nature of fluoride, along with its low solubility and reactivity, 
limits this class of fluorination to reaction with highly reactive systems e.g. reaction of 
potassium fluoride with a perchlorinated ring, whilst the metal fluoride must be 
rigorously dry to maximise the nucleophilicity of fluoride ion55 
Alternatively, fluorine can be introduced to a molecule by reaction of a suitable 
precursor with a fluorinated building block, for example in the following formation of a 
pyrimidine intermediate in the synthesis of a novel fluoroquinolone: 56 
N,.__ 
" 
NH2.HCI 
HN 
'-':: 
F i)HCI/ EtOH F 
~ ii)NH3 
F F 
90% 
Figure 1.21 
ONa 
Fx 
EtO 0 
MeOH, NEt3 
reflux 
F~N JL.~ HO N 
50% 
F 
F 
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Amidination of the benzyl nitrile gave a difluorinated system, which was condensed 
with the sodium salt of an a, {:3 unsaturated ester to give the desired trifluorinated 
pyrimidine. 
Perfluorination is the replacement of all the hydrogen atoms in a molecule with fluorine 
atoms, and will be focused on in this review, as the molecules resulting from this 
process are the ones that are of relevance to this thesis. Perfluorination using cobalt 
trifluoride is a process run at plant scale. 57 The reagent is generated by passing fluorine 
over cobalt difluoride in a reactor vessel and reacted with a hydrocarbon species at high 
temperatures to give fluorination as indicated below: 
co 
_ _c._ __.,.. 
280-320 °C 
+ CoF2 + HF 
Figure 1.22 
The drawback to this method is that unsaturated systems become saturated, though in 
the case of aromatic compounds, defluorination can restore unsaturation,58 e.g. 
Iron, 500 °C FWF."" ~ F 
I """ ---" F F 
F F 
52% 
Figure 1.23 
Passage of the vaporised fluorocarbon, in a stream of nitrogen, over iron gauze brings 
aromaticity to the fluorocarbon, whilst oxidising the iron to iron fluoride. Subsequent 
passage of hydrogen gas reduces the metal fluoride back to elemental iron. 
Another common perfluorination technique is the reaction of a perchlorinated ring with 
potassium fluoride via the so called "Halex reaction", as shown in the following 
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fluorinations of the monocyclic heterocycles tetrachloro-pyrazine and -pyrimidine,59 
and perchloroquinoline:60 
Cl)(:(l 
Cl N Cl 
Cl 
CI0N 
CI)LNJ___CI 
Cl Cl 
CIW"" Cl 
I h "' Cl N Cl 
Cl 
KF, sealed tube.,. 
340 °C 
KF, sealed tube 
340 °C 
KF, autoclave 
480 °C 
F)(:( 
F N F 
70% 
15% 
71% 
Figure 1.24 Representative reactions of perchloroheterocycles with potassium fluoride 
to give the corresponding perfluorinated systems 
1.3 Pentafluoropyridine 
In light of its central importance to this thesis, the following section will detail the 
synthesis, properties and reactivities of pentafluoropyridine. 
1.3.1 Synthesis 
Pentafluoropyridine was first prepared in low overall yield by electrochemical 
fluorination of pyridine, followed by defluorination61 • 62 
~ FJxF 0 F F Fe F N F I "' N F N F F 1 F 
F 
8% 26% 
Figure 1.25 
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A subsequent synthesis, involving the reaction of pentachloropyridine with potassium 
fluoride, in an autoclave at high temperature, improved the above yield and provided a 
more convenient route for the synthesis of pentafluoropyridine.63 
Cl 
CI~CI 
Y-.. ~ Cl N Cl 
1.3.2 Reactivity 
KF, 480 °C 
--'-----~ 
1 d 
" F~CI 
_J .. ~ F N F 
7.7% 
Figure 1.26 
+ 
F~F 
_J~ 
F N F 
68.5% 
Pyridine is not very reactive towards electrophilic aromatic substitution, but will readily 
undergo nucleophilic aromatic substitution. In the perfluorinated analogue, the electron-
withdrawing effect of the fluorine atoms makes attack by an electrophile even more 
unlikely. However, it readily undergoes nucleophilic substitution para to the ring 
nitrogen as can be seen clearly in the following reaction with hydrazine hydrate giving 
clean conversion to the corresponding 4-substituted-tetrafluoropyridine:64 
Dioxan 
-.,---~ ... 
reflux, 2 h 
Figure 1.27 
70% 
This remarkable reactivity and selectivity can be explained in terms of whether or not 
the negative charge developed in the Meisenheimer complex can be delocalised over the 
electronegative pyridine nitrogen. 
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F~F F~F F~F X .. -k-F ____ .,_ Y-~-k-F _.,_ JL..~ 
F N Nuc F ~ Nuc F N Nuc 
FXit:= F Xi" F ~!:= F r- F r- F 
_ "" N~_.,_ " _ Nuc_,._.,_ 1 -"" Nuc 
FNF FNF FNF 
Figure 1.28 
The activating influence of the nitrogen in pentafluoropyridine has been determined and 
found to activate the positions in the order; para (2.3x I 0\ ortho (6.2x 104), and meta 
(8.5x102),65 and is the main factor in dictating the site of attack by a nucleophile. Para 
attack gives a carbanion intermediate with the negative charge localised on the 
electronegative nitrogen. This intermediate is also free of I~ repulsions, and is thus 
highly favoured. Ortho attack gives an intermediate with the negative charge localised 
on C-3, and thus I~ repulsion is experienced. Although resonance gives a structure with 
the charge on the nitrogen, the initial electron pair repulsion makes attack at this 
position less energetically favourable. Meta attack gives an intermediate that cannot 
resonate to give a structure that has the negative charge delocalised on the nitrogen, thus 
attack at this position is heavily deactivated. 
Initial state effects can further explain the orientation of attack. The order of the 
activating effect of fluorine is: 
F ortho > F meta > > F para 
A fluorine para to the site of attack is actually slightly deactivating since, although it is 
withdrawing electron density through induction, it is donating electron density back into 
the ring by resonance. The electronegative nitrogen atom also activates the ring to 
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attack. Combining these effects, it can be seen that the carbon para to the ring nitrogen, 
C-4, is most susceptible to attack followed by the 2- and 6-positions: 
F~F N~.:L 
F N F 
1 ortho N activating 
1 ortho F activating 
2 meta F activating 
1 para F destabilising 
1 para N activating 
2 ortho F activating 
2 meta F activating 
Figure 1.29 Initial state effects dictating site of attack 
Early examples of reactions of pentafluoropyridine to g1ve substituted 
perfluoropyridines include the following mono- di- and tri-substituted systems.64• 66 
OMe 
NMe2 F~F OMe F'/~> }_,~ F~F 
}_, .~ F N F JL .. ~ 
Me2N N"" F ti) MeO N"" F 
NMe2 ~ XX" A) OMe 
FnF ";;1 F '.::: F FnF I .-';'!!L I I ~ ...-:: --nn-- .....:: 
F N F F N F MeO N OMe 
;JV v~ i' 
Fn: F FnF F~F 
I "" I "" Jl.~ F N F F N F F N F 
Reagents and conditions: i) NaOMe, MeOH, reflux, 3 h, 57 %; ii) 2.2 eq NaOMe, MeOH; iii) excess 
NaOMe, MeOH, reflux, 6 h, 74 %; iv) NH3 , ethanol, heat, 8 h, 81 %; v) AILiH., reflux, 4 h, 74 %; vi) 
PhLi, RT, I h, 26 %; vii) aq Me2NH, RT, 51 %; viii) xs aq Me2NH, ethanol, heat, 20 h. 
Figure 1.30 Early examples of reactions of pentafluoropyridine with nucleophiles 
The orientation of monosubstituted perfluoropyridines was established by examination 
of the 19F NMR spectra, which showed that the system had two-fold symmetry, 
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meaning the substituent must be in the 4-position. Substitution by a second equivalent 
of nucleophile was found to be possible under more forcing conditions, occurring 
exclusively at the 2-position, and resulted in three peaks in the 19F NMR, whilst the 
trisubstituted 3,5-difluoro-2,4,6-trimethoxypyridine was accessed through refluxing 
pentafluoropyridine with an excess of methanolic sodium methoxide. 
A large amount of work involving substitution in pentafluoropyridine has subsequently 
been undertaken in light of this excellent reactivity and selectivity and because of the 
ability to access compounds difficult to synthesise by other means.67• 68 
1.4 Pentafluoropyridine: Its Uses in Synthetic Organic Chemistry Over the 
Last Ten Years 
The following section will highlight research carried out involving the chemistry of 
pentafluoropyridine, with particular relevance to work in this thesis, since it was last 
reviewed by Brooke.67 Advances in C-F activation in pentafluoropyridine by metal 
complexes69• 70 and reactions of 2,4,6-tribromo-3-5-difluoropyridine71 are outside the 
scope of this review and will not be discussed here. Reactions with mononucleophiles 
will be discussed first, followed by binucleophiles. Finally, there will be a section 
detailing the synthesis of partially fluorinated pyridines from pentafluoropyridine and 
other halogenated heterocycles as it could be argued that many of the nucleophilic 
displacement reactions discussed in this thesis could be adapted to reaction with tetra-, 
tri-, and difluorinated pyridines to give partially fluorinated derivatives. This could 
provide a useful technique in probing the effects of having fluorine atoms around the 
pyridine motif on physical properties and biological activities. 
1.4.1 Reactions with Mononucleophiles 
Scaffolds for Drug Discovery 
There are few examples of the employment of pentafluoropyridine as a scaffold for drug 
discovery. The factors VIla I TF complex and X a are proteins known to be involved in 
the blood coagulation cascade 72 and as such are validated targets in the search for novel 
antithrombotic drugs.73 ' 74 Having established a series of 2,6-diphenoxypyridines, 
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including several 3,5-difluoro,4-methyl-diaryloxypyridines derived from 4-methyl-
tetrafluoropyridine, to be modest inhibitors of factor Xa, medicinal chemists synthesised 
a selection of 3,5-difluoro-triaryloxypyridines from pentafluoropyridine.75 The 2,4,6-
substitution pattern was obtained through sequential nucleophilic substitution by 
substituted phenols in typically high yields, whilst multiple additions could often be 
accomplished in a single reaction vessel. 
OH CN R 
!;: 6 ~0 ¢1 0 CN 0 F~C( R- 0 FnF OH ¢1Ft.:( OBn I ~ ~ I ~ ~ I ~ F N F Cs2C03, MeCN F N F Cs2C03, MeCN 0 N F 
RT, 12 h 
100% 35 °C, 15 h OBn 86% 
Figure 1.31 Synthesis of3,5-difluorotriaryloxypyridines from pentafluoropyridine 
(yields given for R = 2-0Me, 4-C02Et) 
Surprisingly high reactivity is shown by the fluoropyridine at each stage of substitution, 
despite the relatively poor nucleophilicities of the corresponding phenols. 
In a similar vein and using compounds from the senes of 2,6-diphenoxypyridines 
mentioned above as the basis for creating a more potent inhibitor, chemists synthesised 
a series of 4-amino-3,5-difluoro-2,6-diphenoxypyridines, agam from 
pentafluoropyridine.76 Derivatisation of the hydroxybenzoic acid side chain, to give 
compound G, led to an increase in potency whilst limited optimisation of substituents 
located at the 4-position of the core pyridine led to the potent FVIIa!TF inhibitor, H. 
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F R = H IC50 = 1200 nM 
G R = NMe2 IC50 = 190 nM 
H R= H ICso = 86 nM 
Figure 1.32 Lead inhibitors of Fila /TF 
To enhance the binding affinity of this series of compounds, a small library based on H 
. I 1 2 (14 compounds, R =Me, 'Pr, Bu, Ph, NR R, OR) was synthesised: 
F~/F 
J__;L 
F N F NEt3, DCM 
RT 
t: 
~NH 
F~F 
~ .. A F N F 
i) Raney Ni. 
H2, NEt3, MeOH 
ii) LiOH, H20. 
dioxane, RT 
Cs2C03, 
DMSO, 80°C 
Figure 1.33 Synthesis of 3,5-difluoro-4-amino-2,6-diaryloxypyridines from 
pentafluoropyridine 
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Compounds containing mono- or dialkylated ammo groups at the 5-position (R = 
NR1R2) gave the most improved potency, with 2- to 5-fold increases over lead 
compound H. 
The same group of workers undertook a similar investigation in which a N(Pr)2 group 
was located at the 4-position of the pyridine.77 
It is thought that inhibition of the p38 kinase protein could treat the underlying cause of 
chronic inflammatory diseases and stop its progression and it is in this context that 
chemists in Switzerland identified the motif shown in Figure 1.34 to give potentially 
high affinity binding to the active site.78 
Figure 1.34 Pyridine motif identified as potetntial kinase inhibitor 
A synthesis starting from pentafluoropyridine was developed that allowed variation of 
ring A: 
X = NH, NCH(OEt)2 
O,S 
nBuli, -78 °C, THF 
------c ... 
F,~_.,-F 
JL .. :l F N F 
25% aq NH3 
170 °C, autoclave 
54-78% 
Figure 1.35 Difluoropyridine synthesis via autoclave reaction 
18-34 % 
Methodology for the preparation of a diverse set of aryl substituted pyridinylimidazoles 
was also developed: 
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Reagents and conditions: i) nBuLi, THF, -40 'C, 10 min, pentafluoropyridine, 74 %; ii) Br2, AcOH, 
AcONa, 15 min, RT, 86 %; iii) 4-trimethylstannylpyridine, PdC12(PPh3), toluene, reflux, 12 h, 46 %; iv) 
Stille or Suzuki coupling; v) EtOH/conc HCI, RT, Ih, 78-85 %; vi) 25% aq NH 3, 170 'C, autoclave, 12 
h, 30-36% 
Figure 1.36 
Deprotonation at the 2-position of the SEM-protected imidazole gave an anion which 
reacted with pentafluoropyridine to give the expected 4-substituted pyridine. 
Bromination at the 4- and 5-positions of the imidazole was followed by regioselective 
Stille reaction to yield a pyridinylimidazole whilst subsequent Suzuki or Stille coupling 
at the remaining carbon-bromine bond was followed by deprotection of the imidazole. 
Finally, diarnination at the 2- and 6- position of the tetrafluoropyridine gave the desired 
3,5-difluoropyridine. 
Of all the antibacterial agents, the fluoroquinolones have proven to be the most 
successful class both economically and clinicalli9 and, as such, 2-pyridones, as 
bioisosteres of quinolones, are a valuable source of potential new therapeutic agents. 
The following tricyclic 2-pyridone was synthesised using pentafluoropyridine as a 
template and displacing all but one fluorine: 80 
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F~F F~F JL.'l Na01~u )l,}_ 
F N F F N F 
70% 
o1Bu i)Li~OTBDMS HO)J):"'> F 
----------~ I 
ii) F- N"" F 
63% 
i) NH2NH2 I 
ii)NaOH, 02 'f 
o1su 0 1Bu 0 1Bu 
"'> F LOA rO~F NaH HO-...., F~F 
I ... )J,,) - )J,,) 
EtO 0 
I i) DBU y ii) TFA 
EtO 
60% 
0 
F 
EtOYOEt 9~:, 82 ~ 
EtO 
Cl 
F 
POCI3/ DMF 
62% 
Figure 1.37 2-Pyridone synthesis 
The high reactivity and selectivity of pentafluoropyridine is used to great effect here 
with tetrasubstitution (4-, 2-, 6-, and 3- respectively) proceeding in high yields. 
Formation of Glycosyl Donors 
The electron deficient nature of pentafluoropyridine has seen its use as a leaving group 
in the development of glycosylation strategies.81 
OR 
1:' R040R 0 
FnF RO OH 
"" 0 
I "' Base, solvent 
F N F 
4
0R R~~QO OR' 
RO O R'OH ~O~ 
RO 0 · OK Catalyst + F~J F F~F 
F Jl .. ~ F N F 
Figure 1.38 Glycosylation via fluoropyridine-based glycosyl donor strategy 
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Nucleophilic substitution at the 4-position ofpentafluoropyridine with a protected sugar 
gives the glycosyl donor intermediate. Reaction of this species with an alcohol (i.e. 
another protected sugar), in the presence of a Lewis acid, gives the coupled product 
(disaccharide) and 2,3,5,6-tetrafluoro-pyridin-4-ol. 
This concept has been developed through the employment of derivatised 
fluoropyridines, with the aim of introducing variation into the ability of the leaving 
group:82 
F~F 
Sugar...,0AN~F 
ROH 
Catalyst.,_ 
ROH 
+ 
Catalyst,. Sugar...,
0
,R + 
Figure 1.39 
F~F 
)t .. ~ 
HO N F 
F~F 
A:l Y N OH 
The normally electron-rich nature of nucleophilic species means that the introduction of 
groups X and Y will lead to a less electron-deficient pyridine ring hence requiring, in 
principle, a stronger Lewis acid to achieve the desired coupled product in the 
glycosylation step. 
Functionalised, Fluorinated Pyridine Synthesis 
The synthesis,83 and some representative nucleophilic aromatic substitutions,84 of 
perfluoro-(4-isopropylpyridine), a compound that has proven to be highly reactive and 
regioselective to nucleophilic aromatic substitution,84"89 are shown in Figure 1.40: 
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CF(CF3)2 
F~F 
JL.~ MeO N OMe 
CF(CF3)2 
F~OMe 
)L~ 
MeO N OMe 
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Reagents and conditions: i) 1 eq KOH, 'BuOH, reflux, 24 h, 61 %; ii) 1 eq NaOMe, MeOH, reflux, 24 h, 
69 %; iii) 2.4 eq NaOMe, MeOH, reflux, 24 h, 66 %; iv) 11 eq NaOMe, MeOH, reflux, 24 h, 75 %; v) 1 
eq CH30CH20Na, THF, reflux, 24 h, 38 %; 4 eq CH30CH20Na, THF, reflux, 24 h, 76 %. 
Figure 1.40 Synthesis and reactions ofperfluoro-(4-isopropylpyridine) 
Reaction ofTDAE, a very strong electron donor, with CF2=CFCF3 gives a fluoride salt, 
F-(TDAEt-CF=CFCF3, which in tum reacts with a second equivalent of the 
fluoroalkene to give (CF3)2CF. This can then attack the electron-deficient 
fluoropyridine ring to give perfluoro-4-isopropylpyridine along with fluoride ion, which 
can propagate carbanion formation and hence the formation of the 4-substituted 
pyridine. As can be seen from the diagram, nucleophilic aromatic substitution of this 
perfluorinated heterocycle proceeds regioselectively, and in the order 2-, 6- then finally, 
due to the highly electron-withdrawing 4-substituent, at the usually inaccessible 3-
position of the fluoropyridine. 
Research into the synthesis of high energy compounds has involved the strategic 
placement of electron withdrawing N02 groups onto the pyridine ring in order to 
activate to nucleophilic aromatic substitution, as shown in Figure 1.4 L Reduction of 
pentafluoropyridine to 3,5-difluoropyridine, followed by formation of the N-oxide and 
26 
Chapter I 
then trinitration should give a pyridine highly reactive to nucleophilic attack in the 3-
and 5-positions by, for example amines, to give heterocycles high in nitrogen content 
and hence potential explosives: 
F N02 N02 FXxF FUF FWF Fi:(F Nuc1UNuc2 I _,.. I _,_ I _,.. I _,.. I~-
.....-:: .....-:: @.....-:: ~ ~ ..... 
F N F N N 02N N N02 02N N N02 
I I I 
0 0 0 
e e e 
Figure 1.41 Approach to the synthesis of high energy pyridines 
Formation of the difluoropyridine was achieved through bromination with HBr and 
A1Br3 followed by hydrogenation: 
F~F 
J_ __ ;L 
F N F 
HBr, AIBr3 
autoclav~ 
150 °C, 84 h 
Br 
F~F 
~ .. ~ Br N Br 
91% 
FUF Pd/C, H~ I 
NE13, DCM, RT N 
63% 
Figure 1.42 Synthesis of 3,5-difluoropyridine 
Formation of the N-oxide was achieved with ethaneperoxoic acid and, whilst reaction 
with a mixture of fuming sulphuric and nitric acids only yielded a mixture of 
mononitrated pyridines, their reactivity towards nucleophilic attack was shown by 
reaction with ammonia to give the mixture of products shown in Figure 1.43: 
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F~F 
LJ N 
F~F 
~(j)J 
t;J 
0 
e 
71% 
N02 N02 
F'GiF H2N~NH2 I e~ I e~ 
N N 
6 6 
e e 
32% NH N02 
+ 
Me6N.,_ H2N~F 
e~ 
F'G.XF 
t;J 
0 
I e~ e 
I';J N02 F'G.XNH2 0 I e~ e t;J N02 3% 0 
e 
Figure 1.43 Derivatisation of 3,5-difluoropyridine 
1.4.2 Reaction with Binucleophiles 
Pyridine-Fused Ring Synthesis 
57% 
15% 
8% 
Recent work has focused on the reaction of pentafluoropyridine with binucleophilic 
species to give fluoropyridine fused-ring systems. Once formed, these structures should 
still be reactive to further nucleophilic attack, hence making further elaboration of the 
fluoropyridine possible. This approach is illustrated conceptually in Figure 1.44: 
F N~ F~F Wuc2 F~Nuc2 i)Nuc3 }__)_ }_ ;l ii)Nuc4 
F N F F N F 
Figure 1.44 Approach to pyridine ring-fused heterocycle synthesis from 
pentafluoropyridine 
[6,6) Pyridine-Fused Ring Formation 
Reaction with a selection of diamine nucleophiles gave a series oftetrahydropyrido[3,4-
b ]pyrazines. Further displacement of fluorine from these scaffolds was shown to be 
possible:14 
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f 
RNI 
RNl NaOMe RNl H HN 
Ft.:( 'R FnNH MeOH FnNH I , .... I , ,... I 
F N F NaHC03, F N F reflux, MeO N' F 
MeCN, 2d 
reflux R % R=Me 64% 
R = Me, ;Pr, Bn Me 97 76% ipr 26 
Bn 33 
Figure 1.45 
An alternative strategy is to functionalise pentafluoropyridine first at the 4-position and 
then form a fused ring at the 2- and 3-position: 
F~F 
J___;l 
F N F 
X= H, Br, CN, 
S02Ph, N02 etc 
Figure 1.46 
This strategy has proven effective where X = H, Br, CN, N02,9° CF(CF3)287 and 
S02Ph91 • In this last case, pentafluoropyridine was reacted with the sodium salt of 
phenylsulfinic acid to give the 4-substituted pyridine whilst subsequent reaction with a 
range of diamines led to a series oftetrahydropyrido-[2,3-b )-pyrazine scaffolds. 
NaHC03 
MeCN, reflux 
Figure 1.47 
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Diamine 
H 
/N~N/ 
H 
Products 
Ph02S H F~N Ph JL'l X 34% 
F N ~ Ph 
1.3 : 1 ratio 
85% 
Ph02S I F~~ ~ N) JL.~ 65% 
F N N 
I 
Figure 1.48 
Chapter I 
The 4-S02Ph group is electron-withdrawing to such an extent that a percentage of initial 
attack on the pyridine occurs at the 3-position, which gives rise to the mixture of 
products observed when reacted with unsymmetrical binucleophiles. 
Further nucleophilic aromatic substitution of these scaffolds (R1 and R2 = H, Me) with 
representative oxygen, nitrogen and sulfur centred nucleophiles gave differing results. 
Hard nucleophiles (NaOMe, KOPh) gave inseparable mixtures arising from substitution 
of 4-S02Ph and 3-F whereas reaction with softer nucleophiles (LiNEt2, NaSPh) gave 
substitution of the 4-S02Ph group. 
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The synthesis of the tricyclic 2-pyridone80 discussed in Section 1.4.1 includes the 
interesting annulation to give a pyran ring at the 2- and 3-position of the fluoropyridine 
template through the formation and subsequent nucleophilic aromatic substitution of a 
tethered alkoxide ion. 
NaH 
_,.. 
90% 
Figure 1.49 [6,6] pyridine fused-ring annulation 
Despite the relatively electron-rich nature of the uncyclised pyridine (I ortho 0 1Bu, I 
meta fluorine to site of attack) the cyclisation proceeds in excellent yield. The removal 
of the slightly deactivating fluorine para to the site of attack probably has some bearing 
on the effectiveness of this ring formation. 
[5,6] Pyridine Ring-Fused Formation 
In light of research showing improved biological activity upon the replacement of a ring 
nitrogen in ribavirin, a broard spectrum antiviral agent, with a CF group,92 Paul Coe et 
a/ investigated extending this idea to replacing a pyrimidine nitrogen of purine, 
probably the most ubiquitous of all biologically active molecules, to give a fluoro-
imidazopyridine. After initial failed attempts focused around forming a suitable ortho-
diaminopyridine from 3-chlorotetrafluoropyridine with which the imidazole ring could 
then be formed,93 the Birmingham group reacted pentafluoropyridine with the 
binucleophilic species guanidine, urea and thiourea in an attempt to create a [5,6] 
pyridine ring-fused bicycle which could then yield the desired fluoro deazapurineY4 
Figure 1.50 shows this approach schematically: 
X 
HN-{ HN\\ HN\\ 
FnNH .. _XH" ~'(~,;N 0 N I _,.. _Jt .. ~ cf NaH F N F F N-"' F N-"' 
X = 0, S, NH Purine 
Figure 1.50 Approach to fluoroimidazopyridine synthesis 
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However, in practice only monosubstitution at the 4-position ofpentafluoropyridine was 
achieved in the reaction with guanidine, whilst the reactions with urea and thiourea 
yielded bis-pyridyl compounds: 
64% 
F~~ 
Solvent E.g. 
DMSO,NMP, 
sulpholane, DMSO 
------· Base E.g. NaH, 
NEt3, 80- 200 °C 
NH2 
F~F 
JL.~ F N F 
xVF F~/ 
JL .. ~ 
X = NH (Urea), 93 % 
= S (thiourea), 71 % 
F N F 
Figure 1.51 
Attempts to cyclise the 4-pyridyl guanidine through the use of polar solvents, base and 
high temperatures only gave 4-amino-tetrafluoropyridine. Formation of the unexpected 
bis-pyridyl compounds was explained through the following base-induced mechanism: 
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e 
s 
~F~F 
)L_~ 
F N F 
N)yF 
~vNH fi:~F 
_)L __ ~ 
F N F 
N)yF 
~¥s fi:~F 
_)L __ ~ 
F N F 
Figure 1.52 Base-induced decomposition pathway 
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Interestingly, the fluoro-imidazopyridine target molecule was reported independently in 
the same year95 Also in pursuit of novel antiviral agents, a seven step synthetic route 
was taken, starting from 3-chlorotetrafluoropyridine via the formation and subsequent 
condensation of 3,4-diamino-2,5,6-trifluoropyridine with diethoxymethyl acetate to give 
the pyridine-fused heterocycle in a 24% overall yield. 
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Figure 1.53 Synthesis of 4,6, 7-trifluoro-imidazo[ 4,5-c ]pyridine from 3-chloro-
tetrafluoropyridine 
Chambers et al, through the study of fluoride ion induced polymerisation of perfluoro-
alkenes and -alkynes, reported the formation of the following fluorinated [5,6] ring-
fused pyridine:96 
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Figure 1.54 
CsF-induced oligomerisation of hexafluorobutadiene gives a series of carbanions whjch 
were trapped by pentafluoropyridine to give a number of simple products along with 
hydrogen terminated oligomer. Formation of K proceeds via the fluoride induced 
cyclisation ofl and J. 
Macrocycle Synthesis 
Appropriate use of 4-substituted polyfluoropyridine derivatives have been shown to 
react with binucleophilic compounds to form various novel macrocycles.89• 97• 98 The 
general approach to their synthesis and an example is given below: 
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Desilylation of the ethane-diol by caesium fluoride gives the activated binucleophile 
which then attacks two equivalents of the tetrafluoropyridine, at the most activated 2-
position, to give dimer L. The reason why the tethered nucleophile does not attack at the 
3-position (in both steps) to form a 6-membered ring is also due to the deactivated 
nature of this site to nucleophilic attack and the high dilution conditions employed. 
1.4.3 Synthesis of Partially Halogenated Pyridines 
Although the following research carried out involved perhalogenated pyridines other 
than pentafluoropyridine (though it is employed), it is worth incorporating due to the 
possibility of these partially fluorinated pyridines themselves being of use as scaffolds 
for functionalised pyridine synthesis. 
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Schlosser and co-workers have set about synthesising all three tetrafluoropyridines , all 
six trifluoropyridines and five non-commercially available difluoropyridines through a 
combination of site-selective defluorinations and fluorinations99 Loss of fluorine was 
achieved by reduction with metals or complex hydrides; 
FnF 
Zn powder 
F:rr:::( 
Proceeds through SET 
aq NH3 
ArF ~ ArF .:.J;.. Ar ~;._ Ar !:!_:. ArH I "" 0 °C, 6 h I "" F N F F N F e. e 
90% 
" 
Fi:(l 
NaBH4 
FnCI 
I "" EIQI:J .. I "' 
Nucleophilic aromatic substitution at most 
0 °C, 1 h activated position by H-
F N F F N F 
92% 
" 
Fn FnCI 
Pd I C 
I "' 
HCOONH4 
I " TransmetalfaUon of the more labile C-CI 
F N F Octanol, RT F N F (C-F too strong) 
6h 89% 
Figure 1.57 Defluorination Strategies 
Alternatively, displacement of fluoride by hydrazine, followed by dehydrogenation-
dediazotation when treated with cupric sulphate, or dehydrochlorination-dediazotation 
when heated with sodium hydroxide solution, gave access to 3-chloro-2,5-
difluoropyridine and 2,5-difluoropyridine respectively: 
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Introduction of fluorine into the pyridine ring was accomplished by insertion of a 
chlorine or bromine, followed by a Hal ex reaction. 
F~F t~ nBuli., 
N F 
F~F tJ nBuli., 
N 
Li 
F~F 
t~ N F 
Li 
F~F 
tJ N 
-=B:..rz'--1.,~ F~F _M.,_ 
N F 
78 o/o 
F....,~_...F 
t.;L 
N F 
70 o/o 
F'(r: F . Fn~ F I __1SE..,. I 
/. _.., 
N N 
73 o/o 51% 
Figure 1.59 
These reactions also illustrate the potential for tuning functionalised fluoropyridines e.g. 
a suitable perhalogenated pyridine may be reacted with nucleophiles and then 
dehalogenated in various positions to give a series of products. 
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1.5 Conclusions 
It has been shown that the modem approach to "lead" generation in the drug discovery 
is often via relatively small, focused libraries of compounds often based around a 
heterocyclic core. Halogenated heterocycles, in particular perfluorinated systems, can be 
excellent scaffolds for the synthesis of functionalised heterocycles in short, efficient 
routes. 
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Chapter 2 
[5,6] Pyridine Ring-Fused Heterocycle Synthesis from 
Pen tafl uoropyri dine 
2.1 Introduction 
As discussed in Chapter 1, pyridine ring-fused heterocycles are an important source of 
biologically relevant compounds and have been made through various methods, often 
involving building the fused ring by attaching functionality around pyridine, a 
compound that is difficult to derivatise in a quick and flexible manner. Our approach to 
the synthesis of functionalised heteroaromatic systems is through the sequential 
nucleophilic substitution of highly fluorinated pyridines with suitable nucleophilic or 
binucleophilic species (see Section 1.4.2) and this has been shown to be successful for 
the synthesis of several [6,6] and [6,7] pyridine-fused heterocycles. This chapter will 
detail the reaction of pentafluoropyridine with various binucleophiles, with the aim of 
synthesising analogous [5,6] systems by a short, simple and flexible strategy. The 
resulting heterocycle should still be reactive to further nucleophilic aromatic 
substitution, due to the presence of three remaining fluorine atoms, thus opening up the 
possibility for further elaboration of the fluoropyridine core scaffold. A general scheme 
outlining this approach is shown below: 
Base, 
Polar solvent 
X= Y = N (amidines) 
X= 0, S; Y = N (amides I thioamides) 
X= O; Y = C (1 ,3 dicarbonyls) 
R 
x--{ FnY I"' 
F N"" F 
Further 
Reactions? 
Figure 2.1 Approach to pyridine-fused heterocycle synthesis 
We anticipated that the reactions should occur under basic conditions, to activate the 
binucleophile and quench the hydrogen fluoride byproduct and in a polar solvent to 
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stabilise the charged transition state, whilst high dilution would be employed to 
minimise intermolecular attack of a tethered binucleophile, though the desired 
intramolecular condensation is en tropically favoured. 
Reaction of pentafluoropyridine with a 1,3 binucleophile to give a [5,6] pyridine-fused 
ring is limited to only the two following examples, namely Chambers' et al. 's fluoride 
induced ring closure (See Section 1.4.2), though this was only formed as a very minor 
product, and the following single example of a condensation of a fluorinated 
heterocycle with a cyclic enamine to give the following tetrahydrocarboline in moderate 
yield: 1 
FnF~ F 
I + 
/. 
F N F 
neat, 
reflux 
24 h 
Figure 2.2 
F 
F 
61% 
Coe et al. 's attempted condensation of pentafluoropyridine with guanidine, urea and 
thiourea (see Section 1.4.2) is probably the most relevant point of reference to the work 
carried out within this thesis on fused ring synthesis from pentafluoropyridine. 
Although each binucleophile was reactive enough to attack the 4-position of 
pentafluoropyridine, the resulting compounds either remained inert to cyclisation 
attempts or followed an undesired decomposition pathway. 
Formally replacing an amino group of guanidine with either a methyl or aryl group 
(making the system more nucleophilic) allowed a study of condensation reactions 
between pentafluoropyridine and a range of ami dines. 
2.2 Reaction of Pentafluoropyridine with N, N-Unsubstituted Amidines 
Commercially available benzamidine hydrochloride (R = Ph) and acetamidine 
hydrochloride (R = Me) were chosen as suitable N, N-centred 1,3 binucleophiles for 
reaction with pentafluoropyridine. DMF was initially employed as the polar solvent to 
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dissolve the relatively insoluble amidine salts whilst an excess of inorganic base was 
added to neutralise any acidic byproducts. 
Accordingly, stilling at room temperature gave two major new resonances by 19F NMR 
of the reaction mixture after 20 h, indicative of the formation of symmetrical 4-
substituted pyridines. Extraction followed by recrystallisation of the organic product 
from hexane gave the desired 4-aminido-tetrafluoropyridines in moderate yields (R = 
Ph, 61 %; Me, 56 %). A better synthesis was devised utilising acetonitrile as the 
reaction solvent and resulted in such a clean reaction as to negate the need for 
recrystallisation and giving excellent yields. 
FnF~ F I + 
.--: 
F N F 
R 2 eq NaHC03, 
2 ~ -'M""e"'C'-'-N --~ 
H2N NH.HCI Reflux, 17 h 
Figure 2.3 
R 0/o 
1 Ph 96 
2 Me 88 
Many attempts were made to cyclise these two compounds, including using sodium 
hydride, refluxing aqueous potassium hydroxide, and heating at high temperature in 
polar solvents. It was found that the tethered amidine appeared to be somewhat fragile 
to these harsh conclitions (strong bases, high temperatures etc) and often resulted in 
decomposition to give 4-amino-tetrafluoropyridine, presumably similar to Coe's base-
induced mechanism (see Section 1.4.2). 
R R R~ 
Nj__NH2 HN~NH H)_?~N ~H NH2 
FnF FnF F)C(_:n~nF FNFFNFFNF FNFFNF 
Figure 2.4 Decomposition of 4-amidino-tetrafluoropyridines 
Bearing this in mind, a reaction was devised that would limit the temperature of the 
reaction attained and employ a strong base that should formally deprotonate the amidine 
moiety and allow the entropically favoured intramolecular attack at the 3-position to 
47 
Chapter 2 
occur. Thus, LDA was added to a stining solution of 1 in dry THF at -78 °C, left for 2 h 
and gradually allowed to warm to room temperature. 19F NMR of the reaction mixture 
after one day showed there to be no starting material remaining, only one new 
compound that gave three resonances by 19F NMR spectroscopy. An aqueous acid work 
up followed by recrystallisation from acetonitrile yielded imidazopyridine 3 in excellent 
yield. Full NMR characterisation, mass spectrometry and elemental analysis confirmed 
the structure of the desired heterocycle. 
2.2 eq LDA, THF 
- 78 °C - RT, 1 d 
Np 
F~NH ===="" 
~--).__ F ' N 4 F 
3, 91% 
Figure 2.5 
The heterocycle exists as a rapidly interconverting mixture of tautomers, which causes 
the broadening of the resonances observed in 19F NMR and can even give rise to two 
sets of resonances (Figure 2.6); as such, for clarity, only one tautomer will be drawn 
(and named) from hence forth. 
l 
' 
-·· 
_, 
U.ll 
E 
' - 1-
' ~ 
-100 
1.11 
n.u. 
-110 -lZO -130 -uo -ISO 
1 
i 
'i 
-160 
11,11 
Figure 2.6 19F NMR spectrum of 3; lip (DMSO-d,;) major tautomer (67 % by 19F NMR) 
-83.08 (lF, br s, F-6), -102.02 (IF, br s, F-4), -I61.60 (IF, br s, F-7); minor tautomer 
(33 %) -82.60 (IF, br s, F-6), -104.33 (lF, br s, F-4), -I63.00 (IF, br s, F-7) 
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It is worth pointing out that the pH of the aqueous layer during extraction of the product 
is extremely important. Basic work up (resulting from the excess of LOA solution 
employed) only leads to a small amount of black tarry substance being extracted. This is 
presumably because the imidazole hydrogen atom is reasonably acidic, giving the 
formation of a water soluble lithium amine salt. 
Thus, in two steps, pentafluoropyridine can be convetted into a highly desirable 
fluorinated imidazopyridine. Furthermore, the cyclisation step has been carried out 
several times on various scales with consistently high yields. 
Adopting these conditions to attempt cyclisation of 4-acetamidino-tetrafluoropyridine 2, 
however, resulted again in the decomposition product 4 and, unfortunately, more 
sterically hindered amine bases, potassium and sodium hexamethyldisilazane, gave the 
same result. 
2 eq LDA, THF 
-78°C-RT 
Figure 2.7 
NH2 F~F 
~--~ F N F 
4 
From this we can suggest that the phenyl group resists the base induced elimination of 
4-amino-tetrafluoropyridine 4, either through its steric bulk or electronically through 
resonance stabilisation: 
2 HN ...-::::NH 
F~F 
~--~ F N F 
~ etc. 
Figure 2.8 
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To extend the series of condensations with amidines, pentafluoropyridine was reacted 
with formamidine hydrochloride (R = H). In this case, refluxing the reaction mixture 
gave 4-amino-tetrafluoropyridine 4 as a byproduct (implying even less stability) along 
with the desired 4-substituted fluoropyridine. Repeating the experiment at room 
temperature gave improved conversion to the target molecule, whilst reaction with LDA 
gave the decomposition product. 
Fn~ F I + 
"" F N F 
4 eg NaHC03 ,. 
MeCN, RT, 23 h 
Figure 2.9 
NH2 
LDA,THF F~F 
-78 °C - R; )L.,.l 
F N F 
2.3 Reaction of Pentafluoropyridine with N-Substituted Amidines 
Although the three amidines (R =Ph, Me, H) exhibit sufficient nucleophilicity to attack 
pentafluoropyridine, the tethered amidines are not sufficiently nucleophilic to achieve 
ring closure apart from under the specific conditions discussed. It was hypothesised that 
the employment of an N-substituted amidines, e.g. N-alkyl, should give a more 
nucleophilic species and, hence, increase the likelihood of imidazopyridine synthesis 
when reacted with pentafluoropyridine. 
A sample of N-methyl-benzamidine hydrochloride was reacted with pentafluoropyridine 
under basic conditions and microwave heating. LCMS of the resulting reaction mixture 
indicated two compounds to be present; the first at 3.1 minutes and representing 24 % 
of the total ion content (TIC) trace, with [~ + W]264.1 and the second at 3.3 minutes 
and representing 76 % of the TIC trace, with [M+ + W] 284.0. Mass directed auto 
purification (MDAP) of this crude material yielded these products as two white solids. 
19F NMR of the first sample (shown in Figure 2.10) revealed 3 major ( -81.33, -100.31, -
169.52 ppm) and three minor resonances (-86.72, -102.39, -162.03 ppm) whilst the 
other isolated solid consisted of two very broad resonances ( -91.30, -152.58 ppm). From 
this data, we can deduce the two sets of isomers shown in Figure 2.11 
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~~~; 
) 
~~~~ 
·~.._ 
_., _, 
-111 ·IZD -130 ·1SO ,. 
Figure 2.10; 19F NMR spectrum of 6 and 7; Op Major isomer -81.33 (JFF 32.6, JFF 12.7), 
-100.31 (]pp20.3, JFF 12.8), -169.52 (JFF32.7, JFF20.7); Minor isomer -86.72 (IF, m),-
102.39, -162,03 (dd, Jpp32.5, JFF 19.2,) 
p Me, _p 
N 
Fi(N FnN-Me 
2 I"' I"' /. F N"' F F N F 
FnF 
6 7 1.5 eq 
Me,N NH.HCI + + 
H 2 2 I "" 3 eq NEt3, THF I DMSO F N F MW, 180 °C, 30 min // Me,N NH N ,..- N,Me 
F:(~( Fn~ I "" I " F N F F N F 
8 9 
Figure 2.11 
The characteristic pattern observed in the 19F NMR of the first sample, along with the 
single [M+ + W] peak observed by LCMS, indicates the desired [5,6] pyridine-fused 
heterocycles 6 and 7, though which isomer predominates is unclear. It also follows that 
the other solid isolated must be the respective 4-substituted intermediates 8 and 9. This 
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assignment was corroborated through the optimisation of the reaction by employing five 
equivalents of the slightly less volatile base OIPEA and microwave heating at 200 °C 
for 30 min. LCMS of the resulting mixture showed clean conversion again to the same 
compounds, this time in a ratio of 37 : 63% (cyclised: uncyclised respectively) by TIC 
trace, implying a higher conversion to the disubstituted, fused heterocycle due to the 
more forcing reaction conditions. 
The commercially available N-phenyl-benzamidine was also explored as a potentially 
useful binucleophile. Reaction with pentafluoropyridine gave the following products: 
F,~_..-F 
JL.;l + F N F 
(J 
HNJN...-0 
H 
5 eq NEt3, 
THF 
MW, 150 °C, 
25min 
Figure 2.12 
x~ HNJ0 
Fn~ FnF I + I 
...., """' F N F F N F 
10,32% 
Along with the desired 4-aminido substituted pyridine 10, a 4-substituted byproduct was 
observed, presumably through the decomposition, in an analogous manner to the 
unsubstituted amidine examples previously discussed, of an unstable species resulting 
from the initial attack of pentafluoropyridine by the N-phenyl nitrogen. It is for this 
reason that structure 10 has been assigned as the other possible isomer. Attempts to 
cyclise 10 with LOA resulted only in a 2-, 4- disubstituted trifluoropyridine, most 
probably through nucleophilic attack of "N1Prz at the most active position ortho to the 
pyridine ring nitrogen. This is logical as, although LOA is supposedly a non-
nucleophilic base, it has been shown to readily attack polyhaloaromatic compounds.2 
The condensation of pentafluoropyridine with 2-imino-piperidine gave the most 
successful result in this series of reactions, forming tricycle 11 in a one pot process and, 
after optimisation of the reaction conditions, in moderate yield. 
52 
Chapter 2 
" FtxF 3 eq NEt3, 
?' I u THF/DMSO 
" + 1.5 ~ 
F N F N NH.HCI Microwave 
H 180 °C, 30 min 
Q 
F~N 
FA)lF + 
4 
ONH 
F~F 
A .. J.. F N F 
11,52% 
Figure 2.13 Reaction of pentafluoropyridine with 2-imino-piperidine hydrochloride 
Initial attack of the binucleophile through the piperidine ring nitrogen, which, therefore 
must be the more nucleophilic site, is followed by attack of the tethered imine at an 
adjacent C-F bond to give ring annulation. A byproduct was also observed by LCMS of 
the reaction mixture and appeared to be the uncyclised intermediate. 
A substructure search for this nitrogen-containing heterocyclic core reveals only one 
reference and involves the synthesis of the non-fluorinated analogue of tricycle 11 by 
the pyrolitic cyclisation of pyridine azide.3 The only other similar structure to arise from 
the literature search is the following tetrahydro-pyridoimidazoquinoline motif that 
appears in three separate patents detailing immune response modifiers (R = NH2) 4' 5 and 
as a compound useful for inducing interferon biosynthesis (R = NH2, N(Bz)z) 6 
Q 
~N 
UNJlR 
R = NH2 , N(Bz)2 
Figure 2.14 
2.4 Further Reactions of Trifluoropyridine Ring-Fused Heterocycles 
Inspection of heterocycle 3 reveals several potential sites for further elaboration to give 
polyfunctional systems: derivatisation of the phenyl ring (or use of functionalised aryl 
amidines) as mentioned in the previous section, reaction of the imidazole ring nitrogens 
and nucleophilic substitution at one or more C-F bonds. The next stage of research 
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investigates these latter two reactions, establishing reactivities and selectivities of these 
processes, in order to expand the developing pyridine-fused ring synthetic methodology. 
F N. 
1 
F N · F 
Nuc 1 or Nuc2 Nucf or Nuc 1 
Figure 2.15 Potential sites for functionalisation of imidazopyridine 3 
2.4.1 NH Functiooalisatioo of lmidazopyridioe 3 
The functionalisation of imidazole amine moieties via reaction with a suitable alkyl 
halide is a common method for their derivatisation and, as such, there are various 
procedures for their synthesis. Reaction between 3 and methyl iodide, in the presence of 
sodium bicarbonate and in acetonitrile, proceeded slowly, emphasising the deactivating 
effect the electron-deficient nature of the fused fluoropyridine ring has on the imidazole 
moiety. Changing the base to n-butyl-lithium resulted in a far more rapid reaction, 
forming the two expected and previously observed (see Section 2.3) isomers in 
essentially equal amounts (52 : 48 % by 19F NMR) and excellent yield: 
Me 
N i) 1.1 eq nBuli, -78 °C N N ' 
F NH F N Me F N ii) xs Mel, - RT 
~ + 
F N F F N F F N F 
6 7 
3 87% 
Figure 2.16 
2.4.2 Nucleophilic Substitution of lmidazopyridine 3 by Amine Nucleophiles 
To further develop the synthetic potential of these scaffolds, reactions of bicycle 3 with 
nucleophiles were explored. Early experiments involved refluxing with an excess of a 
very strong nucleophile such as the lithium salt of diethylamine, or hydrazine, in the 
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knowledge that the presence of the two nitrogen substituents on the fluoropyridine ring 
could have a deactivating effect to nucleophilic substitution. Though these reactions 
proceeded accordingly slowly, taking several days to achieve moderate conversion, they 
encouragingly showed the formation of only one product (by 19F NMR of the resulting 
mixture) containing two fluorine atoms, implying the desired displacement of fluoride 
ion by the nucleophile. However, due to the small scale of the reactions and the forcing 
conditions, which gave a somewhat complex crude material, isolation of these products 
proved difficult. 
Microwave heating of chemical reactions has become a reliable way of improving 
reaction times and yields, and is an especially useful technique in cases, such as above, 
where thermal decomposition of the reactants and products occurs due to prolonged 
heating. The ability to optimise reaction conditions quickly and efficiently, through 
automatically run arrays, on a small scale, are further advantages to this approach. 
Adopting this technology to the reactions of some of the deactivated fluoropyridines 
reported herein yielded suitably impressive results. 
The optimised reaction conditions for the reaction of bicycle 3 with N-methyl-
benzylamine are shown in Figure 2.17. It was found that an excess of the amine (to act 
as a base as well as nucleophile), along with heating at 180 °C for 30 min gave 
quantitative conversion to one compound with m/z (ES+) 351.1 (~ + W) and 19F NMR 
(2 doublet peaks; -100.09 and -174.97 ppm) corresponding to the desired substitution of 
a fluorine atom. A small quantity of DMSO was employed to help absorb microwave 
energy as THF alone was insufficiently polar to achieve the desired temperature. Single 
crystal X-ray analysis of a suitably prepared sample showed the product to have arisen 
from substitution at the 4-position of the imidazopyridine core scaffold. 
6~'Me THF/DMSO 5 / ~~~~~~ N Microwave, 
180 °C, 30 min 
Figure 2.17 
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Figure 2.18 X-ray structure of 12 
This result is surprising for the following two reasons. Firstly, studying the initial state 
effects on the reactivity of the two potential C-F sites of attack (the third C-F site would 
be deactivated to attack relative to the sites ortho to the pyridine nitrogen and thus will 
not be considered) of the starting material, one would expect attack to occur at the other 
C-F site: 
> 
N 
F 7 NH 
6 4 
F N F 
1 ortho N 1 ortho N 
1 ortho F 1 meta F 
1 meta F 1 para F 
Figure 2.19 
The 6 C-F position is activated by one ortho and one meta fluorine atoms, both 
activating this site to attack by a nucleophile whereas the 4 C-F position is only 
activated by one meta fluorine atom. As stated in Chapter 1, a para fluorine atom is 
actually slightly electron donating by resonance and hence will have a deactivating 
effect. Therefore, the selectivity obtained in practise appears to go against these 
56 
Chapter 2 
established reactivity rules developed for monocyclic perf!uorinated heteroaromatic 
systems. 
Secondly, this result is also in contrast to work reported on analogous [6,6] pyridine 
ring-fused heterocycles in which nucleophilic substitution follows the case expected if 
only the activating effects of fluorine are taken into account (see Section 1.4.2). 
Me,Nl Me,Nl 
F+.N'Me ~~g~e, ,._ F+.N'Me 
)_ .. ~ reflux, 2 d _1_ .. ~ F N F MeO N F 
76% 
Figure 2.20 
The influencing effects of the nitrogen substituents also fail to justify this observation. 
For example, the imine substituent, as drawn in Figure 2.17, would be expected to 
withdraw electron density by resonance ortho and para to itself, i.e. the 4- and the 6-
position, leading to a mixture of the two substituted products. As this is not the case, it 
can only be deduced that there must be some sort of neighbouring group effect exerted 
by the 4c-C substituent on the site of nucleophilic attack. As detailed in Chapter 1, 
displacement of halogen from an electron deficient aromatic ring tends to proceed via a 
two-step addition elimination reaction, whereby the initial addition is the rate 
determining step. In the example of this reaction of fused heterocycle 3, it is the 
formation of the following intermediate: 
p HNP F~N. F~NH -"HF" ~===""" Jl.,k~~Me-..==="" Jt.,A--N-M~ 12 
F ~F) F ~F) 
Ph Ph 
Figure 2.21 
Hence the lone electron pair of the imine nitrogen can interact with the incoming 
nucleophile, "guiding" it in to displace fluoride ion. More importantly, intramolecular 
deprotonation can occur, which presumably lowers the energy of activation for this rate 
limiting step thus favouring attack at this site over the other activated C-F bond. 
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A similar phenomenon has been witnessed in the reactions of a range of fluorobenzene 
derivatives of the formula C6F5X with nucleophiles, whereby substitution ortho to the X 
group occurred as opposed to the expected para-fluoride displacement.7 As an example, 
the reaction of nitropentafluorobenzene with methylamine is shown below: 8 
e e e F*OI"~~O F F*Oi'~'~ ~FI HMe ~ ether-EtOH 
+ MeNH2 
F a F F a F 
F F 
Figure 2.22 
An interesting experiment, but one that was not carried out due to limited time and 
material, would be the reaction of the inseparable mixture of isomeric N-methyl 
imidazopyridines 6 and 7 with a nucleophilic species. If the neighbouring group 
participation hypothesis is correct, one would expect 7 to react in an analogous manner 
to 3, that is react at the unexpected 4C-F site ortho to the imino group of the fused 
imidazole ring. On the other hand, it could be predicted that 6 would react in a manner 
akin to the example shown in Figure 2.20 and react in accordance with the established 
initial state effects i.e. displace fluoride ion from the 6-C position. As well as following 
by 19F NMR of the reaction mixture, separation of the products could prove possible. 
The reaction of 3 with diethylamine in a similar manner gave rise to the analogous 
diethylamino heterocycle 13 along with a small amount of inseparable impurity (- 5 %; 
[M+ + W] 363.1; OF -99, -181 ppm) which at first was assumed to be from attack at the 
alternative C-F site. However this was not consistent with results obtained thus far so 
the reaction was optimised to try and increase conversion in an attempt to find out more 
about the structure. More forcing conditions gave accordingly higher conversion to the 
byproduct. Purification by mass directed auto purification gave a red solid whose 
structure was deduced to be compound 14: 
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FxXNH I"' 
.--; 
F N F 
3 
5 eq HNEt2 
_T'-'H-"F-"/D~M-'-'S=-0=---:.,_ 
MW, 180°C, 4.5 h 
0 
F~--\ ~-~ + F N..-o N/'...... 
13 l.__ 
Figure 2.23 
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1H NMR clearly showed there to be 2 resonances (5.37 and 2.00 ppm) not present in the 
spectrum of 13 and were indicative of a CH2 and CH3 group. Computer analysis of an 
accurate mass value suggested an empirical formula of SC2H5 surplus to 13. Finally, a 
heteronuclear nOe NMR experiment was devised, whereby running a 1H NMR 
experiment whilst irradiating the sample, with a frequency corresponding to the fluorine 
atom at -181 ppm, revealed any protons in close proximity(< 4 A) to this fluorine atom. 
As can be seen from the corresponding spectrum in Figure 2.24, the unknown 
resonances at 5.37 and 2.00 ppm both gave strong positive peaks in the upper section of 
the spectrum, implying strong nOe couplings. From this data, structure 14 was 
suggested, whereby selective alkylation of the 1 H-imidazole nitrogen has occurred. 
Figure 2.24 heteronuclear nOe NMR of 14 
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The following mechanism, involving an electrophile derived from dimethyl sulfoxide 
reacting with the nucleophilic imidazole nitrogen, is proposed to explain this result. 
Selectivity towards this site for electrophilic substitution presumably occurs because of 
steric hindrance at the other (3H) imidazole nitrogen by the ortlw dialkylated amino 
functionality. 
o B'e ~ II I /s, ..... _.. -c-,s,~ (i) 
Figure 2.25 
Why this is not the case in the reaction of bicycle 3 with N-methyl-benzylamine is 
uncertain. This byproduct formation could easily be circumvented by switching the 
dopant to another polar solvent, such as NMP. 
2.4.3 Nucleophilic Substitution of lmidazopyridine 3 by Oxygen and Sulfur 
Nucleophiles 
Reaction of scaffold 3 with sodium methoxide in dry methanol failed to provide the 
desired difluoro-imidazopyridine, despite the highly nucleophilic nature of NaOMe and 
the employment of microwave heating. It is suggested that instead of acting as a 
nucleophile, the methoxide ion is acting as a base and deprotonating 3 to give a 
relatively electron rich, inactive system. 
Reflux of 3 with an excess of lithium thiophenoxide proceeded slowly but selectively to 
give one new product by 19F NMR of the reaction mixture (see Figure 2.27) consisting 
of two doublet resonances at -107.65 and -164.43 ppm, presumably to give the 
regioisomer shown in Figure 2.26, in line with previous results. The low conversion (-
15 % by integration) precluded purification of this small scale reaction. 
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F~NH 
)L_~ 
F N F 
3 
JWOO"'M jjP :Vi, 4 rm; ,.,j4: ,.,d 
NaOMe, MeOH 
Microwave ~ 
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LiSPh, THF 
Reflux, 
4d ..... 
Figure 2.26 
-90 - ~10 0 ·-11o·- - -120 -- - -130- -
28.33 ZI.~O 
0 
N~ 
FtiNH 
"' I "" F N OMe 
0 N=< F'v~)\IH ~-~·0 F N S~
-140· -150 
Chapter 2 
-160 ppm 
Figure 2.27 Reaction of imidazopyridine 3 with LiS Ph (19F NMR of reaction mixture) 
One way of obtaining these difluorinated systems could be to N-protect the 
imidazopyridine before attempting nucleophilic substitution, thus preventing the 
deprotonation that presumably reduces the reactivity of this system to attack by a 
nucleophile 
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2.4.4 Nucleophilic Substitution of lmidazopyridine 11 
The following reaction was carried out on a small scale to demonstrate that tricycle 11 
was also reactive to further nucleophilic substitution and to ascertain as to whether the 
regioselectivity of displacement was as high as with the reactions of bicycle 3 with 
nitrogen nucleophiles. The protected nature of the imidazole moiety (I.e. N-R as 
opposed to NH) led to the employment of milder reaction conditions (160 °C and hence 
no need for DMSO) however the reaction proceeded sluggishly, taking 5 h to achieve 
around 80 %conversion, albeit with the same high selectivity observed in the analogous 
reactions with imidazopyridine 3. In light of this high selectivity, the same reasoning as 
described in Section 2.4.2 is used, hence the regiochemistry of the product, 15. 
Q FtiN I"" 
F N F 
11 
5 eq HNEt2, 
THF 
MW, 
160°C, 5h 
Figure 2.28 
Q FtiN 
""" I "' F N N~ 
15,32%~ 
It is worth noting that optimisation of this reaction could be achieved quickly through 
carrying out a small screen of reactions and changing variables such as temperature and 
concentration of reactants in order to give a more satisfactory reaction and conversion. 
2.5 A Complimentary Strategy to Difluoro-imidazopyridine Synthesis 
As shown in Sections 2.4.2 and 2.4.4, trifluoropyridine-fused heterocycles derived from 
pentafluoropyridine appear to be highly regioselective and moderately reactive towards 
nucleophilic attack. In the case of bicycle 3, whose synthesis necessitates a two step 
reaction from pentafluoropyridine, it was hypothesised that the 4-substituted uncyclised 
intermediate could be reacted with a mononucleophile to give a 2-, 4-disubstituted 
trifluoropyridine, treatment of which with LDA should affect ring closure at the most 
electron deficient para position to the newly introduced 2-substituent. This concept is 
shown in Figure 2.29: 
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Nuc= Amine, 
alkoxide etc 
2 _ij 1 meta F 1 para F ,.. 
'\}, N NH2 F~F }__. ,.:<l ~ 1 ortho F 
Nuc N F 1 meta F 
Figure 2.29 
Ring 
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F~-{" 
Y-.~ Nuc N"' F 
In light of the synthesis of the isolation of difluoro-imidazopyridine 12, 1 was reacted 
with an excess of N-methyl-benzylamine to obtain the desired trifluorinated pyridine 16. 
Reaction of this with LDA gave two new resonances only by 19F NMR of the reaction 
mixture whilst purification by mass directed auto purification gave a white solid with 
different resonances, to those observed previously for isomer 12, in the 1H and 19F 
NMR spectra. From this we can conclude that the desired regioisomer 17 was indeed 
successfully synthesised. 
c;·· 
F N F Mw. 18ooc.U I "" 
30 min I ~ N F 
1 -& Me 
16,48% 
Figure 2.30 
4.2 eq LDA, 
THF 
-78 °C- AT 
1 d 
17,64% 
The microwave synthesiser also proved vital in this synthesis, providing a quick and 
clean route to 16. Previous attempts by conventional heating took several days and 
resulted in such an extent of decomposition that purification was unreasonable. 
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2.6 Comparison of Reactivity between Uncyclised and Cyclised Systems to 
SNAr 
As part of this work, reactions of tetrafluoropyridine 1 and its trifluorinated 
imidazopyridine derivative 3 were screened for reactivity towards diethylamine under 
identical reaction conditions to one another while varying the temperature of the 
samples (Figure 2.31). Reaction times were kept constant at 30 min whilst conversions 
were obtained from the TIC trace from LCMS analysis of the reaction mixtures. 
Interestingly, the less fluorinated, and hence expected to be less reactive, 
imidazopyridine 3 showed far greater conversion under various conditions than 1 
(Figure 2.32). 
2 2 
,:i:"' 5 eq HNEt2, N:NH2 THF/DMSO FnF I ..., MW, 30min I ..., F N F /'oN N F 
1 _) 
p p 
FANH 
N 
5 eq HNEt2, FnNH I"' THF/DMSO _. I"' 
..., MW, 30 min F N" N~ F N F 
3 13 ~ 
Figure 2.31 
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Temperature Vs.% conversion 
100. 
80. ;,!! 0 
• 
-c 60 0 • • Tetrafluoropyridine 
"i!! 
• • Trifluoropyridine CD 40. > • c • 0 
• • 0 20. 
• • 
0 
130 150 170 190 
Temperature I deg C 
Figure 2.32 Conversion of 1 and 3 to respective products under varying reaction 
tern peratures 
The special activating and directing effect of the 4c-C imine functionality present in 
bicycle 3 presumably gives this surprising observation. 
2. 7 Reaction of Pentafluoropyridine with Other Binucleophiles 
So far this chapter has dealt with the formation of imidazopyridine scaffolds via the 
reaction of pentatluoropyridine with suitable N,N binucleophiles. The following section 
will detail research carried out exploring various other binucleophiles. 
2.7.1 Reaction with Guanidine 
Following the breakthrough of employing LOA to form bicycle 3, the reaction 
conditions were adapted to the cyclisation of 18, attempted previously in other 
laboratories (See Section 1.4.2). Synthesis oftetrafluoropyridine 18 proceeded smoothly 
under identical conditions used to synthesise the 4-amidino-tetrafluoropyridines (see 
Section 2.2) and yielded the target molecule as a pale yellow solid. Attempts to cyclise 
with LOA, however, failed to yield the desired annulated product, and only succeeded 
in forming 4-amino-tetrafluoropyridine (observed in the reaction mixture by 19F NMR; 
OF -102 and -164 ppm), as observed in the literature example. 
65 
4 eq NaHC03, 
MeCN 
reflux, 69 h 
Chapter 2 
NH NH 
HNANH2 HN-{ F~F LDA, THF F~NH )L;L ~~ y__ ;L 
F Nh F F N F 
18, 18% 
Figure 2.33 
This is in keeping with the amidine work reported in this chapter whereby an aryl group 
is required on the binucleophile to give the desired annulation reaction as opposed to the 
unwanted elimination process. 
2.7.2 Screen for Potential Cyclic Binucleophiles 
As already mentioned, microwave technology is highly amenable to array chemistry, 
both in terms of being able to quickly optimise a specific reaction, but also to test 
reagents for suitable reactivity. The following screen was carried out in order to access 
the reactivity of three potentially binucleophilic heterocycles with pentafluoropyridine. 
The conditions shown in Figure 2.34 were chosen; forcing enough to permit reaction if 
sufficiently reactive whilst mild enough to prevent decomposition. 
Fix~ F I + 
-" F N F 
3 eq NEt3, 
THF/DMSO ,. 
MW,t50°C, 
30 min 
Figure 2.34 
q FXxY I"" 
F ~ F 
Automated LCMS analysis of the reaction mixtures was chosen, for its ease and quick 
results, as the method for deducing whether or not each reaction had worked. The 
following substrates were studied: 
~s ~0 
H H 
Figure 2.35 
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No desired product was observed in any of the reactions. In each case, the respective 
heteroatoms must withdraw electron density away from the ring nitrogen atoms to such 
an extent that they are insufficiently nucleophilic to attack pentafluoropyridine. 
2.7.3 Reaction with 1,3 Dicarbonyl Compounds 
The 1,3-dicarbonyl ethyl acetoacetate was reacted with pentafluoropyridine in an 
attempt to form a desirable furopyridine fused heterocycle and in an analogous manner 
to the following literature example involving tetrachloropyrazine: 9 
0 0 
}lJlOEt 
Cl N Cl ~ O O CI)N:X~ 
THF ~OEt 
Figure 2.36 
10% 54% 
Adapting these conditions to the reaction with pentafluoropyridine gave only the 4-
substituted product, 19. Repeating this reaction with additions of excess base (such as 
LDA) failed to force cyclisation to occur. 
0 0 
~OEt e 
F,~/F 
JL .. ~ F N F ~~"~==== 
F N F 
19,8% 
Figure 2.37 
1H NMR clearly shows us the configuration this pyridine derivative adopts: 
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Figure 2.38; 1H NMR spectrum of 19; 8H 13.52 (1H, s, OH), 4.22 (2H, q, 3JHH 7.1, 
CH2CH3), 1.94 (3H, t, 6JHF 0.9, COCH3), 1.21 (3H, t, 3JHH 7.0, CH2CH3) 
Apart from the alkyl protons at 4.2, 1.9 and 1.2 ppm, the only other resonance occurs at 
13.5 and is indicative of a hydroxyl proton. As there is no sign of a methine resonance, 
it can be concluded that the 4-substituted group exists solely in the enol configuration. 
The lack of cyclisation presumably stems from an insufficiently electron deficient 3C-F 
site. It is worth noting that the following reaction has successfully been carried out at 
Durham, between ethyl acetoacetate and 4-cyano-tetrafluoropyridine, to give the 
furopyridine shown below and its uncyclised isomer. 10 
0 0 
~OEt e 
Figure 2.39 Furopyridine formation from pentafluoropyridine 
2.8 Conclusions 
A series of highly desirable fluorinated imidazopyridine fused heterocycles have been 
synthesised and, in the case of bicycle 3 and tricycle 11, shown to be excellent scaffolds 
for further embellishment. 
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Although the reaction of pentafluoropyridine with N. N-unsubstituted amidines is 
limited to benzamidine-based systems in this work, it is possible to envisage the 
following type of aryl-substituted structures, which could contain further sites for 
functionalisation e.g. metal-catalysed coupling reactions (R =halogen). 
R{7) 
N=< 
FnNH I"" 
/-
F N F 
R1, R2 =Halogen, OH, C02H, 
CN etc 
Ar N=< 
FtiNH I"" 
.-'0 
F N F 
Ar =pyridine, thiophene, pyrrole etc 
Figure 2.40 
The one-pot synthesis of heterocycle 11 also provides an extremely interesting 
opportunity for the creation of a series of novel heterocycles, while a search for 
commercially available iminopiperidines reveals a range of chemicals available, 
including enantiomerically pure samples e.g. 
~ MeO~ ~NANH N NH 
H H H 
Figure 2.41 Examples of commercially available iminopiperidine derivatives 
Hence a range of unusual and potentially biologically interesting fluorinated tricyclic 
tetrahydro-dipyrido-imidazole analogues could be synthesised in single and efficient 
steps. 
The ability to synthesise these highly novel imidazopyridine scaffolds, in conjunction 
with the ability to introduce selectively a nucleophile in the ortho position of the 
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fluoropyridine scaffold, opens the possibility to make libraries of drug-like molecules in 
short, efficient syntheses, given sufficient time and resources. 
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Pyridine Ring-Fused Tricycle Synthesis from Pentafluoropyridine 
3.1 Introduction 
As shown in Chapter 2, pentafluoropyridine reacts with the N. N-unsubstituted 
benzamidine hydrochloride, in two steps, to furnish highly functionalised pyridine ring-
fused heterocycle 3 in excellent overall yield. The analogous reactions with acetamidine 
and formamidine hydrochloride, however, failed to yield the desired imidazopyridine 
heterocycles. It was hypothesised that through fixing the amidine motif in a ring the 
binucleophile would possibly be more stable and, indeed, this was found to be the case 
when pentafluoropyridine was reacted with 2-imino-piperidine hydrochloride to yield 
the highly novel tricycle 11. Furthermore, the condensation proceeded in one step, 
illustrating an improved reactivity of theN-alkyl amidine species over the unsubstituted 
phenyl amidine. In the knowledge that the ring nitrogen of pyridine can act as a 
nucleophile, the study was extended to ascertain whether aromatic diamino species, 
such as 2-aminopyridine, could act as suitable binucleophiles for fused pyridine 
synthesis (Figure 3.1 ). 
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Reaction with benzamidine.HCI [() 
Fn" F 2 1!. 2.2 eq LOA, 
I "" + 2 2 2 eq NaHC03 nN"' NH2 _T:..:H-"F-,!'--1~ 
--' . ~F F o 
F N F H N NHHCI MeCN, "" -78 C-RT, 
Np 
F~NH 
Jl •. ~ 2 reflux16h I 24h 
"" 
Reaction with 2-iminopiperidine.HCI 
1.5Q 
N NH.HCI 
H 
Proposed reaction with 2-aminopyridine 
3.2 Background 
F N F 
1,96% 
3 eq NEt3, 
THF/DMSO 
MW, 
180 °C, 30 min 
Q 
F~N 
FJlN~F 
Figure 3.1 
F N F 
3, 91% 
Q F~N 
FJlN~F 
11,52% 
If the condensation between pentafluoropyridine and 2-aminopyridine proved 
successful, it would provide access to a highly novel tricyclic heterocycic system. 
Indeed, there are very few examples of this motif in the scientific literature. 1'3 One of 
the more efficient procedures is given below:2 
A 
i!.,N.).._NH2 EIOH, 
reflux 6 h 
Q 
N~o 
Me 
24% 
nitrobenzene 
210°C,9h 
Q 
0So 
M<JMe 
48% 
Figure 3.2 
rlo 
H2N OEI 
EIOH, 
8d,RT 
Q 
»
'N 
I"' 
0 N Me 
OEt 
61% 
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In this case, 2-aminopyridine is reacted with 1-bromo-butane-2,3-dione to gtve an 
imidazo[l,2-a]pyridine, which is then acylated and reacted with amino-acetic acid ethyl 
ester to yield the desired dipyridoimidazole in a 7 % overall yield. 
Searching the literature for the reaction of an aminopyridine with a halogenated 
heterocyclic species also reveals a lack of work reported in this area.4-6 In the following 
example, chemists reacted the highly electron deficient 2,3-dichloro-5,6-
dicyanopyrazine with a selection of substituted 2-aminopyridines to give a series of 
pyridine ring-fused heterocycles.4 
NC1 N1 CI cl 1 1 ~ dioxane "" + 2.4 ..< NC N Cl N NH2 
R = H, 3-, 4-, 5-, 6-Me, 
4,6-Me2, 3-0Bz, 5-CI, 
5-Br 
Figure 3.3 
NC](NyN~ ~~rR 
NC N N 
15-79% 
Electron-rich pyridines, such as the methyl-substituted systems, were sufficiently 
reactive to allow cyclisation at room temperature, while electron-deficient 5-chloro and 
-bromo analogues required reflux in dioxane. Dihalo- and nitro-aminopyridines failed to 
show any reaction and this is attributed to the more electron-rich pyridine systems being 
stronger nucleophiles than the electron-poor systems. 
The following metal-catalysed coupling reactions have also been reported very recently 
between a dihalopyridine and a range of amino-substituted nitrogen heterocycles (six 
compounds) to give a series of tricyclic and tetracyclic systems, which are predicted to 
have potential antitumour properties: 
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C( 
VNHz 
Pd(OAc)z, CXb + BINAP or XANTPHOS N Cl CszC03. toluene, 
reflux 17 h 
Amidine Product 
Cl ecNu 96% N N ~ N NHz 
CQ CcNtP N N~_ ~ ,1 98% N 
NH2 
N~ CcN~ 
u._N"' NH2 N N '\ 
82% 
'=N 
Figure 3.4 Representative examples of polycyclic rings formed by the metal-catalysed 
coupling of2-chloro, 3-iodopyridine with diamino species 
The one-pot double Buchwald-Hartwig amination of 2-chloro-3-iodopyridine with a 
selection of amino-azines and -diazines proceeds selectively and in high yields, going 
via an uncyclised intermediate resulting from the intermolecular C-N bond formation 
between the amino substituent of the binucleophilic species and the 3C-I site of the 
dihalopyridine.5 
Altering the dihalogenated-species to 2,3-dibromopyridine gave only uncyclised 
material, resulting from intermolecular bond formation between the amino functionality 
on the binucleophile and the 2C-Br site of the dibromopyridine, but not the subsequent 
intramolecular bond formation desired.6 
CCBr + /-N Br 
Pd(0Ac)2, 
BINAP or XANTPHOS 
Cs2C03, toluene, 
reflux 17 h 
Figure 3.5 
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Employing the following orthogonal tandem palladium and copper-catalysed amination 
strategy was found to affect the desired annulation reaction. 
CCBr + _.,; N Br 
Pd2(dba)a, 
XANTPHOS 
Cui -.::::~:-::----~ 
Cs2C03, 
DME, 140 °C 
24-30 h 
Figure 3.6 
av N N 
44-88% 
However, in the process of exploring these more forcing DME-mediated reaction 
conditions, it was found that the following ring annulations occurred without the 
presence of a metal catalyst and under basic conditions i.e. implying that, in these cases, 
reaction proceeds via nucleophilic aromatic substitution of bromide by the 
aminopyridine ring nitrogen. 
Reactant 
(J(" {) N Nu 
H 
~BX6r"" I ~N)l_N "'-
H I 
"" 
~Br~~N) 
~N)l_N~ 
H 
DME, 140 °C av N N 
Product 
53% 
92% 
16% 
Figure 3.7 
3.3 Reaction of Pentafluoropyridine with 2-Aminopyridine Binucleophiles 
To extend the study of the reactions of suitable diamino derivatives with 
pentafluoropyridine and also to ascertain the reactivities of aminopyridines with 
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fluorinated electrophilic pyridines, pentafluoropyridine was reacted accordingly with 
the electron rich (to increase the nucleophilicity of the diamino species) 2-amino-3-
picoline, under basic conditions. 19F NMR of the reaction mixture after three days at 
reflux showed there to be no starting material remaining and one product displaying 
three resonances (-82, -105 and -164 ppm), implying the formation of a [3,4]-fused 
fluoropyridine ring system. Regular work up and recrystallisation of this product gave a 
white solid whilst X-ray crystallography confirmed the structure of the product. 
FXX"""' F I + 
_..-: 
F N F 
MeCN. 
-'4-'e"'q""N.:..:a::cH.;_CS9•3 
Reflux 70 h 
Q-Me 
F~N 
F)LN""'L'F 
20, 82% 
Figure 3.8 Reaction of pentafluoropyridine with 2-amino-3-picoline 
Figure 3.9 X -ray structure of 20 
Initial attack of pentafluoropyridine through the ring nitrogen of 2-amino-3-picoline 
gives the highly reactive pyridinium salt shown in fig 3.1 0. The highly electron-
withdrawing nature of this quaternary amino substituent affects ring annulation at the 
adjacent C-F site by the tethered amino nucleophile, indeed, this uncyclised 
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intermediate must be short-lived as it IS not observed by 19F NMR of the reaction 
mixture at any point. 
Q-Me 
FtiN I ...-; 
F N F 
20 
~Me 
\1fd{~ Base FtiNJ_H) 
I""' 
--" F N F 
"- HF'' 
Figure 3.10 Mechanism for the formation of tricycle 20 
Despite the high reactivity of the intermediate pyridinium salt, the reaction proceeded 
slowly overall and this can be attributed to the relatively poor nucleophilicity of the 
picoline. Microwave heating, to provide a greater amount of energy to aid conversion 
and reduce reaction time, proved ideal in this case, with I 00 % clean conversion to 20 
being obtained after heating at 160 °C for 15 minutes only. 
With this result in hand, the reaction of pentafluoropyridine with 2-aminopyridine was 
carried out. The reaction proceeded even more sluggishly and less cleanly, giving a 
correspondingly lower isolated yield of 25 %. This is attributed to the lower 
nucleophilicity of the binucleophile, compared to the previous example, leading to 
slower conversion and, also, the formation ofbyproducts. 
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Fn~ F I + 
/-
F N F 
4 eq NaHC03, 
MeCN ., 
reflux, 96 h 
Q F~N 
F)lN~F 
21,25% 
Figure 3.11 Reaction of pentafluoropyridine with 2-aminopyridine 
These subtle electronic effects were also observed in the reaction with 2-amino-5-
bromo-3-picoline, which was employed in an attempt to add further functionalisation to 
the tricyclic scaffold. Although the presence of a methyl group on the nucleophilic 
species would no doubt aid the nucleophilicity of the reagent, the bromine atom would 
be expected to deactivate accordingly. After optimisation, tricycle 22 was obtained in 
low yield, illustrating the significant deactivating effect the bromine atom exerts. In this 
example, microwave irradiation proved paramount, as regular heating showed no 
conversion whatsoever, even after prolonged refluxing of the reaction. 
F~/F 
JL.:l F N F 
srUMe 
+ I /-
N NH2 
3 eq NEt3, 
THF/DMSO 
Microwave 
150 °C, 2 h 
Figure 3.12 
Br H-~~Me ( -"\N-{ 
FtiN I"' 
/-
F N F 
22, 10% 
In the case of this heterocycle, the structure was confirmed by a heteronuclear nOe 
NMR experiment, which revealed a strong interaction between F-4 and H-6 (8.7 ppm), 
implying the two atoms to be in close proximity through space and hence structure 22. 
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_I 
_I 
~-~~~~·-.....-~~------r-,-·-··~,-.~~~-~-~~~-··.,-.--·-· ··~r·····-·-·-····--' • · ~~~~·-
9 7 t; ~ .: J 2 I 0 
Figure 3.13 heteronuclear nOe NMR of22 (F-4 irradiated) 
3.4 Reaction of Pentafluoropyridine with other Aromatic Species 
To extend the range of pyridine-fused heterocycles obtainable via the condensation of 
pentafluoropyridine with a suitable binucleophilic species, a small selection of 
commercially available N. Nand N, X-centred heterocycles (X = 0, S) were chosen and 
tested for suitable reactivity, under identical microwave conditions. 
Substrates screened: 
3 eq NEt3, 
THF/DMSO 
Microwave 
150 °C, 30 min 
n 
l!__N.yl_OH Cl ...-: N SH 
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In each experiment, no desired annulation product or uncyclised intermediate was 
identified by LCMS analysis of the crude reaction mixtures. In the case of the N, N 
centred systems 2-aminopyrimidine and 2-aminoimidazole, the presence of a further 
electronegative ring nitrogen clearly reduces the nucleophilicity of the species to an 
extent whereby they are unreactive towards pentafluoropyridine. The same can be said 
for pyridine-2-ol, where the electronegative (relative to nitrogen) oxygen substituent 
effectively renders the ring nitrogen non-nucleophilic towards displacement of fluoride 
ion from the fluoropyridine reactant. The lack of reactivity shown by pyridine-2-thiol is 
somewhat harder to explain due the fact that sulfur is less electronegative than nitrogen 
and should therefore not greatly affect the nucleophilicity of the ring nitrogen. It can be 
argued, however, that the pyridine-thiol is in equilibrium with its thioamide tautomer, 
and this intramolecular electron delocalisation is favourable to the desired 
intermolecular nucleophilic attack. 
Figure 3.15 Tautomerisation ofpyridine-2-thiol 
3.5 Further Functionalisation of Tricycle 20 
Given that the dipyridoimidazoles obtained have three fluorine atoms remaining, study 
into their reactivity towards further nucleophilic aromatic substitution was carried out. 
Tricycle 20 was chosen as the substrate for the following reactions due to its quick and 
high yielding synthesis. 
3.5.1 Reaction with Nitrogen Nucleophiles 
Compound 20 proved to be an excellent reagent for nucleophilic aromatic substitution 
by nitrogen nucleophiles, reacting smoothly and under both microwave and 
conventional heating with benzylamine, N-benzylamine and diethylamine, in each case 
giving one product, observable by 19F NMR of the reaction mixtures, with two 
resonances. Regular work-up of the reactions and recrystallisation of the crude solids 
gave the corresponding products in good to excellent yields. 
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5 eq HNR1R2 
THF/DMSO, 
.... 
MW, 170 °C, 30 min 
Amine Compound no. I 
yield 
23,63% 
24,77% 
25,83% 
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Figure 3.16 Microwave-mediated reaction of 20 with amine nucleophiles 
In the reaction with the primary amine benzylamine, X-ray crystallography of a suitable 
grown sample led to confirmation of the site of attack by the nucleophile. 
Figure 3.17 X-ray structure of23 
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As discussed in Section 2.4.2, this selectivity contradicts the predictions from the initial 
state activation effects of the three fluorines and must therefore be due to a 
neighbouring group participation effect by the N=C group ortho to the site of attack. 
The reaction of 20 with the less nucleophilic aniline p-anisidine was also investigated 
and, after optimisation, yielded compound 26 in low yield. 
r\--Me 
Fn'~i 
""""' I "'"' 
F N F 
20 
~ 
1.5eqY 
OMe ______ ,,.. 
3 eq NEt3, 
THF/DMSO, 
MW, 170 °C, 2 h 
Figure 3.18 
r\--Me 
F~ f"'YOMe 
Jl .. ~ AJ F N N 
H 
26, 12% 
Even under these forcing conditions the reaction failed to achieve high conversion to the 
difluorinated product (45 % by LCMS reaction mixture analysis). This is in keeping 
with the poor nucleophilic nature of ani lines due to the donation of electron density, by 
resonance, of the nitrogen electron lone pairs into the benzene ring, thus making them 
less accessible for attacking, intermolecularly, the trifluorinated core scaffold. 
3.5.2 Reaction with Oxygen Nucleophiles 
In light of the excellent reactivity shown by 20 towards nucleophilic aromatic 
substitution by nitrogen nucleophiles, the study was extended to reactions with oxygen 
nucleophiles. Sodium methoxide was chosen as a simple, reactive alkoxide ion and was 
reacted with the fluorotricycle in dry methanol and under microwave heating. Complete, 
clean conversion was observed by 19F NMR and, as such, simply evaporating the 
reaction mixture to dryness and washing the resulting solid with water to remove 
unreacted NaOMe and KF yielded the product as a white solid. 
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1. 1 eq NaOMa, 
__,d"'ry,_M:.::..::.eO:::Hc.:..__• 
3 eq NEt3, MW 
140 °c, 30 min 
Figure 3.19 
Q-Me 
F~N 
F)LN__.lOMe 
27,90% 
Extending the methodology to reacting 20 with KOH was seen as important due to 
potential for N-alkylation or derivatisation to brominated systems amenable to metal-
catalysed coupling reactions (Figure 3.20). 
r\-Me 
'N--1 R-V F~N / JL.'l F N"""' OH 
r\-Me 
Fn'Ni 
I"" 
F N 0 
I 
R 
r\-Me 
F~ 
r\-Me 
'N--1 / 
JL.~ Nuc N....: Br 
f~N Nuc 
JL.~ F N Br 
~ 
Metal 
catalysed 
coupling 
Figure 3.20 
The reaction was first attempted by reaction with KOH in refluxing 'butanol and 
although this did show some desired reactivity, it was not deemed to be a viable route 
due to low conversion. Although another strategy considered was via the demethylation 
of 27 by refluxing in HI solution, the eventual successful procedure was inspired by 
literature examples involving refluxing fluorinated heterocycles in aqueous KOH 
solution to give the desired substitution reaction (Figure 3.21 ).7• 8 
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KOH(aq)., 
Reflux, 20 h 
~Me 
F~ )L_~ 
F N"' OH 
28, 10% 
Figure 3.21 
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!/\-Me 
Fn'N~ I"" 
F N 0 
H 
Despite the starting material appearing insoluble in the boiling aqueous solution, a 
suitably prepared (reaction mixture plus a small amount of acetone to aid dissolution) 
19F NMR sample taken after one day at reflux showed I 00% conversion to one product 
with two resonances. The low isolated yield is thus attributed to loss of material during 
work up. Scale up and improvement of the work up could yield a synthetically useful 
intermediate obtainable in two short efficient steps from pentafluoropyridine. 
3.5.3 Reaction with a Carbon N ucleopbile 
To widen the scope for functionalisation of these novel fluorinated dipyridoimidazoles, 
20 was reacted with a representative carbon nucleophile, phenyl magnesium bromide, to 
give difluorinated system 29. The site of attack is assumed the same as the analogous 
nitrogen-substituted systems discussed previously and, again, can be justified through 
neighbouring group participation of the -N=C group, possibly helping to disrupt the 
electrostatic charges between the charged nucleophilic species and hence facilitating 
attack (figure 3.23). 
2 eq PhMgBr 
THF, 
reflux, 93 h 
Figure 3.22 
Q-Me 
\ 
F N 
I"" 
.--: 
F N 
"""' 
29,48% ~ 
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Q-Me 
MgBr 
Q-Me QMe @eO 
FUN 
I"' \ @ @ 
# FnN-MgBr F N 'MgBr I"' "' ' ... I __, __ eo F N"' F F N F I # F 
20 
- "FMgBr" ~ 
Q-Me 
\ 
F N 
I"' 
/-
F N 
29 
Figure 3.23 
The reaction proceeded cleanly and, although no other reactions with carbon centred 
nucleophiles were carried out, the assembly of a large series of carbon-substituted 
heterocycles, such as 29, could be envisaged due to there being a plethora of 
commercially available functionalised phenyl and aryl Grignard reagents. 
3.5.4 Reaction with a Snlfur Nucleophile 
Expanding the methodology further still to encompass sulfur nucleophiles brought the 
only anomaly to the series of nucleophilic displacement reactions of 20, whereby 
reaction with two equivalents of lithium thiophenoxide gave 100 % clean conversion to 
one compound, with only one resonance, by 19F NMR of the reaction mixture. Full 
analysis of this product (NMR, mass spectrometry, elemental analysis) confirmed that 
two fluorine atoms had been displaced by the sulfur reagent to give a monofluorinated 
tricyclic species. 
20 
2 eq LiSPh, THF 
reflux, 17 h 
Figure 3.24 
~Me 
sn'~i ~ 1-: ~ VF N s~ 
30,61 % 
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The reaction was repeated accordingly using one equivalent of the nucleophilic reagent. 
However, as can be seen from a 19F NMR spectrum of the reaction mixture, this also 
resulted in the formation of a monofluorinated system (singlet peak at -76 ppm), with 
only a small amount of the desired difluoro pyridine remaining (weak doublet 
resonances at -102 and -167 ppm). 
~ ............. """' 
... l•ool< U•Tkr 
.......... , ....•.. 
lloo /Oolo{o .. UI/IIUUII 
•ou1100 on •uo•u•O" 
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u.n 
,-I., 
-110 -120 -130 -140 
Figure 3.25 
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. ' u.u t.n 
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Assuming initial attack of 20 by the nucleophile occurs, as before, at the C-F site ortho 
to the activating imine group, this would give the difluorinated intermediate shown in 
Figure 3.26. A second equivalent of lithium thiophenoxide then attacks the 
fluoropyridine core scaffold para to the first sulfur group to give the monofluorinated 
derivative, 30. Mechanistically, this is logical due to the stabilisation effect resulting 
from the ability to delocalise negative charge, developed in the Meisenheimer complex, 
over the first sulfur substituted carbon. This could not be possible if attack occurred at 
the other remaining C-F site as the negative charge could not develop over the C-SPh 
site. In terms of deducing this structure by physical characterisation, the only possible 
indicator as to the regiochemistry of the displacement reactions is by 19F NMR; in this 
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case, the singlet resonance occurs at -75 ppm which, in fluoropyridine-based systems, is 
indicative of a fluorine atom situated ortlzo to the ring nitrogen of pyridine. 
Q-Me Q-Me 
FUN FuN~ I"" LiS Ph 1/- ""I 
F N"" F F N S 
20 
LiSPh l 
Q-Me Q-Me 
stjN ~ u 1-: ~ -F" Us ,_~~ N~ F N s""- F N 7J S ""-
30,61% 
Negative charge 
stabilised by S 
Figure 3.26 
3.6 Penultimate Fluoride Displacement 
As shown in Section 3.5, the trifluorinated tricycle 20 readily reacts with a range of 
nucleophiles ih a regioselective fashion and under relatively mild reaction conditions. In 
light of this surprisingly high reactivity it was hoped that a further nucleophilic aromatic 
displacement of the resulting difluorinated derivatives be possible. 
The diethylamino-substituted heterocycle 25 was studied first and reacted with 
benzylamine. No conversion was observed, even when the experiment was run with at 
high temperature and a large excess of the nitrogen nucleophile (Figure 3.27, entry 1). 
This was also found to be the case when 25 was reacted with NaOMe. A similar lack of 
reactivity was found when methoxy-substituted tricycle 27 was reacted with 
benzylamine and diethylamine (Figure 3.27, entries 3 and 4). 
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Nuc' Nuc" I 
equivalents 
NEt2 I 0 Benzylamine 
NEt2 1.5 NaOMe 
OMe 5 Benzylamine 
OMe 5 diethylamine 
Nuc2 
~Qlvent 
' ... 1crowave 
Solvent 
THF/DMSO 
MeOHINEt3 
THFIDMSO 
THFIDMSO 
r\.-Me 
'('J~ 
F~N 
JLrl Nuc2 N Nuc1 
Temperature I °C 
220 
140 
180 
180 
Reaction 
Time I min 
30 
30 
30 
30 
Figure 3.27 Attempted reactions of heterocycles 25 and 27 with nucleophiles 
The reaction of 27 with NaOMe did show some reactivity, however, to the desired 
monofluorinated product, with 66 % clean conversion by LCMS reaction mixture 
analysis to a product with an m/z (ES+) value corresponding to the expected 
mono fluorinated heterocycle ([M+ + H+) 262.1 ). Mass directed auto purification yielded 
two fractions corresponding to the following isomeric products (ratio calculated from 
masses obtained): 
Q-Me Q-Me Q-Me 
FUN 
\ \ 
1.1 eq NaOMe, MeotiN FUN I~ dry MeOH I .-- + I "'"' F N.-- OMe 3 eq NEt3, MW F N OMe MeO N OMe 
27 140 °C, 30 min 2 
31, 1% 32,3% 
Figure 3.28 
Clearly the methoxy substituent is slightly less deactivating than the comparative 
amino-functionalised systems tested, as the analogous reaction carried out on 
diethylamino-substituted heterocycle 25 gave no conversion (Figure 3.27, entry 2), 
while the strongly nucleophilic alkoxide reagent is needed to affect reaction, as 27 
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showed no desired reactivity when heated with nitrogen nucleophiles (Figure 3.27, 
entries 3 and 4). 
-90 -!30 ~t40 -150 -160 -!70 -180 
Figure 3.29 19F NMR of the reaction mixture resulting from microwave irradiation of 
27 (-106, -172 ppm) with NaOMe to give 31 (-98 ppm) and 32 (-174 ppm) 
Though poorly phased, this spectrum illustrates the prominence of isomer 32 as a major 
product( singlet peak at -174 ppm). 
Repeating this reaction with phenyl substituted derivative 29 gave one product by 19F 
NMR of the resulting mixture. Though the reaction was carried out on a small scale, 
work up yielded a yellow solid, which was shown by LCMS analysis to have a mass 
corresponding to the desired monofluorinated product. Furthermore, the singlet 
resonance observed by 19F NMR (52 %conversion by integration) at -93 ppm suggested 
the product to be highly functionalised dipyridoimidazole derivative 33 (Figure 3.30). 
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, .. 
Figure 3.30 19F NMR of the crude obtained from the reaction of29 with NaOMe (top); 
suggested product from this reaction (bottom) 
The phenyl substituent activates and directs the site of attack by the oxygen nucleophile 
due to its ability to stabilise the negative charge developed in the course of the reaction 
(Figure 3.31). This would evidently not be the case if attack occurred at the other C-F 
site. 
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Me Me 
N N 
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29 N N 
F N F N ~ etc . ~ .... .. .... 
F N F N MeO MeO 
Figure 3.31 
3. 7 Fluorescence Studies 
Virtually all the tricyclic compounds discussed m this Chapter proved to be highly 
fluorescent when exposed to long wave UV light. As this is an area of interest to 
material scientists, in particular electron deficient heterocycles,9 emission spectroscopy 
was undertaken on tricycle 20 to establish the characteristics of this emitted light. 
1.2 
c 
.2 i 0.8 
E 
• 0 .6 
i 
.!! 
• o• ~ 
~ 02 
Wavlength vs emmision 
500 550 600 
W•velength/nm 
Figure 3.32 Emission spectrum and sample, under UV light, of20 
Excitation at 325 nm gave the above spectrum and, while the observed 
photoluminescence with "-max 397 nm is in the violet region of the electromagnetic 
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spectrum, the sample appears blue violet due to the shoulder of the emission trace 
extending well into the blue region. 
3.8 Conclusions 
To summarise, the synthesis of three partially fluorinated and highly novel tricyclic 
dipyridoimidazoles have been developed in facile one pot processes from the 
commercially available pentafluoropyridine. In particular, the methyl-substituted 
heterocycle 20 has proven to be an excellent scaffold for further nucleophilic aromatic 
substitution, reacting regioselectively and under relatively mild conditions to yield a 
series of nitrogen, oxygen, carbon and sulfur-substituted heterocycles. Further 
substitution has been proven possible with the formation of dibenzenethiol-, dimethoxy-
and phenyl-methoxy-substituted monofluoro heterocycles. Using this methodology, a 
wide range of highly functionalised compounds, built around a novel core scaffold, can 
be envisaged and would be of interest to organic chemists in both the life sciences and 
materials arenas. 
Fix~ F 
I -,.., 
F N F 
Figure 3.33 
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Chapter 4 
3-Chloro-2,4,5,6-tetrafluoropyridine as a Scaffold for Pyridine 
Ring-Fused Heterocycle Synthesis 
4.1 Introduction 
As shown in Chapters two and three, pentafluoropyridine reacts with suitable N, N-
centred binucleophilic species, in one or two steps, to give novel trifluorinated pyridine 
ring-fused heterocycles in mainly very good to excellent yields. Furthermore, a 
selection of the core scaffolds were shown to be reactive to further nucleophilic 
displacement, hence providing scope for library synthesis based upon such drug-like 
motifs. 
Figure 4.1 Possible [5,6) systems from pentafluoropyridine 
In light of its close structural similarity to pentafluoropyridine, 3-chloro-2,4,5,6-
tetrafluoropyridine was hypothesised to undergo reaction with the aforementioned 
binucleophiles in a closely analogous manner. The planned reaction with benzamidine 
is given as an example to illustrate this (Figure 4.2): 
2 N:NH2 
CI~F 
)L .. ~ F N F 
0 
N~ CltiNH I"" 
...-: 
F N F 
Figure 4.2 Predicted reaction of3-chloro-2,4,5,6-tetrafluoropyridine with benzamidine 
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The resulting chlorinated heterocycles could possibly undergo reaction at the C-CI site, 
such as metal-catalysed coupling reactions or reduction to C-H, giving rise to other 
functionalised ring-fused systems and expanding considerably the range of products 
available. 
4.2 Background 
3-Chloro-2,4,5,6-tetrafluoropyridine is a byproduct from the large scale synthesis of 
pentafluoropyridine and, as such, is a cheap and commercially available perhalogenated 
starting material. 1 
Cl 
CI~CI 
Y- .. ~ Cl N Cl 
KF 
Autoclave 
480 °C 
F~F 
_l .. ~ F N F 
68% 
£0.88/ g 
f 
CIUF 
+ I 
..< 
F N F 
7% 
£0.80 I g 
Figure 4.3 Fluorination of pentafluoropyridine to give pentafluoropyridine and 3-
chloro-tetrafluoropyridine 
Although the majority of early work in perhalogenated heteroaromatic chemistry 
focused on the reactions of pentafluoropyridine, a kinetic study carried out on a range of 
perhalogenated heterocycles showed that, as well as reacting with ammonia to give 
exclusively 4-substituted product, 3-chloro-2,4,5,6-tetrafluoropyridine actually reacted 
more rapidly than its perfluoro counterpart.2 
X~F 
_l~ 
F N F 
NH3, 
dioxan-water 
RT 
NH2 
x-vl:> 
Y- .. ~ F N F 
X 
Cl 
F 
1.9 X 10"3 
6.8 X 10"4 
Figure 4.4 Rate constants for reactions ofpentafluoropyridine and 3-chloro-2,4,5,6-
tetrafluoropyridine with ammonia 
It is argued that the higher reactivity shown by the chlorine-containing ring towards 
nucleophilic attack cannot be explained by comparing the intermediate Meisenheimer 
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complexes of the two reactions, rather, the initial state effects must be studied (Figure 
4.5). 
Nuc: 
Ffl I"' 
/-
F N F 
(i) 
N)2cuc F F F ( e '; 
F N F 
Nuc: vs 
Ffll I /-
F N F 
(i) 
N)2cuc F F Cl 
:·e:· 
·-~" 
F N F 
Nuc = NH3 
Figure 4.5 Initial states (I) and Meiseheimer complexes (r) between perhalogenated 
pyridines and nucleophile 
It is suggested that in the case of pentafluoropyridine, a strong repulsion would be 
expected between the two highly polarised and electron dense fluorine atoms, whereas, 
in the chloro-system, the more diffuse chlorine would provide less of a destabilising 
effect. 
This trend is reversed, however, when the study was carried out with the more sterically 
demanding nucleophile, diethylamine. Not only did the reaction proceed more slowly in 
the chlorine containing system but a proportion of the 6-substituted product also 
formed, reflecting the more crowded nature of the 4-position by the relatively bulky 
chlorine atom. 
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F~F )L_;L 
F N F 
" 
FnCI 
I "" F N F 
HNEt2, 
dioxan 
RT 
HNEt2, 
dioxan 
RT 
... 
NEt2 
F~~.> 
JL .. ~ F N F 
5.1 x 10·3 
NEt2 
FnCI 
I .-< 
F N F 
9.7x10'4 
" 
FnCI 
+ I ~ 
Et2N N F 
1.7 X 10'3 
Figure 4.6 Rate constants (k I I mo1'1 s'1) for reactions ofpentafluoropyridine and 3-
chloro-2,4,5,6-tetrafluoropyridine with ammonia 
More recently, 3-chloro-2,4,5,6-tetrafluoropyridine has been used as a scaffold for the 
synthesis of novel fluorinated pyridones3 and nucleoside analogues by multistep 
strategies as shown in Section 1.4.2 and the following example:4 
" F~CI RJ:l 0 N 0 FtxCI JL .. ;L F N F 
87% 
[ Raney Ni, 
~dry EtOH 
H I "" 
"' F N F 
F~2 
N F 
73% 
o={ 
R 0 N 0 
i)'suNH2 ~
ii) CF3COOH F)l_l Cl 
H2N N F 
FY} 
N F 
55% 
(from SM) 
NH2 
F~NH2 
t;L N F 
~ 0 o-< _/ 
0 .... Fti 
N F 
95% 78% 
Figure 4.7 
1Bu-CN, 
THF 
R 0 N 0 
F~CI 
lL.;l 
N F 
NH40H(aq)l 
NH2 
Pd/C, H2 F~CI 
t~ N F 
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Reaction of 3-chloro-tetrafluoropyridine with phthalimide gave the 4-substituted 
system, which was then substituted at the 6-position by terl-butylamine. Reduction and 
subsequent removal of this group gave the desired difuoropyridine core scaffold, which 
was then reacted appropriately to give 4,7-difluoro-imidazo[4,5-c]pyridine via an ortho-
diamine annulation strategy. 
With the methodology developed in Chapters two and three in hand, 3-chloro-2,4,5,6-
tetrafluoropyridine was concisely explored as a scaffold for [5,6] heterocycle synthesis, 
starting with the reaction with the N, N-unsubstituted binucleophile, benzamidine 
hydrochloride. 
4.3 Reaction with Benzamidine 
Nucleophilic substitution of benzamidine occurred under the same conditions as 
employed in the analogous reaction with pentafluoropyridine and also more rapidly, 
going to completion in only three hours, consistent with kinetic studies carried out on 
these systems as discussed above. While attack by the sterically relatively undemanding 
amidino-species occurred exclusively at the 4-position, by 19F NMR, recrystallisation 
was necessary to provide a pure sample, hence a lower yield was obtained than in the 
equivalent reaction with pentafluoropyridine. 
4 eq NaHC03, 
MeCN 
refiux, 3 h 
Figure 4.8 
34,53% 
A sample of this 4-amidino-substituted pyridine was reacted with LDA and resulted in 
the successful formation of imidazopyridine 35, in an unoptimised yield of 34 %, with 
no attack at the C-CI site being observed. 
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2.2 eq LDA, THF .,._ 
-78°C-RT 
0 
N=( 
CI~NH JL.'l F ' N""• F 
Figure 4.9 
35,34% 
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0 HN~ 
CI'-/~_)-J Jl.~ F•N"''.F 
X-ray crystallography confirmed the bicyclic structure, whilst two sets of fluorine 
resonances were observed by 19F NMR of the isolated solid, consistent with 
trifluorinated analogue 3 (Figure 4.1 0). 
-80 . -90 
'· 
Figure 4.10 Crystal structure and 19F NMR of 35; Of (DMSO-d6) major tautomer -81.62 
(IF, br s, F-6), -85.38 (IF, br s, F-4); minor tautomer -81.10 (IF, br s, F-6), -86.88 (IF, 
br s, F-4) 
Co-crystallisation of the heterocycle with acetonitrile illustrates the acidic nature of the 
NH group, which coordinates to the basic nitrogen of the acetonitrile solvent. 
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Although chloride ion is a weaker base and thus a better leaving group than fluoride, the 
rate determining step of nucleophilic aromatic substitutions, in general, is the initial 
attack of nucleophilic species on the pyridine ring. Hence in this case, attack by the 
tethered amidine occurs at the C-F site due to this being more electron deficient than 
C-CI. 
4.4 Reaction with 2-amino-3-picoline 
The reaction of 3-chloro-2,4,5,6-tetrafluoropyridine with 2-amino-3-picoline reacted 
accordingly to give tricycle 36 in good yield. 
1:' CIUF ccMe I + I 
"" /-F N F N NH2 
4 eq NaHC03, 
MeCN 
Reflux 
Figure 4.11 
Q-Me 
CltiN I"" 
/-
F N F 
36,69% 
Subsequently, with multigram quantities at disposal, this core scaffold was reacted with 
a small selection ofnucleophiles to give a series ofmonofluorinated derivatives in work 
carried out by L. Convery (M.Chem student, 2006). 
r\---Me 
'~-i 
CltiN I"" 
/-
F N F 
Nuc 
Figure 4.12 
r\---Me 
'N-i 
CltiN I"" 
/-
F N Nuc 
Nuc %yield 
NHBu 97 
NEt2 71 
OMe 32 
In each case, 19F NMR of the reaction mixture indicated substitution was occurring 
regioselectively at the same site as in the pentafluoropyridine derived system. This is 
due to the close similarity of the two heterocycles.5 
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Furthermore, reduction of the C-CI bond was achieved using conditions employed by 
Schlosser et a/ on halogenated pyridines6 to yield difluoro compound 37 in an 
unoptimised yield of 40 %. 
r\--Me 
ti'N~ HCOONH4, Cl "" N Pd I C, THF I "" reflux, 2 d F N F 
Figure 4.13 
Q-Me 
~N 
F)_N__,lF 
37,40% 
Insertion of the metal catalyst occurs at this position, as opposed to a fluorinated site, 
due to the weaker bond strength of the C-CI bond relative to C-F. Indeed, reduction of a 
C-F bond would not be possible at all under these reaction conditions. 
4.5 Conclusions 
Though relatively few reactions are reported in this chapter we have demonstrated that 
partially fluorinated analogues of the pentafluoropyridine-derived compounds discussed 
in Chapters two and three can be readily synthesised from 3-chloro-2,4,5,6-
tetrafluoropyridine. This is especially important in the context of probing the effects of 
fluorine on physical properties and also biological activities. Figure 4.14 shows an 
example of how this could be implemented. Further to providing data on the change in 
physical properties depending on the positioning of fluorine on the pyridine ring, by 
employing a range of nucleophiles a large number of compounds could be created in 
short and high yielding syntheses. 
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~Me 
'N--{ 
i.':( 
F N Nuc 
~Me 
Fu'Ni 
I"' 
/-
N F 
F~ 
Nuc .,_ t-:1 
N Nuc 
Figure 4.14 
Nuc = NHR1R2, OR, 
Grignard reagent etc 
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Chapter 5 
4-Substituted Tetrafluoropyridines as Scaffolds for [5.6] Pyridine 
Ring-Fused Heterocycle Synthesis 
5.1 Introduction 
As shown in Chapter I, pentafluoropyridine, since it was first synthesised in the 1960s, 
has proven a most reactive and selective species towards nucleophilic substitution by 
mononucleophiles, as shown in the following example of a 4-amino-3,5-difluoro-2,6-
diphenoxypyridine synthesis: 1 
17 F~F 
_A __ ;L 
F N F 
Steps 
Figure 5.1 
It has also been shown in chapters 2 and 3 that pentafluoropyridine reacts with suitable 
binucleophiles to give highly novel pyridine ring-fused heterocycles. Thus it was 
reasoned that reaction of 4-substituted tetrafluoropyridines, obtained either through 
commercial sources or synthesised from pentafluoropyridine, with binucleophiles 
should, potentially, give access to a range of [2,3]-pyridine-fused core scaffolds. This 
strategy is illustrated schematically in Figure 5.2 
X 
F~F R 
JL;l +A FN"'fYZ 
Base, 
Polar solvent 
Y = Z = N (amidines) 
Y = 0, S; Z = N (amides I thioamides) 
Y = 0; Z = C (1 ,3 dicarbonyls) 
X 
F~y 
J. .. J- }-R F N z 
Figure 5.2 
Further 
Reactions? 
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As shown in Section 1.4.2, this approach has proven to be effective for [6,6] ring-fused 
synthesis when 4-benzenesulfonyl-tetrafluoropyridine was reacted with a series of 
ethylene-diamino species:2 
R1, R2 = H, Me 
R3, R4= H, Ph 
NaHC03 
MeCN, reflu~ 
Figure 5.3 
Ph02S R 
FnNxR3 
F N N R4 
R2 
34-92% 
As well as giving access to [2, 3]-pyridine ring-fused heterocycles, this strategy could 
yield compounds bearing useful functional groups, such as a bromine atom for further 
derivatisation. Furthermore, if a strongly electron withdrawing group were employed, it 
should aid nucleophilic attack at the usually least activated 3-position of the pyridine 
scaffold, e.g. in a similar manner to the perfluoroisopropyl activating effect as shown in 
Section 1.4.1: 
FtxCF(C~3)2 
"""' 11 eq NaOMe, I '""' MeOH, reflux, 1 ! 
F N F 
Figure 5.4 
CF(CF3)2 
F~OMe 
~--)_ MeO N OMe 
75% 
As such, the following section will detail the reaction of a small selection of 4-
substituted tetrafluoropyridines with N. N -<:entred binucleophilic species with the aim 
of achieving a range of novel heterocyclic scaffolds. A range of fluoropyridine 
derivatives were tried in order to assess functional group compatibility of this process 
(Figure 5.5}. 
X F~F Wuc1 
~--;l F N F 
F:CcX F I ~ Nuc2) 
F N Nuc1 
F~Nuc) F~N~Nuc1 
X= H, Br, S02Ph, CN 
Figure 5.5 Desired reaction between 4-substituted tetrafluoropyridines and 
binucleophilic species 
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5.2 Reaction of 2,3,5,6-Tetrafluoropyridine and 4-Bromo-2,3,5,6-
tetrafluoropyridine with Benzamidine 
Reaction of the commercially available 2,3,5,6-tetrafluoropyridine with benzamidine 
hydrochloride proceeded extremely slowly, taking eleven days at reflux to achieve 90 % 
conversion. As expected, attack occurred exclusively at the 2-position, whilst a yield of 
34 %was obtained: 
F~F 
)l .. A F N F 
4 eqNaHC03, 
MeCN 
reflux, 270 h 
Figure 5.6 
N~nF ~N N F 
u 38,34% 
Attempts to cyclise this tethered amidino-substituted system using the strong organic 
base LDA failed and this can be attributed to the lower electrophilicity of the pyridine 
ring. As such, this fluoropyridine derivative is unsuitable for imidazopyridine synthesis 
via the developed methodology. 
2.2 eq LDA, 
THF 
' \ 
-78 °C - RT- reflux 
Figure 5.7 
H F ~NNn 
N F 
Reaction of 4-bromotetrafluoropyridine with benzamidine gave the uncyclised system 
39 after prolonged refluxing in acetonitrile, with attack by the hard nucleophilic species 
occuring at the hard 2C-F position rather than the softer C-Br site. 
Br 
F~F 
)l .. ~ F N F 
4 eq NaHC03, 
MeCN 
reflux, 21 0 h 
Figure 5.8 
Br 
N~UF ~N N F u 39,47% 
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However, even the presence of a bromine atom in the 4-position failed to affect 
cyclisation, when 39 was reacted with LDA, in an attempt to reach the imidazopyridine 
target molecule. 
Br 
N~~F ~ JL.:l N N F 
39 
1.1 eq LDA, 
THF 
' 
-78 °C- RT- reflux 
Figure 5.9 
H~F ~Nj!_)_ 
N N F 
From these systems we can deduce that a more electron deficient pyridine is required, 
not only to aid cyclisation but also so that the binucleophilic species can be initially 
tethered under reasonable reaction conditions. Thus, our study led us to explore the 
reactions of 4-benzenesulfonyl-2,3,5,6-tetrafluoropyridine (X = S02Ph) and 2,3,5,6-
tetrafluoro-4-pyridinecarbonitrile (X = CN), as highly electron-deficient pyridine 
systems, with suitable binucleophilic species. 4-Nitro-2,3,5,6-tetrafluoropyridine (X = 
N02) was not included as this has been shown previously to be a poor scaffold for 
derivatisation, with nucleophilic substitution of the nitro group competing significantly.3 
5.3 Reaction of 4-Benzenesulfonyl-2,3,5,6-tetrafluoropyridine with 
Binucleophilic Species 
5.3.1 Reaction with Amidines 
Synthesis of 4-benzenesulfonyl-2,3,5,6-tetrafluoropyridine 40 was achieved according 
to literature procedure,4 giving a 62% yield after recrystallisation. 
DMF 
130 °C 
40,62% 
Figure 5.10 
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Reflux of 40 with benzamidine hydrochloride was followed by 19F NMR of the reaction 
mixture and, although proceeding slowly, a major product containing two fluorine 
atoms by 19F NMR could be seen to form. Work up and recrystallisation of this 
experiment yielded a yellow solid, which proved to be the desired [2,3]-pyridine 
annulated system by NMR and MS characterisation. Analogous reaction of the sulfonyl 
derivative with acetamidine hydrochloride gave similar results and X-ray spectroscopy 
gave definitive proof as to the ring formation (Figure 5.12). 
o l o 
s oso 
F F 4 eq F H R NaHC03 N + 2 .... R 
F N F H2N NH.HCI 
MeCN N F N 
40 R % 
41 Ph 36 
42 Me 26 
Figure 5.11 Reaction of 40 with benzamidine and acetamidine hydrochloride 
Figure 5.12 X-ray structure of 42 
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Although both initial attack and ring annulation was achieved in a one-pot process, the 
yields are moderate to low. This is due, in part, to prolonged heating of the reactions, 
leading to thermal decomposition of the materials. Another probable factor in this case 
is the undesired displacement of the 4-substituent by the nucleophilic species, with 4-
substituted byproducts clearly observed by 19F NMR of the reaction mixture. 
----~ 
R 
HN~NH 
F~F 
~--~ F N F 
Figure 5.13 
+ 
Consistent with previous chemistry carried out on this compound that showed a similar 
displacement of the sulfonyl group by lithium diethylamide to occur,2 it can be reasoned 
that the highly electron withdrawing nature of the benzenesulfonyl group makes the 
carbon to which it is attached liable to attack as well as the desired 2C-F site. 
Elaboration of these core scaffolds was studied briefly through the reaction with oxygen 
nucleophiles. Refluxing 41 with sodium ethoxide gave 86 % conversion to several 
products (by 19F NMR of the reaction mixture), whilst this observation was 
corroborated through NMR and GCMS analysis obtained from the mixture resulting 
from the reaction between 42 and sodium methoxide. 
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2 1 
(s. -150 ppm) (s, -92 ppm) 
nOEl H F N -t-0 F N N 
1 
(d. -100; d, -178 ppm) 
~~~~~~~~.~~~.!!· ~~·~. ~~~~~~.~~. !'~~-n~.IIII.••J-_.,,~~ 
-90 
. 
it. I& 
-100 -110 -120 -130 -140 -1511 -160 -110 -180 pp• 
U.ll 
• 
"·" 11.11 
Figure 5.14 Products formed from the reaction of 41 with NaOEt and their appearance 
by 19F NMR of the reaction mixture 
This result is logical as, although one would expect the C-F site ortho to the pyridine 
nitrogen to be the most activated site to nucleophilic substitution, the benzenesulfonyl 
group has such an electron-withdrawing effect that displacement of the fluorine located 
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adjacent to the C-S02Ph site occurs. Again, displacement of the benzenesulfonyl group 
is also a competing process. Purification of products proved to be too difficult to 
achieve. 
5.3.2 Reaction with 2-Amino-3-picoline 
Reaction with the cyclic binucleophile 2-amino-3-picoline proceeded slowly in keeping 
with its low initial reactivity, giving roughly 50 % conversion after one week at reflux 
and resulting in a complicated 19F NMR of the reaction mixture. Work up and 
purification, along with the knowledge that the benzenesulfonyl group is also labile in 
these nucleophilic displacement reactions, led to the assignment of the following three 
compounds as the main products. 
9 o.,S""o 
FxXF+ ~.~)[) 
F N F H2N N 
40 
4 eq NaHC03, 
MeCN ., 
Reflux 
7 
43,8% 
Figure 5.15 
+ 
9 
Me~ 
);--~ 
+ 1'(/"":Y F 
JL .. ~ F N F 
44,4% 
3 
20 
Marginally the major isomer, 44 was the desired compound in that initial attack at the 2-
position of the fluoropyridine and subsequent cyclisation was expected, whilst X-ray 
crystallography confirmed the structure of this product: 
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Figure 5.16 X-ray structure of 44 
X-ray crystallography of the other major product revealed the surpr1stng isomeric 
structure 43: 
Figure 5.17 X-ray structure of 43 
This unexpected product presumably arises from initial attack of the picoline at the 3-
position of the fluoropyridine followed by ring closure at the most activated 4-position, 
via the displacement of the benzenesulfonyl group. The newly displaced sulfonyl group 
being anionic and hence nucleophilic, then attacks the fluoropyridine at the 6-position to 
give tricycle 43. As the third major product, the [3, 4)-pyridine-fused tricycle 20 could 
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clearly be observed by 19F NMR of the reaction mixture. Overall, attack occurs at C-2 
and C-3 in roughly equal quantities. This is not in keeping with previous studies, where 
attack by amine nucleophiles occurred at C-2, and is attributed to the ortho-directing 
effect of the benzenesulfonyl group towards the binucleophilic species. 
As well as forming two functionalised and highly novel heterocycles, this reaction 
illustrates the selectivity of this fluoropyridine to nucleophilic attack. It goes without 
saying that these new tricyclic species were both highly fluorescent. 
5.4 Reaction of 2,3,5,6-Tetralluoro-4-pyridinecarbonitrile with Binucleophilic 
Species 
To further the scope of this chemistry, the commercially available 2,3,5,6-tetrafluoro-4-
pyridinecarbonitrile was deemed a potentially excellent core for fused ring synthesis, 
having been used previously to make [6,6] systems upon reaction with ethylene diamino 
binucleophilic species.3 
5.4.1 Reaction with Amidine Nucleophiles 
Reaction with two equivalents of benzamidine hydrochloride led to two maJor 
resonances by 19F NMR after seven days at reflux, while work up and recrystallisation 
gave a yellow solid in good yield. Analysis of this compound clearly showed that this 
was not the expected [2, 3]-pyridine ring-fused structure but a [2, 5]-substituted system. 
X-ray analysis of a suitable crystalline sample showed the product to be the [6,6) fused-
pyridopyrimidine 45 (Figure 5 .19). A similar result was obtained in the reaction with 
acetamidine hydrochloride. 
CN FUF I + 
-"' F N F 2 
4 eq 
NaHco,. 
MeCN 
Figure 5.18 
R % 
45 Ph 58 
46 Me 17 
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Figure 5.19 X -ray structure of 45 
The reactions were repeated with one equivalent of the binucleophile to see whether the 
fused rings could be obtained without the addition of a second amidine moiety to the 
fluoropyridine (I.e. 48 and 50) and, although this was found to be the case, the 
uncyclised isomers 47 and 49 were also formed to give a roughly 1 : l mixture of the 
isomeric structures shown in Figure 5.20: 
CN 4 eq 
F F R NaHC03.,.. .-
+ MeCN 
F N F H2N NH.HCI 
Mechanism for (6,6] pyridopyrim1dine formation 
.-NH2N H2 
R N N R 
.( 
... 
F N F N W shift 
i .... 
F N F F N F 
CN 
Nf{ F T + 
R 
HN 
~ 
F 
F 
N N F 
1 
47 R =Ph, 20% 
49 R = Me,17% 
H 
N R H2N 
... 
N F 
-.. 
l. 
N F F 
Figure 5.20 
H2N N R 
F N 
.-
F N F 
1 
48 R =Ph, 5% 
50 R =Me, 8% 
N R 
N 
N F 
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Figure 5.21 X-ray structures of 47 (1) and 48 (r) 
From these isomeric products we can deduce that, in the case of the formation of 45 and 
46, the first equivalent of amidine attacks both the 2- and 3-position of 2,3,5,6-
tetrafluoro-4-pyridinecarbonitrile at roughly equal rates to give the uncyclised 
intermediate and the pyridopyrimidine respectively while the second equivalent attacks 
para to the site of initial attack, in both cases (Figure 5.22). This is somewhat surprising 
in the case of pathway II, where one might expect attack to occur ortho to the first 
equivalent, in light of the neighbouring group effect -N=C showed in the 
imidazopyridine systems. This is presumably down to differing electronic properties 
between the imidazo- and pyrimido- fused rings. 
R N~ U CN~F k:. I H2N NH.,... 
CN R N N F H2N N R J ..... I F F 
" ~~ 1 N Pathway 1 F N ' F II H2N N R R N N F 
R ....... 
..,... 
" 
F N 
H2N NH 
F 
Figure 5.22 Two routes to compounds 45 and 46 
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5.4.2 Reaction with 2-Amino-3-picoline 
Although reacting slowly, reaching 70 % conversion after two weeks, owing to the low 
nucleophilicity of the picoline and despite the electron deficient nature of the 
fluoropyridine, 19F NMR of the reaction mixture showed one major product consisting 
of two doublet resonances. The reaction was worked up and the crude subjected to 
column chromatography to yield the main product as a yellow solid. Whilst 
characterisation of this compound indicated that two fluorine atoms had been displaced 
by a single picoline species the structure of this pyridine-fused ring could not be 
established. Thus, it has been assumed that initial attack through the ring nitrogen of 2-
arnino-3-picoline occurred at the least sterically hindered 2-position of the 
fluoropyridine core scaffold, leading to the formation of tricycle 51. 
CN 
FnF I + 
/-
F N F 
4 eq NaHC03, MeCN 
Reflux, 
2 weeks 
CN 
Me)----fJC:C F + GN N F 
4 
51,52% 
Figure 5.23 
FN__LF 
J---< .JL .. ~ Me N N F 
This reaction is surprisingly selective given the mixture obtained from the analogous 
reaction on the 4-S02Ph substituted tetrafluropyridine and illustrates how these 
condensation reactions are very dependent on both the nature of the binucleophilic 
species and the fluoro-core scaffold. 
This compound was shown to be a useful scaffold for functionalisation through the 
reaction with diethylamine, under relatively mild reaction conditions, to give 
mono fluorinated tricycle 52 (Figure 5.24). Although an unoptimised yield of only 17 % 
was obtained, 19F NMR and LCMS of the crude showed this to be a surprisingly 
selective reaction, both techniques clearly showing this to be the predominant product. 
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N~F MeKJLl GN N F 
51 
5.5 Conclusions 
5 eq HNEt2, THF 
MW, 150 °C, 30 min 
Figure 5.24 
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CN 
M N~F 
e 'Jl ~ )---<N N" N~ v l__ 
52, 17% 
To summarise, 4-substituted tetrafluoropyridines can be effective reagents for the 
synthesis of [5,6] and [6,6] pyridine ring-fused heterocycles as long as a strongly 
electron withdrawing group activates the heterocyclic ring and hence favour this 
process. In the case of the benzenesulfonyl substituted rings, a small library could be 
envisaged through the employment of substituted benzamidines and also the use of 
commercially available benzenesulfonyl anionic species: 
R1 
R1 9R2 
o"s"'o FJ.xF 
QR2 
I ..., + 0 0 
's' F~(:( F N F e I " Na 
(j) F N F 
R1 = 4-Me, R2 = 2-CI 
R1 = 4-F, Cl or Br, R2 = H 
R1 = 4-0Me, R2 = 2-NHAc 
R1 = 3-CFJ, R2 = H 
R1 = 4-CH=CH2 
R3 
2'' H2N NH.HCI 
R3, R4 =Hal, OH 
C02H, CN etc 
Figure 5.25 
~R2 
""-' 
o.;::::5 -:::.o 
txH F N - R3 1>--0 
F N N I 
R4 
Reaction with the 4-cyano substituted fluoropyridine with the acyclic amidines 
benzamidine and acetamidine, rather than forming an imidazopyridine fused ring, gave 
the intriguing [6,6] aza quinoline motif. 
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Perhalogenated Cyanopyridines as Scaffolds for Pyridine 
Ring-Fused Heterocycle Synthesis 
6.1 Introduction 
The discovery that the presence of a nitrile functionality on the fluoropyridine core, as 
well as activating to nucleophilic attack, could itself act as a site for reaction, gave 
access to a small number of pyrido-pyrimidine heterocycles. A lack of initial selectivity 
of nucleophilic attack, however, led to moderate yields at best of these [6,6] fused ring 
systems for example as shown by the reaction of 2,3,5,6-tetrafluoro-4-
pyridinecarbonitrile with one equivalent ofbenzamidine: 
CN 2"' F~F ~A.l + F N"' F H2N NH.HCI 
4eq CN NaHC03 ~ N~~F 
MeCN if A .. ~+ I"' N N F 
~ 
1 
47,20% 48,5% 
Figure 6.1 Reaction of2,3,5,6-tetrafluoro-4-pyridinecarbonitrile with one equivalent of 
benzamidine hydrochloride 
Exploring this condensation between an N ,N-centred binucleophile and pyridine 
systems containing an ortho-fluorine-nitrile moiety was thus considered appropriate 
both in terms of accessing further pyridine ring-fused heterocycles of this type and also 
to improve upon yields obtained on the 4-cyano-fluoropyridine based systems. 
Both the isomeric 2- and 3-cyano tetrafluoropyridines have been reported in the 
literature and were considered as substrates for reaction with suitable binucleophilic 
species. A consideration of the initial state effects of the electron withdrawing 
substituents resulted in the following predictions as to the site of attack if each ring were 
attacked by a mononucleophile. 
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2 ortho F 
1 para CN 
1 meta F 
~n" F "" I "' 2 F N CN 
1 ortho F 
1 ortho CN 
2 meta F 
1orthoF \n" 1 para CN F "-": 3 CN 
2 meta F ~ I ""' 
F N F 
Figure 6.2 Predicted initial state reactivities of 2- and 3-cyano tetrafluoropyridine 
towards nucleophilic attack 
In the case of 3,4,5,6-tetrafluoropyridine-2-carbonitrile, one would expect attack to 
occur para to the cyano substituent, due to the activating effects of two ortho and one 
meta fluorine atoms, while the negative charge developed in the course of the reaction 
could be delocalised onto the para nitrile functionality: 
Nuc·~F-•N~, - t~' '"-----c.,..NucY;F F)b~N FAN~~ ;;,:~N F)lN~N 
Figure 6.3 
Studying the initial state effects in 2,4,5,6-tetrafluoro-nicotinonitrile, towards attack by 
a nucleophilic species, leads to two potential sites of attack, para and ortho to the cyano 
group. Given that we wish to bring about attack of an amidines binucleophile at a C-F 
site ortho to a cyano functionality, this compound was chosen as the most appropriate 
reagent for exploration. 
As well as reacting with amidines to give [6,6) scaffolds, the reaction with suitable 
reagents, such as hydrazine, could give highly novel and interesting [5,6) pyridine-fused 
heterocycles: 
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x-Y Fft~ NH2 
I ~~------
"' F N F 
X= NR, Y = N (hydrazine) 
X= 0, Y = N {hydroxylamine) 
t; F~CN 
_,l,,;l 
F N F 
Cl 
CI~CN 
~-·~ Cl N Cl 
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Figure 6.4 Synthesis and potential reactions of2,4,5,6-tetrafluoro-nicotinonitrile 
As well as the studying the reactions of 2,4,5,6-tetrafluoro-nicotinonitrile, the reactivity 
of its perchlorinated precursor, through reaction with nucleophilic species, could be 
studied to ascertain whether this precursor could be a useful core scaffold. 
6.2 Background 
There has been relatively little reported on 2,4,5,6-tetrachloro-nicotinonitrile (40 'hits' 
on a Scifinder Scholar structure search). This literature can be split into articles 
concerning its synthesis and characterisation, the fonnation of 2,4,5,6-tetrafluoro-
nicotinonitrile (Halex reaction) from 2,4,5,6-tetrachloro-nicotinonitrile, the oxidation of 
the cyano group to give tetrachloro-3-nicotinic acid and nucleophilic attack to give 
substituted chloro-cyano-pyridines. 
Synthesis of 2,4,5,6-tetrachloro-nicotinonitrile revolves around reacting nicotinonitrile 
with chlorine gas at high temperatures with or without a catalyst.14 In the following 
example, synthesis was achieved by passing nicotinonitrile and a slight excess of Cb 
through a nickel coated U-tube containing an activated C catalyst impregnated with 27 
% BaCb at 370 °C. 1 Recrystallisation from CC14 gave the perchlorinated compound in 
57% yield. 
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r(YCN 
l!.. .. ) 
N 
_C_,I2~/N_.2'-' B...,a,--C__,12._c_a~ 
370 °C 
Figure 6.5 
Cl 
CI~CN 
JL .. ~ Cl N Cl 
57% 
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Large scale synthesis of the perfluorinated system has been accomplished by reaction of 
2,4,5,6-tetrachloro-nicotinonitrile with KF in benzonitrile at elevated temperatures.5•6 
Cl 
CI~CN 
JL .. ~ Cl N Cl 
KF, PhCN, 
autoclave 
-=:=::.:.::._,,.. 
320 °C, 11 h 
Figure 6.6 
F F~CN 
JL~ F N F 
40% 
Though there is no literature concerning the reaction of the perfluorinated nicotinonitrile 
with nucleophiles, the synthesis of the following thio-substituted pyridines from 2,4,5,6-
tetrachloro-nicotinonitrile has been reported (Figure 6.7).7• 8 
24% 44% 
Figure 6.7 
Reaction with the sulfur nucleophiles potassium iso-propyltrithiocarbonate and 
potassium ethylxanthate gave a mixture of 4- and 4, 6-substituted pyridines. 
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Synthesis of the following pyridine ring-fused heterocycles, through the reaction of 
2,4,5,6-tetrachloro-nicotinonitrile with suitable binucleophilic species, has also been 
reported:9 
CCXH 
Cl 
Cl ClnCN Cl 
ClnCN I "' 
NEI3, 
o:YnCN NH2 EtOH 
I "' ~ HN N Cl ~ I "' EtOH, reflux reflux Cl N Cl 
HYl6 
N N Cl 
H 
Y= 0, S, NH ""I 62-78% 66-72% 
Figure 6.8 
6.3 Reaction of 2,4,5,6-Tetrachloro-nicotinonitrile with Nucleophiles 
2,4,5,6-Tetrachloro-nicotinonitrile was accordingly reacted with the sterically 
unhindered mononucleophile butylamine to confirm the assessment of regiochemistry 
of attack and gave two new products by tic and no starting material after 4 h at reflux. 
Work up and purification by column chromatography gave a major fraction consisting 
of predominantly one compound (by 13C NMR) which, after purification by 
recrystallisation, was shown by X-ray crystallography to be isomer 53 (Figure 6.1 0): 
Cl 
CI~CN 
~ .. A Cl N Cl 
1.1eq H2N) 
4 eq NaHC03, 
MeCN, reflux, 4 h 
Figure 6.9 
53, 13% 
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Figure 6.10 X-ray structure of 53 
Reaction with benzamidine hydrochloride also gave complete conversion to two 
compounds (by tic), whilst the major product proved quite insoluble in DCM during 
work up, so was filtered to give 54 as a yellow solid. 
Cl 
CI~CN 
JL .. ~ Cl· N Cl 
0 1.~x. 
H2N NH.HCI 
--==-------] .... 
4 eq_NaHC03, 
MeCN, reflux, 4 h 
Figure 6.11 
Cl 
N~~~CN 
"JL .. ~ N N Cl 
54,36% 
Attack at the 2-position rather than the electronically favoured 4-position is presumably 
due to the relatively large bulk of chlorine atoms thus making the 4-position of the 
pyridine quite sterically congested and making reaction at the more accessible 6-
position the energetically lower pathway. Although this does give access to a range of 
novel trichlorinated pyridines, it doesn't provide any opportunity for the desired 
annulation at the cyano group in the reaction with the binucleophilic amidines and thus 
the focus of the work progressed to the fluorinated analogue. 
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6.4 2,4,5,6-Tetrafluoro-nicotinonitrile as a Scaffold for [6,6) Fused-Ring 
Synthesis 
6.4.1 Synthesis 
Synthesis of 55 was carried out under solventless conditions in line with the group's 
general approach to the synthesis of perfluorinated heterocycles. As such, a stainless 
steel autoclave was charged with 2,4,5,6-tetrachloro-nicotinonitrile and flame-dried 
potassium fluoride, sealed and heated at 320 °C for 22 h. The autoclave was allowed to 
cool to 200 °C, the gaseous fluorinated products removed under reduced pressure and 
condensed in a Young's tap-equipped vessel, 19F NMR of which showed the products in 
Figure 6.12 to be present. The presence of a large amount of 5-chloro-2,4,6-trifluoro-
nicotinonitrile is in keeping with the 5-position being the least activated to nucleophilic 
attack, in keeping with the general reactivities of fluorinated pyridines. 
Cl 
CI~CN 
Jl .. ~ Cl N Cl 
5.1eqKF 
autoclave, 
320 °C, 22 h 
li' 
FnCN + 
F N F 
1 
55, 16% 
Figure 6.12 
li' CI~CN 
JL.;L F N F 
2 
Distillation of this crude oil gave 2,4,5,6-tetrafluoro-nicotinonitrile (4.59 g, 16 %) in 92 
% purity. The remaining crude, along with more 2,4,5,6-tetrachlofo-nicotinonitrile, was 
reacted again in the autoclave, this time under more forcing conditions. A higher 
conversion to the desired product was obtained and distilled to furnish more 
perfluorinated pyridine. With several grams of this starting material in hand, a study to 
explore its reactivity and utility as a core scaffold for elaboration was undertaken. 
6.4.2 Reaction with Butylamine 
Reaction of 55 with butylamine gave two products, the presence of fluorine resonances 
in 19F NMR enabling the assignment to be made and, as is often the case in these 
substitution reactions of perfluorinated pyridines, providing a useful probe for the 
selectivity of reaction. Purification of this reaction mixture was not carried out. 
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" 1.1 eq H2N) 
c 
\Fi:ccN FtxCN FnCN 
I "'"' ... I ..., + F N F 4 eq NaHC03 , F N F N N F H 
55 MeCN, reflux, 19 h 3 2 
56 57 
Figure 6.13 Reaction of 55 with butylamine (ratio calculated from 19F NMR of crude) 
The fact the maJOr tsomer is the 4-substituted pyridine reflects the sterically less 
demanding nature of fluorine atoms compared to chlorine atoms, with attack occurring 
at the ortho position to the cyano substituent as opposed to the para 6-position as 
observed in the reactions of the chlorinated analogues. That the major product resulted 
from attack adjacent to the -CN site meant the desired reaction with an amidine 
binucleophile be possible. 
6.4.3 Reaction with Amidines 
Reaction of 55 with benzamidine hydrochloride proceeded at room temperature to the 
two products shown in Figure 6.14, [6,6] pyridopyrimidine-fused heterocycle 58 being 
isolated by recrystallisation in good yield. The better selectivity towards attack at the 4-
position compared to the reaction with butylamine presumably stems from interaction 
between the binucleophilic species and the nitrile group, providing a directing effect to 
this position . 
" F~CN 
~--~ F N F 
55 
. 2 2 
H2N NH.HCI .... FPNH2 
4 eq NaHCOa, )L. ;.L _ 
MeCN, RT, 70 h F N F 
9 
58,60% 
" 
NJ,nCN +~2 1 ,.... ..-: I : N N F 
1 
Figure 6.14 Reaction of 55 with benzamidine (ratio calculated from 19F NMR of 
reaction mixture) 
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This experiment was repeated with acetamidine and formamidine hydrochloride to yield 
the 2-methyl 59 and -hydro 60 heterocycles respectively (Figure 6.15). The formation of 
the latter is interesting as this is the first and only example from the work reported 
herein of where formamidine has been used successfully to form a pyridine ring-fused 
heterocycle and this can be attributed to the mild reaction conditions (room temperature 
and weak base), which in turn is thanks to the highly reactive nature of the pyridine 
scaffold. In the case of the methyl-substituted system, a sample suitable for X-ray 
analysis was grown, leading to conformation of the annulated product (Figure 6.16). 
R 
F R N N 1.1 
F CN H2N NH.HCI F r NH2 ~ 
F N F 
4 eq NaHC03, 
F N F MeCN, RT 
55 R % 
59 Me 37 
60 H 20 
Figure 6.15 Reaction of 55 with acetamidine and formamidine 
Figure 6.16 X-ray structure of 59 
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Even without crystallographic evidence, cyclisation can be inferred by comparing the 
13C NMR shifts observed for the nitrile carbon in the starting material (I 06 ppm) and 
the respective products (159-160 ppm). This marked difference certainly shows that the 
nitrile group has changed. 
It should be noted at this point that any trace of the 5-chloro intermediate from the 
synthesis of 55 results in its similar reaction to form a highly insoluble pyridine-fused 
ring. In some cases, even a small amount of this impurity precluded its removal via 
recrystallisation or column chromatography. Thus, 55 must be distilled to high purity to 
ensure minimal formation of byproduct. 
6.5 2,4,5,6-Tetrafluoro-nicotinonitrile as a Scaffold for (5,6] Fused-Ring 
Synthesis 
Having shown 2,4,5,6-tetrafluoro-nicotinonitrile to be an effective scaffold for [6,6] 
fused heterocycle synthesis via the reaction with amidine binucleophiles, the reaction 
with hydrazine hydrate was explored to ascertain whether [5,6] synthesis be possible 
using a similar strategy. Carrying out the experiment under the typically employed base 
and solvent choice of sodium bicarbonate and acetonitrile, no starting material was 
observed after 39 h at room temperature. The reaction was worked up to give an orange 
crude product, recrystallisation of which gave a yellow solid. Though 19F NMR of this 
sample consisted three resonances ( -65, -90 and -165 ppm), indicating the desired 
substitution had taken place, mass spectrometry clearly showed the product not to be the 
expected [5,6] fused ring. This product has been tentatively labelled as 61, forming via 
the following mechanism: 
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1:' F~CN )L;L 
F N F 
55 
Mechanism for formation 
oy 
N~N 
F~CN 
)L..~ F N F 
61 
yo yNH 
HN'NH HN'NH 
F~CN Work up F~CN )L __ ;L ~--~ )L_~ 
F N F F N F 
Fn?CN 
-I 
.-< 
F N F 
61 
Figure 6.17 
The reaction was repeated using ethanol as solvent, as in the condensation reaction 
between an ortho-chloro-nitrile species and hydrazine shown in Section 1.1.5. This 
time, analysis (NMR, MS, elemental analysis) of the resulting isolated product was 
consistent with the target molecule: 
1:' F~CN )L. _;L + 2 eq N2H4.H20 Ethanol, reflux, 5 h 
F N F 
55 
HN-N 
F~NH2 )L_;L_ 
F N F 
62,9% 
Figure 6.18 Formation of pyrazolopyridine 62 
Thus, in a single reaction, a highly functionalised and desirable pyrazolopyridine was 
obtained. 
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6.6 Conclusions 
A small series of novel fused pyridopyridimidines have been synthesised in a short 
sequence from 2,4,5,6-tetrafluoro-nicotinonitrile, a compound never previously used as 
a core scaffold for derivatisation, by nucleophilic substitution. Exploration of this 
scaffold, through further nucleophilic substitution on the fluoropyridine core and 
derivatisation of the amino functionality, could yield a range of derivatised products. 
R 
Nj__N 
:t(,B 
Nuc Nuc 
HN-N 
:~ 
Nuc Nuc 
Figure 6.19 
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Conclusions 
The mm of this project was to develop methodology for the synthesis of highly 
functionalised fused-pyridines from fluorinated heterocycles via sequential nucleophilic 
substitution reactions. As stated in Chapter I, there is a great demand for small, novel, 
"drug-like" heterocycles in the lead generation stage of drug discovery, and as such, the 
methodology developed herein could provide quick and efficient routes to library 
syntheses. 
Pentafluoropyridine proved to be an excellent core scaffold when reacted with suitable 
binucleophilic species, giving access to highly interesting imidazopyridine and 
dipyridoimidazole (both fully and partially unsaturated) fused ring systems. Each core 
scaffold proved to undergo further nucleophilic substitution in a highly selective 
manner, giving further scope for rapid analogue synthesis. An example of the formation 
and derivatisation of imidazopyridine 3 is given below: 
2 p p FXxF N:NH2 FxXF FnN FnN 
I "" I "" I"" I"" F N F F N F F N F F N"" N~ 
1, 96% 3, 91% 12, 54 % Me _ij 
Figure 7.1 
Employment of 4-substituted tetrafluoropyridines also proved successful when a 
suitable electron withdrawing group ( -S02Ph) was present on the ring and gave access 
to [2,3) imidazopyridine fused bicycles. 
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R % 
41 Ph 36 
42 Me 26 
Figure 7.2 
The presence of a cyano functionality on the core scaffold led to the surpnsmg 
pyrimidine annulation rather than the expected 5-membered ring formation. This result 
widened the range of heterocycles obtainable and was exploited to give a small series of 
highly functionalised [5,6] and [6,6] heterocycles, in one pot processes, from a 
fluorinated heterocycle never previously studied as a substrate for nucleophilic attack. 
1:' F~CN 
JL .. ;L F N F 
R % 
58 Ph 60 
59 Me 37 
60 H 20 
Figure 7.3 
HN-N 
F~NH2 
JL .. ;l_ F N F 
62,9% 
Overall, a range of polycyclic heterocycles were accessed bearing one, two or three 
fluorine atoms, from perfluoropyridine (five fluorine atoms) some of which are shown 
in Figure 7.4: 
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Ph 
N..( 
F~NH 
,)lNAF 
HN-N 
F~NH, 
• .Jl,A. 
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2 and 1 Fluortnes 
3 Fluortnes 
"'::&" "y" F N 
N F 
Figure 7.4 
In the majority of the developed methodology, much scope remains for varying the 
functional groups upon the binucleophilic species employed for ring annulation as well 
as the nucleophilic species subsequently substituted onto the fused rings, in a parallel 
manner and as described in the Conclusions of Chapters two to five. This, along with 
the general amenability of the methodology to microwave synthesis, could provide 
access to a range of highly novel heterocycles in a quick and efficient manner. 
To conclude, we have shown that a range of fused heterocycles of potential biological 
interest can be synthesised in a facile manner from pentafluoropyridine, or derivatives, 
using standard chemistry and mild reaction conditions. There exists considerable scope 
for library synthesis and, in this context, is of great interest to the pharmaceutical 
industry. 
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Technical Detail 
Ratios of products calculated from 19F NMR of reaction mixture unless stated 
otherwise. All starting materials were obtained commercially (Aldrich, Lancaster or 
Fluorochem) or from GlaxoSmithKiine's chemical stores, Stevenage. All solvents were 
dried using either literature procedures or via the Innovative Technology solvent 
purification system. Column chromatography was carried out on silica gel (Merck no. 
109385, particle size 0.040-0.063 mm) or using the Biotage Horizon flash 
chromatography system and TLC analysis was performed on silica gel or aluminium 
oxide TLC plates. NMR spectra were recorded in deuteriocholoroform, unless 
otherwise stated, on a Varian VXR 500S NMR spectrometer operating at 500 MHz (1H 
NMR), 376 MHz e9F NMR) and 125 MHz (13C NMR) with trichlorofluoromethane as 
an internal standard e9F NMR). Mass spectra were recorded on a Thermo Finnigan 
TRACE GCMS system and a Waters Micromass LCT spectrometer. Elemental analyses 
were obtained on a Exeter Analytical CE-440 elemental analyser. Melting points and 
boiling points were recorded at atmospheric pressure unless stated and are uncorrected. 
The progress of reactions were monitored by either 19F NMR or LCMS analysis. All 
crystallographic data was collected at T = 120 K on a Bruker SMART-CCD 6000 
diffractometer (A.MoKa, w-scan, 0.3 °/frame). The structures were solved by direct 
method and refined by full-matrix least squares on F2 for all data using SHELXTL 
software. All non-hydrogen atoms were refined with anisotropic displacement 
parameters, H-atoms were located on the difference map and refined isotropically. 
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N-(2, 3,5, 6-tetrajluoro-pyridin-4-yl) benzamidine, 1 
Fn~ F I + 
--" 
F N F 
2 eq NaHC03 
MeCN, reflux 16 h 
Chapter 8 
J'S?~' 2 ~ 6' 
' 
' N"' NH2 F~F _t_-:~ 
F 2 N' F 
1, 96% 
Pentafluoropyridine (6.76 g, 40.0 mmol), benzamidine hydrochloride (13.78 g, 88.0 
mmol) and sodium hydrogen carbonate (6.72 g, 80.0 mmol) were stirred under an 
atmosphere of argon in MeCN (400 ml) for 16 h at reflux temperature. The reaction was 
poured onto water (SO ml) and extracted with DCM (3 x 40 ml). Drying (MgS04) and 
evaporation of the organic layer gave N-(2,3,5,6-tetrajluoro-pyridin-4-yl) benzamidine 1 
(10.35 g, 96 %) as a white solid; mp 157-159 °C; (Found: C, 53.4; H, 2.6; N, 15.7. 
C12H7N3F4 requires: C, 53.4; H, 2.6; N, 15.6%); 8p (Acetone-d,;) -94.90 (2F, m, F- 2),-
153.88 (2F, m, F-3); 8H 8.01 (2H, m, H- 2'), 7.56 (lH, m, H- 4'), 7.49 (2H, m, H- 3'), 
7.02 (2H, s, NH2); 8c 159.44 (s, C-7), 144.73 (dm, 1JcF 236.6, C-2), 143.72 (m, C-4), 
136.53 (dm, 1JcF 236.8, C-3), 134.94 (s, C-1 '), 132.31 (s, C-4'), 129.32 (s, C-3'), 128.37 
(s, C-2'); mlz (Er+) 269 (~. 100 %), 253 (~- NH2, 72 %), 249.0 (~- HF, 90 %,), 
77.0 (C6Hs, 94 %). 
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N-(2, 3,5, 6-tetrajluoro-pyridin-4-yl) acetamidine, 2 
Fn~ F I + 
--" F N F 
2 eq NaHC03 
MeCN, reflux 
... 
Me 
N)<_NH2 
F~F FJ,LN~F 
2, 88% 
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Pentafluoropyridine (3.38 g, 20.0 mmol), acetamidine hydrochloride (4.16 g, 44.0 
mmol) and sodium hydrogen carbonate (3.36 g, 40.0 mmol) were stirred under argon in 
MeCN (200 mL) for 17 h at reflux temperature. The reaction solvent was evaporated 
and the remaining residue treated with water (50 ml). Extraction by DCM (3 x 40 ml), 
drying (MgS04) and evaporation of solvent gave N-(2,3,5,6-tetrajluoro-pyridin-4-yl) 
acetamidine 2 (3.64 g, 88 %) as an off-white solid; mp 142-145 °C; (Found: C, 40.6; H, 
2.4; N, 20.2. C7H5F4N3 requires: C, 40.6; H, 2.4; N, 20.3 %); OF (DMSO-d6) -94.96 (m, 
F-2), -154.09 (m, F-3); 8H 7.42, 6.94 (2H, br s, NH2), 1.97 (3H, s, CH3); 8c 161.15 (s, C-
7), 143.34 (dm, 1JcF 237.3, C-2), 142.96 (m, C-4), 135.49 (dm, 1JcF 249.5, C-3), 20.65 
(s, CH3); mlz (Et') 207.0 (M+, 100 %), 192.0 (M+- CH3, 82 %). 
4,6, 7-trijluoro-2-phenyl-3H-imidazo[4,5-c] pyridine, 3 
2 
,h:"' 
F N F 
1 
2.2 eq LOA, THF, 
-78 °C - RT, 24 h 
3, 91% 
LDA (17.19 mL 1.8 M solution in heptanefTHF/ethylbenzene, 30.9 mmol) was added to 
a stirring solution of N-(2,3,5,6-tetrafluoro-pyridin-4-yl) benzamidine 1 (3.79 g, 14.1 
mmol) in dry THF (250 mL) at -78 °C, under an atmosphere of dry argon. After 
warming to room temperature, the solution was stirred at room temperature for 24 h. 
The reaction mixture was evaporated and 50 mL 0.5 M HCI solution added. Extraction 
135 
Chapter 8 
of the organic layer (DCM, 3 x 40 mL) followed by evaporation gave a brown crude 
solid. Recrystallisation from MeCN gave 4,6,7-trifluoro-2-phenyl-3H-imidazo[4,5-cj 
pyridine 3 (3.20 g, 91 %) as an off-white solid and as a mixture of tautomers; mp 208-
209 °C; (Found: C, 57.8; H, 2.4; N, 17.0. C12H6N3F3 requires: C, 57.8; H, 2.4; N,l6.9 
%); lip (DMSO-d6) major tautomer (67 % by 19F NMR) -83.08 (IF, br s, F-6), -102.02 
(IF, br s, F-4), -161.60 (IF, br s, F-7); minor tautomer (33 %) -82.60 (IF, br s, F-6),-
104.33 (IF, br s, F-4), -163.00 (IF, br s, F-7); liH 8.18 (2H, br m, H-2'), 7.56-7.52 (3H, 
br m, H-3' ,4'); lie 155.42 (br m, C-2), 143.80 (dm, RH peak obscured, C-4), 142.50 
(dm, 1JcF 228.5, C-6), 135.20 (br m, C-5c), 131.25 (s, C-4'), 128.95 (s, C-3'), 128.07 (s, 
C-1 '), 127.26 (s, C-2'); m/z (Ef") 249.0 (M+, 100 %). 
Altempted Cyclisation of N-(2,3,5,6-tetrajluoro-pyridin-4-yl) acetamidine 
2 eq LDA, THF 
-78°C-RT 
NH2 F~F 
)_ __ ~ 
F N F 
4 
LOA (l.l1 mL 1.8 M solution in heptaneffHF/ethylbenzene, 2.0 mmol) was added to a 
stirring solution of N-(2,3,5,6-tetrafluoro-pyridin-4-yl) acetamidine 2 (0.21 g, 1.0 mmol) 
in dry THF (25 mL) at -78 °C, under an atmosphere of dry argon. After warming to 
room temperature, the solution was stirred at room temperature for 65 h. 19F NMR of 
the reaction mixture showed 2 new peaks (-96, -165 ppm). GCMS of the worked up 
crude had a major peak (7.8 min); m/z (EI) 165.9 (M+, 100 %). This data corresponds to 
4-amino-tetrafluoropyridine 4. 
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Fnt:='-' F I + 
.<: 
F N F 
4 eq NaHC03 
MeCN,RT 
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Pentafluoropyridine (1.69 g, 10.0 mmol}, formamidine hydrochloride (1.61 g, 20.0 
mmol) and sodium hydrogen carbonate (3.36 g, 40.0 mmol) were stirred under argon in 
MeCN for 23 h at room temperature. The reaction mixture was treated with water (50 
ml) and the organic products extracted into DCM (3 x 40 ml). The organic phase was 
dried (MgS04) and the solvent evaporated to give a white crude. Recrystallisation from 
MeCN gave N-(2,3,5,6-tetrajluoro-pyridin-4-yl) formamidine 5 (0.47 g, 24 %) as a 
white crystalline solid; mp 168-170 °C; (Found: C, 37.2, H, 1.5, N, 21.8. C6H3N3F4 
requires: C, 37.3; H, 1.6; N, 21.8 %); oF (DMSO-d6) -95.17 (2F, m, F-2), -156.89 (2F, 
br m, F-3); oH 7.95 (3H, br m, NH2, H-7); lie 157.66 (s, C-7), 143.73 (m, C-4), 143.38 
(dm, 1JcF 236.5, C-2), 135.97 (dm, 1JcF 248.9, C-3); m!z (EI) 193.0 (M+, 95 %). 
Reaction of Pentajluoropyridine with N-methyl-benzamidine hydrochloride 
p Me,p 
N 
FnN FnN-Me I" '""' 2 I '"' _..., F N F F N F 
FixF 
6 7 1.5 eq 
Me,N NH.HCI + + 
I ....: H 2 2 3 eq NEt3, THF I DMSO F N F MW, 180 °C, 30 min Me,N NH N'"' N'Me 
FnF Fn~ 
I '""' I '""' 
F N F F N F 
8 9 
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Pentafluoropyridine (0.0200 g, 0.1183 mmol), N-methyl-benzamidine hydrochloride 
(0.0303 g, 0.1776 mmol) and triethylamine (0.0359 g, 0.3549 mmol) were stirred 
together, in a mixture of THF (0.75 mL) and DMSO (0.30 mL), in a sealed microwave 
vial at 180 °C for 30 min. LCMS of the reaction mixture consisted of two peaks; the 
first at 3.1 min (24% by TIC trace) with W + W 264.1 and the second at 3.3 min (76 
%) with W + H+ 284.0. MDAP of the crude yielded 4,6,7-trijluoro-3-methyl-2-phenyl-
3H-imidazo[4,5-c]pyridine 6 and 4,6, 7-trijluoro-1-methyl-2-pheny/-1 H-imidazo[4,5-
c]pyridine 7 as a white solid (0.0031 g, 10 %); 8r Major isomer -81.33 (JFF 32.6, Jrr 
12.7), -100.31 (JFF20.3, JFF 12.8), -169.52 Urr32.7, Jrr20.7); Minor isomer -86.72 (IF, 
m), -102.39, -162.03 (dd, hr 32.5, Jrr 19.2,). N-Methyl-N'-(2,3,5,6-tetrajluoro-pyridin-
4-yl)-benzamidine 8 and N-methyl-N-(2,3,5,6-tetrajluoro-pyridin-4-yl)-benzamidine 9 
were also isolated as a white solid (0.0039 g, 12 %); 8r -91.30 (br m), -152.58 (br m). 
N-phenyl-N '-(2,3,5, 6-tetrajluoro-pyridin-4-yl )-benzamidine, 10 
F~F )L_.;L + 
F N F 
5 eq NEt3, 
THF 
MW, 150 °C, 
25 min 
10, 32% 
Pentafluoropyridine (0.51 g, 3.0 mmol), N-phenyl-benzamidine (0.59 g, 3.0 mmol) and 
triethylamine (1.52 g, 15.0 mmol) were stirred together in THF (7.5 mL), in a sealed 
microwave vial, for 25 min at 150 °C. 19F NMR showed starting material and 2 new 
products. The reaction mixture was evaporated, poured onto water (20 mL) and the 
organic products extracted into DCM (3 x 15 mL). Drying (MgS04) and evaporation of 
the combined extracts gave a yellow crude. Column chromatography (silica) yielded N-
phenyl-N'-(2,3,5,6-tetrajluoro-pyridin-4-yl)-benzamidine 10 (0.33 g, 32 %) as a pale 
yellow solid; mp 155-156 °C; ([M + H+] 346.0961. C1sH12N3F4 requires [M + H+] 
346.0967); 8r -93.85 (2F, m, F-2), -154.93 (2F, m, F-3); 8H 7.61 (br m, NH), 7.50-7.35 
(9H, Ar-H), 7.18 (lH, m, Ar-H), 7.03 (br s, NH); 8c 159.05 (s, NCN), 143.79 (dm, 1Jcr 
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238.3, C-2), 142.50 (m, C-4), 138.36 (s, Ph-C), 134.86 (dm, 1Jcp 252.8, C-3), 134.16 (s, 
Ph-C), 131.44 (s, Ph-CH), 129.30 (s, Ph-CH), 129.26 (s, Ph-CH), 127.15 (s, Ph-CH), 
125.21 (s, Ph-CH), 121.20 (s, Ph-CH); m/z (EI) 345.0 (M+, 30 %), 343.9 (~- 1, 50%), 
254.1 (~- PhN, 30 %), 252.8 (~- PhNH, 80 %), 76.5 (Ph, 100 %). 
1,3,4-Trifluoro-6, 7,8,9-tetrahydro-dipyrido[ 1 ,2-a; 3 ',4 '-d) imidazole, 11 
F~F )L __ ;L 
F N F 
+ 1.5Q 
N NH.HCI 
H 
3 eq NEt3, 
THF/DMSO 
MW, 
... 
180 °C, 30 min 
·Q: 
F~N Jl.):d 
F 3 N ' F 
11, 52% 
Pentafluoropyridine (0.30 g, 1.77 mmol), 2-iminopiperidine hydrochloride (0.36 g, 2.67 
mmol) and triethylamine (0.54 g, 5.34 mmol) were stirred together in a mixture of THF 
(11.25 mL) and DMSO (4.50 mL), in a sealed 20 mL vial, under microwave heating, for 
30 min at 180 °C. The reaction mixture was evaporated to dryness, heated in THF (50 
mL) and filtered to remove excess starting material. The crude was absorbed onto silica 
and purified by column chromatography (120 g silica column, 40 - 80 % ethyl acetate 
in hexane over 30 min) to give 1,3,4-trijluoro-6,7,8,9-tetrahydro-dipyrido[l,2-a; 3',4'-
d]imidazole 11 (0.21 g, 52 %) as a white solid; mp 175-178 °C; (Found: C, 52.8; H, 3.4; 
N, 18.1. C10H8N3F3 requires: C, 52.9; H, 3.6; N, 18.5 %); op (DMSO-d,;) -85.36 (dd, 3Jpp 
31.8, 4Jpp 13.3, F-3), -104.36 (dd, 5Jpp 22.0, 4Jpp 13.4, F-1), -167.93 (m, F-4); 8H 4.36 
(2H, t, 3JHH 6.0, H-6), 3.01 (2H, t, 3JHH 6.0, H-9), 2.05 (2H, m, H-7), 1.93 (2H, m, H-8); 
llc 156.11 (q, 4Jcp 1.3,C-2a), 143.06 (dd, 1Jcp 244.5, 3Jcp 14.2, C-1), 141.02 (ddd, 1Jcp 
227.7, 2Jcp 15.2, 3Jcp 15.0, C-3), 134.44 (ddd, 2Jcp 11.7, 3Jcp 7.7, 3Jcp 5.8, C-4'd), 
129.57 (ddd, 1Jcp 253.71, 2Jcp 32.0, 4Jcp 7.8, C-4), 125.57 (dd, 2Jcp 34.8, 3Jcp 3.2, C-
3'd), 44.91 (d, 4Jcp2.8, C-6), 24.97 (s, C-9), 21.65 (s, C-7), 19.17 (s, C-8); mlz (ES+) 
228.05 (M+ + W, 100 %). 
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4,6, 7-trijluoro-3-methyl-2-phenyl-JH-imidazo[ 4,5-c]pyridine, 6, and 4,6, 7-trijluoro-1-
methyl-2-phenyl-1 H-imidazo[4,5-c]pyridine, 7 
Np) 1 1 8 l. 78 °C 
tiNH 1 . eqn u 1,-F ii)xsMei,-RT ._ /-F N F 
3 
87% 
nBuli (1.4 mL, 1.6 M soln in hexanes) was syringed into a stirring solution of 3 (0.49 g, 
2.0 mmol) in THF (40 mL), at -78 °C. After 1 h, methyl iodide (0.37 mL, 6.0 mmol) 
was syringed into the reaction mixture and the vessel allowed to warm to room 
temperature. After 18 h, the resulting mixture was poured onto water (SO mL) and 
extracted into DCM (3 x 40 mL). Drying (MgS04) and evaporation of solvent gave a 
pale yellow solid. Column chromatography on silica (ethyl acetate:hexane, 1:1) yielded 
4,6, 7-trifluoro-3-methyl-2-phenyl-3H-imidazo[4,5-c]pyridine 6 and 4,6, 7-trifluoro-1-
methyl-2-phenyl-1H-imidazo[4,5-c]pyridine 7 (0.46 g, 87 %) as an inseparable mixture 
of tautomers; m.p. 103-106 °C; (Found: C, 59.3; H, 3.0; N, 16.0. C,3HsF3N3 requires: C, 
59.3; H, 3.1; N, 16.0 %); OF major tautomer (52% by 19F NMR) -81.59 (dd, 3hF 32.3, 
4JFF 12.9, F-6), -100.51 (dd, 5JFF 20.6, 4JFF 13.1, F-4), -169.39 (dd, 3JFF 32.6, 5JFF 20.8, 
F-7); minor tautomer (48 %) -86.67 (dd, 3hF 32.8, 4JFF 13.9, F-6), -102.59 (dd, 5JFF 18.8, 
4
hF 14.2, F-4), -162.18 (dd, 3JFF 33.0, 5JFF 19.1, F-7); OH 7.77-7.52 (m, Ar-H), 4.05 (m, 
CH3); Oc 159.79-119.61,34.09 (m, CH3); m/z (EI) 263.0 (M\ 60 %), 261.8 (100 %). 
Benzyl-( 6, 7 -difluoro-2 -phenyl-3H -imidazo[ [ 4,5-c] pyridine-4-yl )-methyl-amine, 12 
0 N=< FtiNH I"' + 
/-
F N F 
3 
THF/DMSO 
MW 
180 °C, 30 min 
{~ 
N~ Fn' NH 
"' 'I , 
F ' N-"' N~ MeV 
12, 54% 
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4,6,7-Trifluoro-2-phenyl-3H-imidazo[4,5-c] pyridine 3 (0.0555 g, 0.2227 mmol) and N-
benzylmethylamine (0.1349 g, 1.1132 mmol) were stirred together in THF (2.25 mL) 
and DMSO (0.90 mL) at 180 °C (microwave) for 30 minutes. LCMS of the reaction 
mixture showed no starting material. The reaction solvents were evaporated and the 
orange crude dissolved in MeOH:DMSO (1:1 mixture, 2 mL). This mixture was 
subjected to mass directed auto purification (x2 injections). Evaporation under reduced 
pressure gave benzyl-( 6, 7 -dijluoro-2-phenyl-3H -imidazo[ 4,5-c 1 pyridine-4-yl )-methyl-
amine 12 as a white solid (0.0424 g, 54 %); mp 79- 83 °C; ([M + H+] 351.1416. 
C20H16F2N4 requires [M + W]351.1416); or (DMSO-d6) -100.09 (IF, d, 3Jpp27.1, F-6), 
-174.97 (IF, d, 3Jpp26.9, F-7); 811 (DMSO-d6) 10.05 (IH, br s, NH), 7.99-7.89 (2H, m, 
H-2'), 7.50-7.43 (3H, m, H-3', 4'), 7.37 (2H, d, 311111 7.6, H-2"), 7.33 (2H, t, 311111 7.6, 
H-3"), 7.27 (IH, t, 311111 7.6, H-4"), 5.34 (2H, CH2), 3.35 (3H, s, CH3); oc (CDC1 3) 
149.12 (m, C-2), 144.92 (dd, 1JcF 222.1, 2JcF 11.4, C-6), 144.63 (m, C-4), 138.94 (m, C-
1 "), 130.22 (s, C-4'), 129.04 (s, C-3'), 128.46 (s, C-3"), 127.81 (s, C-2"), 127.05 (s, 
C-4"), 126.22 (s, C-2'), 54.58 (s, CH2), 36.93 (s, CH3); m/z (ES+) 351.1 (M+ + H+, 100 
%). Crystals suitable for X-ray analysis were grown from MeCN. 
6, 7-Dijluoro-2-phenyl-1 H-imidazo[4,5-c1pyridine-4-yl)-diethyl-amine, 13, and (6, 7-
dijluoro-1-methylsulfanylmethyl-2 -phenyl-1 h-imidazo[ 4, 5 -c 1 pyridine-4-yl )-diethyl-
amine, 14 
13: 
5 eq HNEt2 
THF/DMSO 
MW 
+ 
3 (0.0185 g, 0.0742 mmol) and diethylamine (0.0272 g, 0.3715 mmol) were stirred 
together in THF (0.75 mL) and DMSO (0.30 g), under microwave heating at 180 °C, for 
30 min. LCMS of the reaction mixture indicated 71 % conversion to one product. The 
reaction mixture was evaporated to dryness and purified by reverse phase HPLC to give 
6,7-Dijluoro-2-phenyl-1 H-imidazo[ 4,5-c1pyridine-4-yl)-diethyl-amine 13 (0.0051 g, 23 
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%) as a yellow solid; lir (DMSO-d6) -99.79 (IF, d, 3JFF 27.8, F-6), -176.21 (IF, d, 3JFF 
27.9, F-7); li 11 13.58 (IH, br s, NH), 8.14 (2H, m, H-2'), 7.57-7.47 (3H, m, H-3',4'), 
3.89 (4H, q, 311111 6.9, CH2), 1.21 (6H, t, 3J1111 6.9, CH3); lie 149.83 (s, C-2), 143.96 (dd, 
1Jer216.7, 2Jcr 11.4, C-6), 143.01 (d, 3Jer 14.0, C-4), 132.64 (dd, 2Jer 9.4, 3Jer7.4, C-
5c), 129.90 (s, C-4'), 129.28 (s, C-1 '), 128.94 (s, C-3'), 126.99 (m, C-4c), 126.26 (s, C-
2'), 122.52 (dd, 1Jer 244.3, 2Jer 36.2, C-7), 42.88 (s, CH2), 13.50 (s, CH3); mlz (ES+) 
303.08 (M+ + W, 100 %). 
14: 
A mixture of 3 (0.0370 g, 0.1486 mmol) and diethylamine (0.0543 g, 0.7424 mmol) 
were stirred together in THF (0.3750 mL) and DMSO (0.1500 mL) for 4.5 hat 180 °C. 
The reaction solvents were evaporated and the crude dissolved in MeOH:DMSO (I :I, I 
mL). Mass directed auto purification of this sample gave (6,7-difluoro-1-
methylsu/fanylmethyl-2 -phenyl-1 H-imidazo[ 4, 5-c} pyridine-4-yl )-diethyl-amine 14 
(0.0060 g, II %) as a red solid; (Found: M+ + W 363.1445. C 1sH21 N4FzS requires: M+ 
+ W 363.1455); lir-99.33 (IF, d, 3JFF 30.1, F-6), -181.14 (IF, d, 3JFF 30.1, F-7); li 11 7.77 
(2H, m, H-2'), 7.56 (3H, m, H-3', 4'), 5.37 (2H, s, SCH2), 3.94 (4H, q, 311111 6.9, NCH2), 
2.00 (3H, s, SCH3), 1.28 (6H, t, 311111 7.0, NCH2H3); oe 151.11 (s, C-2), 145.57 (dd, 1Jer 
220.5, 2Jer 12.6, C-6), 143.88 (d, 3Jer 17.6 C-4), 132.92 (m, C-5c) 129.95 (s, C-4'), 
129.60 (s, C-2'), 129.51 (s, C-1 '), 128.88 (s, C-3'), 125.90 (m, C-4c), 123.46 (dd, 1Jer 
243.5, 2Jer 36.4, C-7), 48.91 (d, 4Jer 5.2, NCHzS), 43.47 (s, NCH2), 14.49 (d, 6Jer 2.0, 
SCH3), 13.60 (s, NCH2CH3); m/z (ES+) 363.1 (M+ + W, 100 %). 
3,4-difluoro-6, 7,8,9-tetrahydro-dipyrido[ 1,2-a; 3 ',4 '-d]imidazol-1-yl)-diethyl-amine, 15 
Q FUN 
""' I "' F N F 
11 
5 eq HNEt2, 
THF 
MW, 
160 °C 
Q F~N JL~ F 'N-'"', N~ 
~ 
15,32% 
A mixture of 11 (0.05 g, 0.22 mmol) and diethylamine (0.080 g, 1.10 mmol) were 
stirred together in THF (4 mL) for 5 h in a sealed microwave vial at 160 °C. 19F NMR 
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indicated clean conversion (78 % by integration) to a compound with 2 fluorine 
resonances (-107 and -189 ppm). The reaction was evaporated and poured onto water 
(20 mL). Extraction of the products with DCM (3 x 15 mL), drying of the organic layer 
(MgS04) and evaporation gave a crude solid. Purification by HPLC gave 3,4-dijluoro-
6,7,8,9-tetrahydro-dipyrido[ 1,2-a; 3 ',4 '-d}imidazol-1-yl)-dietlzyl-amine 15 (0.02 g, 32 
%) as a pale yellow solid; oF-107.78 (lF, br s, F-3), -183.97 (1F, d, 3JFF 27.5, F-4); oH 
4.29 (2H, td, 3JHH 6.3, 4JHH 1.4, H-6), 3.86 (4H, q, JHH 7.1, CH2CH3), 3.02 (2H, t, 3JHH 
6.5, H-9), 2.09 (2H, m, H-7), 1.98 (2H, m, H-8), 1.20 (6H, t, 3hiH 6.9, CH2CH3); mlz 
(ES+)28l.l (~+W, 100%). 
N-[2-( Benzyl-methyl-amino )-3,5,6-trijluoro-pyridin-4-yl} -benzamidine, 16 
2 ,;;~"'. 
F N F 
1 
THF/DMSO 
MW, 
180 °C, 30 min 
N-(2,3,5,6-tetratluoro-pyridin-4-yl) benzamidine 1 (0.40 g, 1.4859 mmol) and N-
benzylmethylamine (0.9003 g, 7.4292 mmol) were stin·ed together in THF (7.50 mL) 
and DMSO (3.00 mL) in a 20 mL capped vial, at 180 °C (microwave) for 30 minutes. 
Evaporation of the reaction solvents gave a yellow crude product. Purification by HPLC 
gave N-[2-( Benzyl-methyl-amino )-3,5, 6-trijluoro-pyridin-4-yl} -benzamidine 16 (0.26 g, 
48 %) as a yellow solid; mp 106-110 °C; ([M + W]37l.l478. C2oHnF3N4 requires [M 
+ W] 371.1478); OF (DMSO-d6) -93.73 (1F, t, JFF 27.5, F-6), -144.51 (1F, d, 3JFF 26.7, 
F-5), -164.03 (lF, d, 5JFF 27.5 F-3); oH (DMSO-d6) 7.93 (2H, m, Ar-H), 7.55-7.45 (3H, 
m, Ar-H), 7.37-7.24 (5H, m, Ar-H), 4.55 (2H, s, CH2), 2.91 (3H, d, 5JHF2.5, CH3); oc 
(CDCb) 157.64 (s, NCNH2), 144.67 (dd, 1JcF 226.4, 2JcF 13.1, C-6), 142.25 (dd, 2JcF 
15.1, 3JcF 9.1, C-2), 140.20 (m, C-4), 138.76 (s, Ar-C), 137.63 (dm, 1JcF 245.5, C-3), 
134.73 (s, Ar-C), 131.22 (s,Ar-CH), 130.29 (dd, 1JcF 243.5, 2JcF 32.2, C-5), 128.75 (s, 
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Ar-CH), 128.56 (s, Ar-CH), 127.74 (s, Ar-CH), 127.32 (s, Ar-CH), 55.15 (d, 5JcF 6.0, 
CH2), 37 (d, 5JcF 5.0, CH3); m/z (ES+) 371.1 (W + W, 100 %). 
Benzyl-( 4, 7 -difluoro-2 -phenyl-3H -imidazo[ 4,5-c 1 pyridin-6-yl )-methyl-amine, 17 
...:4c::.2:..:eq=.::L:.::D:....:A,_, T:_:_H:.:...F,.,. 
-78 °C - RT, 1 d 
0 
N~ Fti" NH -..::::: 7j 4c 
~N 'N""• F V ~e 
17, 64 o/o 
LDA (2.0 M solution in heptaneffHF/ethylbenzene, 0.2 mL) was added to a stining 
solution of N-[2-(benzyl-methyl-amino)-3,5,6-trifluoro-pyridin-4-yl]-benzamidine 16 
(0.0351 g, 0.0948 mmol) in THF (5.0 mL) at -78 °C, under argon. After I h the reaction 
was warmed to room temperature and stirred for 4 h. The reaction was quenched with 
water (10 mL) and evaporated. Water (20 mL) was added to the crude mixture and HCl 
solution added to make acidic. Extraction of the organic products into DCM (3 x 20 
mL) followed by drying (MgS04) yielded a brown crude product. Mass directed auto 
purification yielded benzyl-( 4, 7 -difluoro-2 -phenyl-3H-imidazo[ 4, 5 -c 1 pyridine-6-yl )-
methyl-amine 17 (21.4 mg, 64 %) as a white solid; mp 121 °C (decomposed); (Found: 
C, 68.1; H, 4.6; N, 16.2. C2oH1<;F2N4 requires: C, 68.6; H, 4.6; N, 16.0 %); op(DMSO-
d6) -81.18 (IF, d, 5Jpp 28.9, F- 4), -154.54 (IF, d, 5Jpp29.9, F-7); oH(CDC1 3) 8.03 (2H, 
m, Ar-H), 7.47 (3H, m, Ar-H), 7.31 (4H, m, Ar-H), 7.26 (lH, m, Ar-H), 4.65 (2H, s, 
CH2), 3.04 (3H, d, 5JHF 2.6, CH3); oc (DMSO-~) 141.08 (dd, 2JcF 15.0, 3Jcp 6.6, C-6), 
138.78 (s, Ar), 130.89 (s, Ar), 129.14 (s, Ar), 128.73 (s, Ar), 128.43 (s, Ar), 127.77 (s, 
Ar), 127.07 (s, Ar), 126.79 (s, Ar), 56.17 (d, 4JcF 5.2, CH2), 37.78 (d, 4Jcp5.6, CH3); m/z 
(ES+) 351.1 (W + W, 100 %). 
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N-(2, 3, 5,6-Tetrajluoro-pyridin-4-yl )-guanidine, 18 
_4 -::eq-'-N-,aH,.C-"-0--"'3,_M_e;_C_N.,_ 
reflux, 69 h 
NH 
HN;Jl_NH2 
F;(x">' F 
' I 
F 2 N• F 
18, 18% 
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Pentafluoropyridine (1.69 g, 10.0 mmol), guanidine hydrochloride (1.91 g, 20.0 mmol) 
and sodium hydrogencarbonate (3.36 g, 40.0 mmol) were refluxed together for 69 h. 
Evaporation of the reaction mixture followed by the addition of 50 mL water and 
extraction into DCM (3 x 40 mL). Drying (MgS04) and evaporation of the organic layer 
yielded an oil which solidified on standing to give N-(2,3,5,6-tetrajluoro-pyridin-4-yl)-
guanidine 18 (0.38 g, 18 %) as a pale yellow solid; mp 132-135 °C; (Found: C, 34.7; H, 
1.9; N, 27.0. C6~F4N4 requires: C, 34.6; H, 1.9; N, 26.9 %); oF -97.01 (2F, m, F-2),-
154.71 (2F, m, F-3); oH 6.17 (br s, NH); 156.39 (s, C-7), 143.59 (dm, 1JcF 234.1, C-2), 
143.54 (m, C-4), 136.11 (dm, 1JcF 247.8, C-3); m/z (EI) 208.0 (M+, 65 %), 43.1 
(NH=CNH2, 100 %) 
Attempted Cylisation of N-(2 ,3,5,6-tetrajluoro-pyridin-4-yl )-guanidine 
NH 
HN)lNH2 
F~F 
JLA F N F 
18 
NH 
HN---{ 
LOA, THF F~NH 
~ JL.A F N F 
LDA (0.61 mL, 1.8 M solution in heptane/THF/ethylbenzene, 1.10 mmol) was added to 
a stirring solution of ( N-(2,3,5,6-tetrafluoro-pyridin-4-yl)-guanidine 18 (0.1041 g, 0.50 
mmol) in THF (20 mL), at -78 °C. The solution was allowed to warm to room 
temperature after 2 h and stirred for a further 2 d, at which point 19F NMR showed two 
new resonances (-102 and -164 ppm), corresponding to 2-amino-tetrafluoropyridine, 
and starting material only. Reflux of the solution for 2 h gave an identical 19F NMR 
spectrum so the reaction was terminated. 
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3-Hydroxy-2-(2,3,5,6-tetrajluoro-pyridin-4-yl)-but-2-enoic acid ethyl ester, 19 
0 0 
2 
)l___)l_OEt 
0 0 
2egNaH.,_ )U 
e OEI 
F~F 
J..~ F N F 
19,8% 
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Sodium hydride (1.20 g, 30.0 mmol 60 % suspension in mineral oil) was added to a 
stirring solution of pentafluoropyridine (2.56 g, 15.0 mmol) and ethyl acetoacetate (3.90 
g, 30 mmol) in dry THF (50 ml). once the base had fully dissolved, the reaction mixture 
was refluxed at 65 °C for 70 h. 19F NMR showed no starting material so the reaction 
was worked up. The reaction was poured onto water (50 ml) and the organic products 
extracted into dichloromethane (4 x 30 ml). Drying (MgS04) and evaporation of the 
solvent gave a colourless oil. Distillation under reduced pressure gave 3-hydroxy-2-
(2,3,5,6-tetrajluoro-pyridin-4-yl)-but-2-enoic acid ethyl ester 19 (0.33 g, 8 %) as a 
colourless oil; bp 32 °C, 0.50 mbar; (Found: C, 47.8; H, 3.4; N, 5.0. C 11H9F4N03 
requires: C, 47.3; H, 3.3; N, 5.0 %); 8F -91.70 (2F, m, F-2), -140.12 (2F, m, F-3); 8H 
13.52 {IH, s, OH), 4.22 {2H, q, 3JHH 7.1, CH2CH3), 1.94 (3H, t, 6JHF 0.9, COCH3), 1.21 
(3H, t, 3JHH 7.0, CH2CH3); 8c 177.84 (s, COOCzHs), 170.05 (COHCH3), 143.56 (dm, 
1JcF 245.4, C-2), 140.41 (dm, 1JcF 257.3, C-3), 128.62 (m, C-4), 89.60 (d, 3Jcr 2.3, C-7), 
61.86 (s, CHzCH3), 20.08 (s, COHCH3), 14.15 (s, CH2CH3), rnlz (EI) 278.9 (M+, 78 %), 
42.8 (COCH3, 100 %). 
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Experimental to Chapter 3 
1,3,4-Trifiuoro-9-metlzyl-dipyrido[ 1,2-a; 3 ',4 ·-d) imidazole, 20 
Fn~ F I + 
/. 
F N F 
nrMe 
2.2 ~ .. )1.__ 
N NH2 
MeCN, 
4 eq NaHC03 
Reflux, 70 h 
Chapter 9 
7 ' }~\a-Me \~~20 
Fti''"" N 4 I :rd 
/. 
F J N I F 
20,82% 
Pentafluoropyridine (1.69 g, 10.0 mmol), 2-amino-3-picoline (2.38 g, 22.0 mmol) and 
sodium hydrogen carbonate (3.36 g, 40.0 mmol) were stirred in dry MeCN (200 mL) at 
reflux temperature, under an atmosphere of argon, for 70 h. 19F NMR of the reaction 
mixture showed no starting material remaining. Evaporation of the reaction and addition 
of water (50 mL) was followed by extraction into DCM (3 x 40 mL). Drying (MgS04) 
and evaporation of the solvent yielded a green solid. Recrystallisation from MeCN 
yielded 1,3,4-trij7uoro-9-methyl-dipyrido[1,2-a;3',4'-d]imidazole 20 (1.94 g, 82 %) as a 
white solid; mp 174-176 °C; (Found; C, 55.6; H, 2.5; N, 17.8. C 11~F3N3 requires; C, 
55.5; H, 2.6; N, 17.7 %.); OF-79.01 (IF, dd, 3JFF 34.8, 4JFF 13.7, F-3), -102.43 (IF, dd, 
5JFF 20.1, 4JFF 12.8, F-1), -164.73 (1F, dd, 3JFF 33.7, 5JFF20.1, F-4); OH 8.49 (lH, d, 3JHH 
7.1, H-6), 7.36 (1H, dm, 3JHH 6.9, H-8), 6.93 (lH, m, H-7), 2.67 (3H, s, CH3); oc 151.07 
(s, C-2a), 145.22 (dd, 1JcF251.3, 2JcF 14.5, C-3), 140.94 (dm, 1JcF 233.9, C-1), 131.17 
(ddd, 1JcF 257.1, 2Jcr32.8, 4JcF 8.7, C-4), 129.87 (s, C-8), 129.44 (S, C-9), 128.24 (m, 
C-3'd), 127.63 (dd, 2JcF 35.3, 3JcF 3.8, C-4'd), 124.93 (d, 4JcF 5.1, C-6), 113.20 (s, C-7), 
17. 57 (s, CH3); mlz (EI) 237.0 (M+, 60 %). Crystals suitable for X-ray analysis were 
grown from MeCN. 
Microwave Mediated Formation of 20 
Pentafluoropyridine (0.0200 g, 0.1183 mmol), 2-amino-3-picoline (0.0192 g, 0.1775 
mmol) and triethylamine (0.0359 g, 0.3549 mmol) were stirred together in THF (0.75 
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mL) and DMSO (0.30 mL), under microwave heating, for 15 mm at 160 °C. The 
reaction was evaporated to remove NEt3 and the reaction solvents. 1H NMR (DMSO-d) 
of the crude showed there to be 100 %clean conversion to 20. No further work up or 
purification carried out at this point. 
1,3,4-Trijluoro -dipyrido[ 1,2-a;J ',4'-d]imidazole, 21 
F~F )L_,;L 
F N F 
MeCN, 
4 eg NaHC03• 
Reflux 96 h 
·Q' ~9~l 2a ~ Fn· N I ""' ,., 
..-:' 
F N F 
21,25% 
Pentafluoropyridine (1.69 g, 10.0 mmol), 2-amino-pyridine (1.88 g, 20.0 mmol) and 
sodium hydrogen carbonate (3.36 g, 40.0 mmol) were stirred together in dry MeCN 
(200 mL) at reflux temperature, under an atmosphere of argon, for 96 h. Evaporation of 
the reaction and addition of water (50 mL) was followed by extraction into DCM (4 x 
40 mL). Evaporation of the solvent yielded a dark red solid. The crude was refluxed 
with charcoal in MeOH, filtered and dried to give a pale orange solid. Recrystallisation 
from MeCN gave 1,3,4-trijluoro-dipyrido[1,2-a;3',4'-d]imidazole 21 (0.55 g, 25 %) as 
a pale orange solid; mp 197-198 °C; (Found; C, 53.8; H, 1.7; N, 18.9. C 10~F3N3 
requires; C, 53.8; H, 1.8; N, 18.8 %); oF -79.05 (IF, dd, 3JFF 34.3, 4hF 13.4, F-3), -
102.07 (IF, dd, 5JFF 19.9, 4JFF 13.3, F-1), -164.36 (IF, dd, 3JFF 34.4, 5JFF 20.3, F-4); OH 
8.64 (lH, dm, 3JHH 7.0, H-6), 7.77 (lH, m, H-9), 7.59 (lH, m, H-8), 7.03 (lH, m, H-7); 
lie 150.24 (s, C-2a), 145.07 (dm, 1JcF 250.7, C-3), 141.07 (dm, 1JcF 233.7, C-1), 131.95 
(s, C-8), 131.22 (ddd, 1JcF 256.6, 3JcF 32.1, 4JcF 8.5, C-4), 128.00 (dd, 2JcF 35.4, 3JcF 
3.8, C-4'd), 127.73 (hidden m, C-3'd), 127.44 (d, 4JcF 5.0, C-6), 119.30 (s, C-9), 113.08 
(s, C-7); m/z (EI) 222.8 (M+, 100 %). 
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7-bromo-1 ,3,4-trifluoro-9-methyl-dipyrido[ 1,2-a;3 ',4 '-d) imidazole 22 
Br ,~{Me Fn~ F I + 
/-
F N F 
Br~Me 
1.5 t.A 
N NH2 
3 eq NEt3, THF/DMSO 
---'-----'---,-----: .. 
Microwave, 150 °C, 2 h 
" N \20 Fti' N 
""' 4 ! 3'd 
F 3 N~1 F 
22, 10% 
Pentafluoropyridine (0.30 g, 1.77 mmol), 2-amino-5-bromo-3-methylpyridine (0.50 g, 
2.66 mmol) and triethylamine (0.54 g, 5.32 mmol) were stirred together in a mixture of 
THF (10.00 mL) and DMSO (4.00 mL), in a sealed 20 mL vial, under microwave 
heating for 2 h at 150 °C. The resulting mixture was evaporated to dryness and the 
yellow crude absorbed onto silica. Column chromatography of this material (on silica, 
DCM/Me0HJNH3; 0.5 - 4 % MeOH gradient over 15 minutes) gave 7-bromo-1,3,4-
trifluoro-9-methyl-dipyrido[l,2-a;3',4'-d]imidazole 22 (0.06 g, 10 %) as a yellow solid; 
([M+ + W] 315.9687. C 11H,;N3F3Br requires [~ + W] 315.9697); OF -77.80 {lF, dd, 
31FF 34.4, 4JFF 13.8, F-3), -100.90 (dd, 5JFF 20.1, 4JFF 13.2, F-1), -164.49 (dd, 3JFF 34.4, 
5JFF 19.5, F-4); oH 8.65 (lH, s, C-6), 7.45 {lH, m, C-8), 2.72 (3H, s, CH3); lie 149.27 {s, 
C-2a), 145.16 (dd, 1JcF 252.1, 3JcF ll.8, C-1), 141.29 (dm, 1JcF 236.0, C-3), 133.20 {s, 
C-8), 130.83 {ddd, 1JcF 257.0, 2JcF 32.0, 4JcF 8.6, C-4), 130.52 (s, C-9), 127.76 (m, C-
4'd), 124.51 (d, 4JcF 5.2, C-6), 107.42 {s, C-7), 17.33 (s, CH3); m/z (ES+) 318.0 (M+ + 
H•, 100 %), 316.0 (M+ + W, 100 %). 
Benzyl-( 3,4-difluoro-9-methyl-dipyrido[ 1 ,2-a;3 ',4 '-d]imidazol-1-yl)-amine, 23 
Q-Me 
Fn\N 
I "" F N F THF/DMSO, 
20 MW, 170 °C, 30 min 
7 8 ,~Me 
'~~2a 
F~N 
_!:(' 
F 3 N-" 1 N~ Hv 
23,63% 
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20 {0,50 g, 2.11 mmol) and benzylamine (1.13 g, 10.54 mmol) were stirred together in a 
mixture of THF (10 mL) and DSMO (2 mL) at 170 °C for 30 min (MW). LCMS of the 
resulting mixture consisted of I peak only. The reaction mixture was evaporated to 
dryness. 50 mL H20 was added and the organic products extracted into DCM (3 x 40 
mL). Drying (MgS04) and evaporation of the combined fractions gave an orange solid 
(0.78 g). Recrystallisation from MeCN gave benzyl-(3,4-dijluoro-9-methy/-
dipyrido[ 1,2-a;3 ',4 '-d]imidazol-1-yl)-amine 23 (0.43 g, 63 %) as a yellow solid; mp 
148- 149 °C; (Found: C, 66.7; H, 4.3; N, 17.3. C 18H14F2N4 requires: C, 66.7; H, 4.4; N, 
17.3 %); OF -103.97 (IF, m, F-3), -179.55 (IF, d, 3JFF 23.7, F-4); ()H 8.34 (IH, dm, 3JHH 
6.8, H-6), 7.39 {2H, dm, 3JHH 7.6, H-2'), 7.29 {3H, m, H-3' ,4'), 7.14 (IH, dm, 3JHH 6.8, 
H-8), 6.75 (IH, m, H-7), 6.12 {1H, br s, NH), 4.75 {2H, d, 4JHH 5.6, CH2), 2.57 (3H, s, 
CH3); 8c 148.30 {s, C-2a), 144.77 (dd, 1JcF 222.0, 2JcF 12.7, C-3), 144.40 {d, 3JcF 18.4, 
C-1), 139.03 (s, C-1'), 128.74, 128.66, 128.40 (obscured, C-3'd), 128.27, 127.54, 
127.48, 125.65 (dd, 1JcF 246.2, 2JcF 35.3, C-4), 124.89 (d, 4JcF 4.6, C-6), 124.40 (dd, 
2JcF 16.1, 3JcF 8.9, C-4'd), 112.31 {s, C-7), 45.60 (s, CH2), 17.56 (s, CH3); mlz (ES+) 
325.1 (M+ + W, 100 %). Crystals suitable for X-ray analysis were grown from MeCN. 
Benzyl-( 3,4-dijluoro-9-methyl-dipyrido[ 1,2-a;3 ',4 '-d]imidazol-1-yl)-methyl-amine, 24 
MeJl 
5eq l) 
THF/DMSO, 
MW, 170 °C, 30 min 
7 8 
,f"¥-Me 
'\~~2a 
F~N 
)__:(' 
F 'N' N~ MeV 
24,77% 
20 (0,50 g, 2.11 mmol) and N-benzylmethylamine (1.28 g, 10.54 mmol) were stirred 
together in a mixture of THF (10 mL) and DSMO (2 mL) at 170 °C for 30 min (MW). 
LCMS of the resulting mixture consisted of 1 peak only. The reaction mixture was 
evaporated to dryness. 50 mL H20 was added and the organic products extracted into 
DCM (5 x 40 mL). Drying (MgS04) and evaporation of the combined fractions gave an 
orange solid (0.73 g). Recrystallisation from MeCN gave benzyl-(3,4-dijluoro-9-methyl-
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dipyrido{1,2-a;3',4'-d]imidazol-J-yl)-methyl-amine 24 (0.55 g, 77 %) as a dark green 
solid; mp 111-113 °C; (Found: C, 67.7; H, 4.7; N, 16.8. C 19H16N4F2 requires: C, 67.5; 
H, 4.8; N, 16.6 %); OF -102.56 (IF, d, 31FF 26.3, F-3), -I80.QI (IF, d, 3JFF 26.0, F-4); OH 
8.31 (1H, d, 3JHH 7.1, H-6), 7.37-7.22 (5H, m, H-2', 3', 4'), 7.06 (IH, dm, 3JHH 6.7, H-
8), 6.67 (IH, m, H-7), 5.46 (2H, s, CH2), 3.37 (3H, s, NCH3), 2.53 (3H, s, CH3); lie 
146.71 (br s, C-2a), 144.88 (d, 3JcF 16.6, C-1), 143.38 (dd, 1JcF 219.5, 2JcF 12.1, C-3), 
139.09 (s, C-1'), 128.71 (s, C-9), 128.46, 128.12 (m, C-3'd), 127.99, 127.06, 126.50, 
125.90 (dd, 2JcF 8.2, 3JcF 7.0, C-4'd), 124.98 (dd, 1JcF 245.4, 2JcF 36.3, C-4), 124.28 (d, 
4JcF 6.1, C-6), 111.79 (s, C-7), 54.57 (s, CH2), 37.00 (s, NCH3), 17.21 (s, CH3); m/z 
(ES+) 339.1 (M+ + H", 100 %). 
3, 4-Difluoro-9-methyl-dipyrido[ 1,2 -a, 3 ', 4 '-d] imidazol-1-yl )-diethyl-amine, 25 
Q-Me 
Fn\N 5 eq HNEiz, 
I """ DMSOfTHF 
F N"" F MW, 170°C, 30 min 
20 
7 ' ,~Me 
"~~2a 
F~N JL.:r F 3 N""' N~ 
25, 83%~ 
20 (0.50 g, 2.11 mmol) and diethylamine (0. 77 g, 10.54 mmol) were stirred together in a 
mixture of DMSO (4.0 mL) and THF (20 mL) for 30 min at 170 °C (x2 reaction vials). 
LCMS of the crude showed no starting material remaining. The reaction mixture was 
evaporated to dryness and water (50 mL) added. Extraction of the organic products into 
DCM (3 x 40 mL) followed by drying (MgS04) and evaporation of the solvent gave a 
yellow crude. Recrystallisation from MeCN gave 3,4-Difluoro-9-methyl-dipyrido[ 1,2-
a,3',4'-d]imidazol-1-yl)-diethyl-amine 25 (0.51 g, 83 %) as a pale yellow solid; mp 91-
93 °C; (Found: C, 61.8; H, 5.5; N, 19.2. C,sH,6N.F2 requires: C, 62.1; H, 5.6; N, 19.3 
%); OF -102.42 (1F, d, 3JFF 27.0, F-3), -181.52 (IF, d, 3JFF 26.8, F-4); OH 8.42 (lH, d, 3JHH 
6.9, H-6), 7.15 (lH, d, 3JHH 6.7, H-8), 6.77 (lH, m, H-7), 4.03 (4H, q, 3JHH 7.0, CH2), 
2.63 (3H, s, CH3), 1.28 (6H, t, 3JHH 6.8, -N(CH2CH3)2; lie 146.81 (s, C-2a), 144.28 (d, 
3JcF 17.0, C-1), 143.68 (dd, 11cF 218.0, 21cF 12.1, C-3), 128.76 (s, C-9), 127.94 (m, C-
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3'd), 126.16 (s, C-8), 126.00 (obscured m, C-4'd), 124.45 (dd, 1JcF 243.6, 2Jcp 36.7, C-
4), 124.42 (d, 4JCF 6.0, C-6), 111.66 (s, C-7), 43.73 (s, CH2), 17.20 (s, CH3), 13.79 (s, 
NCHzCH3); m/z (EI) 290.1 (M+, 90 %), 275.1 (M+- 15, 100 %). 
( 3,4-Dijluoro-9-methyl-dipyrido[ I ,2-a;3 ',4 '-d] imidazo/-I-yl)-( 4-methoxy-phen yl)-
amine, 26 
NH2 1.5~ ¢ 
OMe 
3 eq NEt3, THF/DMSO, 
MW, 170 °C, 2 h 
7 B '0'-~' Me N ,. 
\ 
Fti" N OMe I -::,, ~ 
F 7 N 'N~ 
H 
26, 12% 
20 (0.10 g, 0.42 mmol), p-anisidine (0.08 g, 0.63 mmol) and triethylamine (0.13 g, 1.26 
mmol) were stirred together in THF (1.0 mL) and DMSO (0.2 mL) at 170 °C for 2 h 
(MW). The reaction was evaporated and subjected to mass directed autopurification. 
Evaporation of the collected fractions yielded (3,4-dijluoro-9-methyl-dipyrido[ 1,2-
a;3',4'-d]imidazo/-l-yl)-( 4-methoxy-phenyl)-amine 26 (0.02 g, 12 %) as a yellow solid; 
mp 161- 162 °C; ([M+ + H+] 341.1208. C18H15N40F2 requires [M+ + W] 341.1214); op 
-102.91 (1F, d, 3Jpp 24.3, F-3), -176.50 (lF, d, 3Jpp 24.1, F-4); OH 8.42 (1H, d, 3JHH 6.9, 
H-6), 7.74 (2H, d, 3JHH 8.8, Ar-H), 7.63 (br s, NH), 7.21 (lH, dm, 3JHH 6.8, H-8), 6.93 
(2H, d, 3JHH 9.0, Ar-H), 6.81 (lH, t, 3JHH 6.9, H-7), 3.82 (3H, s, OCH3), 2.65 (3H, s, 
CH3); m/s (ES+) 341.1 (M+ + W, 100%). 
3,4-Dijluoro-1-methoxy-9-methyl-dipyrido[ I ,2-a,3 ',4 '-d] imidazole, 27 
1.1 eq NaOMe, 
dry MeOH 
3 eq NEt3, MW 
140 °c, 30 min 
7 ' 
,f'¥_Me 
't:.J--i2a 
Fti'' N 
' I "" ,., 
F 3 N"' 1 OMe 
27,90% 
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20 (0.40 g, 1.69 mmol), NaOMe (0.10 g, 1.86 mmol) and NEt3 (0.51 g, 5.08 mmol) 
were stirred together in anhydrous MeOH (4 x 10 mL) under microwave heating for 30 
min at 140 °C. No starting material was observed by LCMS. The reaction mixtures were 
poured onto water (10 mL) to quench any excess NaOMe. Evaporation under reduced 
pressure gave a white crude which was triturated with water to give 3,4-dijluoro-1-
methoxy-9-methyl-dipyrido[1,2-a;3'4'-d]imidazo/e 27 (0.38 g, 90 %) as a white solid; 
m.p 187-I88 °C; (Found; C, 57.3; H, 3.5; N, I6.4. C12H9F2N30 requires; C, 57.8; H, 
3.6; N, 16.9 %.);OF -104.26 (IF, d, 3hF 22.0, F-3), -I72.77 (IF, d, 3JFF 21.9, F-4); OH 
8.45 (IH, dd, 3JH 11 7.0, 4JHH 0.6, H-6), 7.25 (IH, dm, 3JH 11 6.8, H-8), 6.84 (IH, m, H-7), 
4.I6 (3H, s, OCH3), 2.68 (3H, s, CH3); Oc I49.5I (s, C-2a), I48.55 (dd, 3JcF I3.8, 4JcF 
1.2, C-I), I42.70 (dd, 1JcF 227.0, 2JcF I4.0, C-3), I29.35 (s, C-9), I28.7I (m, C-3'd), 
I28.49 (dd, 1JcF 251.5, 2JcF 33.7, C-4), I28.38 (s, C-8), I26.04 (m, C-4'd), I24.82 (d, 
4JcF 5.2, C-6), II2.64 (s, C-7), 54.87 (s, OCH3), I7.73 (s, CH3); m/z (ES+) 250.I (M+ + 
w, 100 %). 
3,4-Dijluoro-9-methyl-2H-dipyrido[ 1 ,2-a;J ',4 '-d]imidazol-1-one, 28 
KOH(aq) 
.. 
Reflux, 20 h 
7 ' ,~Me 
'~~2a 
F~N 
~~.Xd 
F 3 N ' 0 
H 
28, 10% 
20 (0.30 g, 1.26 mmol) was stirred in 0.36 M KOH solution (0.30 g KOH in I5 mL 
H20), under reflux, for 20 h. The reaction mixture was allowed to cool, acidified, and 
the organic products extracted into DCM by continuous extraction. The organic phase 
was dried (MgS04) and evaporated under reduced pressure to give a pale green crude 
(0.22 g). Recrystallisation from MeCN gave 3,4-Dijluoro-9-methyl-dipyrido[ 1,2-
a;3',4'-djimidazol-1-ol 28 (0.03 g, 10 %); mp 229 °C (decomposed); (Found: C, 56.I; 
H, 2.9; N, I7.9. C 11 H7N3F20 requires: C, 56.2; H, 3.0; N, I7.9 %); OF (DMSO-d6)-
I04.56 (IF, br s, F-3), -I72.30 (IF, d, 3JFF 22.I, F-4); OH I2.2I (br s, NH), 8.52 (IH, d, 
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3JHH 6.9, H-6), 7.37 (IH, dm, 3JHH 6.8, H-8), 6.93 (1H, m, H-7), 2.52 (3H, s, CH3); lie 
148.69 (d, 3JcF 16.2, C-1), 148.50 (s, C-2a), 141.37 (dd, 1JcF 221.3, 2JCF 13.4, C-3), 
128.43 (s, C-8), 127.93 (m, C-3'd), 127.66 (s, C-9), 127.00 (d, 1Jcp249.6, C-4), 125.88 
(m, C-4'd), 125.45 (d, 4Jcp4.8, C-6), 112.41 (s, C-7), 16.95 (s, CH3); m/z (ES+) 236.1 
(W + W, 100 %). 
3,4-dijluoro-9-methyl-1-phenyl-dipyrido[ 1 ,2-a;J ',4 '-d) imidazole, 29 
~Me ,~Me '~---{ \~-{2~ 
Fn\N F ,., N I ""' 2 eq PhMgBr , I ""' ,., 
F N"" F THF, F 3 N""' ""' 
reflux, 93 h 
20 29,48% 
20 (0.41 g, 1.70 mmol) and PhMgBr (3.49 mL 1 M soln in THF, 3.50 mmol) were 
refluxed in THF (40 mL) for 93 h. The resulting mixture was poured onto 0.5 M HCl 
solution (50 mL) and extracted into DCM. Drying (MgS04) and evaporation of solvent 
gave a yellow crude. Recrystallisation from MeCN gave 3,4-dijluoro-9-methyl-1-
phenyl-dipyrido[1,2-a;3',4'-d]imidazole 29 (0.25 g, 48 %) as a pale yellow solid; m.p 
188-189 °C; (Found: C, 69.2; H, 3.7; N, 14.2. C 17H 11 F2N3 requires: C, 69.2; H, 3.8; N, 
14.2%); Op -99.81 (lF, d, 3JFF 28.2, F-3), -162.95 (1F, d, 3Jpp 27.5, F-4); OH 8.79 (2H, 
dm, 3JHH 8.3, H-2'), 8.42 (lH, d, 3JHH 6.9, H-6), 7.52 (2H, m, H-3'), 7.44 (lH, m, H-4'), 
7.24 (lH, dm, 3JHH 6.7, H-8), 6.78 (1H, m, H-7), 2.66 (3H, s, CH3); lie 150.60 (s, C-2a), 
144.03 (dd, 1JcF 223.7, 2JcF 11.9, C-3), 140.26 (dd, 3JcF 13.5, 4JcF 5.6, C-1), 139.35 (m, 
C-3'd), 136.19 (s, C-1 '), 131.68 (dd, 1JcF 264.5, 2JcF 36.6, C-4), 129.52, 129.39, 129.20 
(s, C-9), 129.10, 128.52, 125.84 (m, C-4'd), 125.19 (d, 4JcF 5.5, C-6), 112.29 (s, C-7), 
17.49 (s, CH3); rn/z (EI) 295.1 (M+, 100 %). 
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3-Fluoro-9-methyl-1,4-bis-phenylsulfanyl-dipyrido[ 1,2-a;3 ',4 '-d) imidazole, 30 
Q-Me 
Fti~N 
I ""' F N F 
20 
_2_e_,q_L_iS_P_h'-, T_H_F
1 
.,_ 
reflux, 17 h 
' 8 6~Me '\~-{2a Sti" N ~ 'I-::'' ~ v F 3 N 'S.JY 
30,61% 
LiSPh (4.00 mL 1M solution in THF, 4.0 mmol) was added to a stining solution of 20 
(0.47 g, 2.0 mmol) in dry THF at room temperature, under dry argon. The solution was 
refluxed for 17 h, at which point 19F NMR showed no starting material to be remaining. 
Evaporation of the solvent was followed by addition of 0.5 M HCl solution (50 mL). 
Extraction of the organic products into DCM (3 x 40 mL), drying (MgS04 ) and 
evaporation of DCM gave a yellow solid. Recrystallisation from MeCN yielded 3-
fluoro-9-methyl-1,4-bis-phenylsulfanyl-dipyrido[l,2-a; 3 ',4 '-d]imidazole 30 as a yellow 
solid (0.51 g, 61 %); mp 174- 176 °C; (Found: C, 65.9; H, 3.8; N, 10.2. C23H16N3FS2 
requires: C, 66.2; H, 3.9; N, 10.1 %); lip-75.62 (lF, s, F-3); liH 9.31 (lH, d, 3JHH 7.1, H-
6), 7.75-7.72 (2H, m, Ar-H), 7.49-7.45 (3H, m, Ar-H), 7.24-7.17 (3H, m, H-9, Ar-H), 
7.15-7.09 (3H, m, Ar-H), 6.71 (lH, m, H-7), 2.70 (3H, s, CH3); lie 158.57 (d, 1Jcp230.6, 
C-3), 152.00 (d, 3Jcp 17.7, C-1), 150.60 (d, 5JcF 1.8, C-2a), 136.74 (d, 4Jcp 1.9, C-1 '), 
135.58 (s, Ar-CH), 135.25 (br s, C-3'd), 134.86 (d, 3JcF 5.9,C-4'd), 129.58 (s, Ar-CH), 
129.51 (s, C-8), 129.36 (s, Ar-CH), 128.98 (s, Ar-C), 128.76 (s, Ar-CH), 127.99 (s, C-
9), 127.11 (s, Ar-CH), 126.62 (s, Ar-CH), 125.26 (s, C-6), ll2.06 (s, C-7), 93.13 (d, 
2Jcp 44.3, C-4), 17.71 (s, CH3); m/z (ES+) 418 (~ + W, 100 %). 
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Reaction of 3,4-Di.fluoro-1 -methoxy-9-methyl-dipyrido[ 1,2-a,3 ',4 '-d]imidazole with 
NaOMe 
QMe 
F~N 
)_ __ ~ 
F N OMe 
27 
1.1 eq NaOMa, 
dry MeOH 
3 eq NEt3, MW 
140 °C, 30 min 
/!\-Me 
'~--{ 
MeO~·N 
JL.l F ' N"• OMe 
31, 1% 
+ 
QMe 
FxXN 
MeO ' N ' OMe 
2 
32,3% 
3,4-Difluoro-1-methoxy-9-methyl-dipyrido[l ,2-a,3' ,4' -d]imidazole (0.0800 g, 0.32 
mmol), NaOMe (0.0434 g, 0.80 mmol) and NEt3 (0.0974 g, 0.96 mmol) were stirred 
together in dry MeOH (10 mL) for 30 min at 150 °C. LCMS of the resulting mixture 
showed there to be starting material (34 %by TIC trace) and 1 new peak (66 %) with 
m/z (ES+) 262.1, corresponding to the desired monosubtituted product. The mixture was 
quenched (1 mL H20), evaporated and the resulting yellow solid washed with water. 
Following a failed purification attempt by HPLC, mass directed auto purification of a 
crude sample gave 2 fractions both with M+ + H+ 262. Evaporation of the fractions gave 
white solids. 19F NMR of the first fraction (0.0010 g, 1 %) showed there to be 1 fluorine 
present (-98.32 ppm), corresponding to 3-fluoro-1,4-dimethoxy-9-methyl-dipyrido[ 1,2-
a;3 ',4 '-d) imidazole 31. 19F NMR of the second fraction (0.0022 g, 3 %) showed there to 
be I fluorine present (-174.35 ppm), corresponding to 4-fluoro-1,3-dimethoxy-9-methyl-
dipyrido[ 1,2-a;3',4 '-d]imidazole 32. 
Reaction of 3,4-di.fluoro-9-methyl-1-phenyl-dipyrido[ 1 ,2-a; 3 ',4 '-d]imidazole with 
Sodium methoxide 
QMe QMe 
~ 2.7 eq NaOMe, \ F N MeO N 
I "' 4 eq NEt~, MeOI;! "' 
-"' Microwave __.., F N 
"' 
F N 
"' 
~ 
130 °C, 30 min 
~ 29 33,52% 
Conversion 
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3,4-Difluoro-9-methyl-1-phenyl-dipyrido[1 ,2-a;3' ,4' -d) imidazole 29 (0.0150 g, 0.0508 
mmol) ), NaOMe (0.0074 g, 0.1372 mmol) and triethylamine (0.0206 g, 0.2032 mmol) 
were stirred together in dry MeOH ( 1 mL) for 30 min at 130 °C. The reaction mixture 
was evaporated, diluted with water (20 mL), the organic products extracted by DCM (3 
x 15 mL) and subsequently evaporated to give a yellow solid (0.01 g). 19F NMR of this 
crude showed starting material and 3-jluoro-4-methoxy-9-methyl-1-phellyl-dipyrido[ 1,2-
a;3 ',4 '-d) imidazole 33 (52 % by integration) to be present; i5r -93.03 (s, F-3); LCMS of 
this solid resulted in a TIC trace with two main peaks; 20.5 min (100 % relative 
abundance; m/z (ES+) 308.1 (product M+ + W, 100 %)) and 21.0 min (90 %relative 
abundance; m/z (ES+) 296.1, starting material M+ + W)). 
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Experimental to Chapter 4 
N -( 3 -Chloro-2, 5, 6-trifluoro-pyridin-4-yl )-benzamidine, 34 
f 
ClnF I + 
/. 
F N F 
4 eq NaHC03 
MeCN, reflux 3 h 
Chapter 10 
''S?~'' 2 ,..,.-:::. 6' 
' 7 
N"' NH2 CI~F 
JL.l F 2 N.--6 F 
34,53% 
3-Chloro-2,4,5,6-tetrafluoropyridine (1.86 g, 10.0 mmol), benzamidine hydrochloride 
(3.13 g, 20.0 mmol) and NaHC03 (3.36 g, 40.0 mmol) were refluxed together in MeCN 
(200 mL) for 3 h. After evaporation of the reaction solvent, water (50 mL) was added 
and the organic products extracted into DCM (3 x 40 mL). Drying (MgS04) and 
evaporation of solvent gave a white solid. Recrystallisation from MeCN gave N-(3-
chloro-2,5,6-trifluoro-pyridin-4-yl)-benzamidine 34 (1.50 g, 53 %) as a white solid; mp 
206-208 °C; (Found: C, 50.4; H, 2.4; N, 14.8. C12H1N3F3Cl requires: C, 50.5; H, 2.5; N, 
14.7 %); lir -77.08 (lF, dd, 3Jrr 23.6, 4lrr 13.5, F-6), -99.36 (1F, dd, 5Jrr 22.9, 4Jrr 13.7, 
F-2), -154.36 (lF, t, JFF 23.5, F-5); liH 7.98 (2H, m, H-2'), 7.57 (lH, m, H-4'), 7.50 (2H, 
m, H-3'), 7.15 (br s, NH); lie 157.41 (s, C-7), 151.71 (dm, 2Jcr 13.4, C-4), 150.82 (ddd, 
1JcF 235.8, 3JcF 16.4, 4JcF 2.2, C-2), 146.92 (ddd, 1JcF 238.3, 2JcF 17.5, 3JcF 16.3, C-6), 
135.41 (ddd, 1JcF 248.1, 2Jcr 26.0, 4JcF 6.0, C-5), 133.77 (s, Ar-CH), 131.39 (s, Ar-C), 
128.41 (s, Ar-CH), 127.62 (s, Ar-CH), 106.26 (dd, 2Jcr 33.2, 3JcF 5.6, C-3); m!z (EI) 
287.0 (~, 30 %, 37Cl), 285.0 (M+, 85 %, 35Cl), 250.0 (M+- Cl, 70 %). 
158 
Chapter 10 
7-Chloro-4,6-dijluoro-2-phenyl-3H-imidazo[4,5-c]pyridine, 35 
2 N:NH2 
CI~F 
_)_ __ ~ 
F N F 
34 
2.2 eq LOA, THF .,._ 
-78°C-RT 
Np 
CJnNH 
7 I "" 
F 6 N"' F 
35,34% 
LDA (1.22 mL 1.8 M soln in THF, 2.20 mmol) was syringed into a stirring solution of 
34 (0.29 g, 1.0 mmol) in THF (30 mL) at -78 °C. After stirring for I h, the reaction 
mixture was allowed to warm to room temperature. 19F NMR after 20 h showed no 
starting material remaining. The reaction was evaporated and poured onto 50 mL 0.5 M 
HCl solution. The organic product was extracted into DCM (4 x 30 mL), dried (MgS04) 
and evaporated to give a yellow solid. Recrystallisation from MeCN gave 7-chloro-4,6-
dijluoro-2-phenyl-3H-imidazo[4,5-c]pyridine 35 (0.09 g, 34 %) as an off-white solid; 
mp 2I6- 2I8 °C; (Found: C, 53.9; H, 2.3; N, I5.7. C 1zHsN3F2Cl requires: C, 54.3; H, 
2.3; N, I5.6 %); lir (DMSO-d6) major tautomer -81.62 (IF, br s, F-6), -85.38 (IF, br s, 
F-4); minor tautomer -SUO (IF, br s, F-6), -86.88 (IF, br s, F-4); liH 8.26 (2H, m, H-
2'), 7.59 (3H, m, H-3', 4'); lie I56.3I (br s, C-2), 149.84 (dd, 1Jcr 230.1, 3Jcr I5.6, C-6), 
131.5I (s, C-4'), I29.12 (s, C-3'), I28.20 (s, C-1'), I27.58 (s, C-2'); m/z (EI) 267.0 (M+, 
30 %, 37Cl), 265.0 (~, 30 %, 35Cl). Crystals suitable for X-ray analysis were grown 
from MeCN. 
4-Chloro-1,3-dijluoro-9-methyl-dipyrido[ 1,2-a,J ',4 '-d]imidazole, 36 
F 
CIUF cxMe I + 1.2 I 
/ " F N F N NH2 
7 • 
,~Me 
'r.J-i2a 4 eq NaHC03, Gin·,'' N MeCN , 
--"-'-'--'-'-'-------c... ' I ,., 
Reflux, 120 h .---: 
F ' N ' F 
36,69% 
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3-Chloro-2,4,5,6-tetrafluoropyridine (1.86 g, 10.0 mmol), 2-amino-3-picoline (1.30 g, 
12.0 mmol) and NaHC03 (3.36 g, 40.0 mmol) were refluxed together in MeCN for 120 
h. The reaction mixture was evaporated, 50 mL water added and the organic products 
extracted into DCM (3 x 40 mL). Drying (MgS04) and evaporation of these combined 
organic fractions gave a crude solid, recrystallisation of which gave 4-ch/oro-1,3-
dijluoro-9-methyl-dipyrido[l,2-a,3',4'-d]imidazo/e 36 (1.74 g, 69 %) as a yellow solid; 
mp 193 - 194°C; (Found: C, 52.0; H, 2.3; N, 16.6. C 11 H,;N3F2Cl requires: C, 52.0; H, 
2.3; N, 16.5 %); OF -77.84 (1F, d, 4JFF 12.8, F-3), -86.15 (1F, d, 4JFF 12.7, F-1); 011 9.04 
(lH, dm, 3JHH 7.2, H-6), 7.34 (lH, dm, 3J 1111 6.9, H-8), 6.90 (1H, t, 3J 1111 7.1, H-7), 2.67 
(3H, br s, CH3); lie 151.37 (m, C-2a), 149.72 (dd, 1JcF 234.3, 3JCF 13.9, C-3), 149.46 
(dd, 1JcF 253.5, 3JcF 14.9, C-1), 135.61 (dd, 3JcF 10.9, 3JcF 5.2, C-4'd), 129.66 (s, C-8), 
129.43 (s, C-9), 127.19 (dd, 2JcF 33.9, 4JcF 3.9, C-3'd), 124.37 (s, C-6), 112.69 (s, C-7), 
97.34 (dd, 2JCF 40.2, 4JcF 8.6, C-4), 17.58 (s, CH3); mlz (EI) 254.9 (M+, 10 %, 37Cl), 
252.9 (M+, 25 %, 35Cl). 
1,3-Dijluoro-9-methyl-dipyrido[ 1,2-a; 3 ',4 '-d]imidazole, 37 
r\-Me 
ti'N~ HCOONH4 Cl """' N Pd I c. THF I -'"' reflux, 2 d F N F 
36 
7 8 
,Q.-Me 
b~ 
F ' N ' F 
37,40% 
4-Chloro-1 ,3-difluoro-9-methyl-dipyrido[ I ,2-a;3' ,4' -d]imidazole 36 ( 4.0 lg, 15.81 
mmol), ammonium formate (1.00 g, 15.81 mmol) and 30% palladium on charcoal were 
stirred together and refluxed in THF (160m!) for 48 hours. 19F NMR indicated 80% 
conversion of starting material to one product. The reaction mixture was filtered, poured 
onto water (lOOm!) and extracted with DCM (4 x 30m!). The resulting mixture was 
dried (MgS04) and the solvent was removed under reduced pressure to yield a white 
crude, recrystallisation of which from methanol gave 1,3-difluoro-9-methyl-
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dipyrido[ 1,2-a;3',4'-djimidazole 37 (l.38g, 40%) as a white solid; m.p. 234- 235°C; 
(Found: C, 60.1; H, 3.3; N, 19.2. C 11 H1N3F2 requires: C 60.3; H 3.2; N 19.2 %); op-
74.92 (IF, d, 4Jpp 13.1, CF), -79.47 (IF, d, 4Jpp 12.9, CF); 011 8.20 (lH, d, 3JHH 7.0, H-6), 
7.32 (IH, dm, 311111 6.8, H-8), 7.26 (lH, m, H-4), 6.89 (IH, t, 3JHH 6.9, H-7), 2.70 (3H, br 
s, CH3); lie (DMSO-d,;) 152.99 (dd, 1Jcp 230.5, 3Jcp 13.6, CF), 150.61 (br s, C-2a), 
149.88 (dd, 1JcF 248.1, 3Jcp 17.2, CF), 140.83 (t, 3Jcp 12.4, C-4'd), 130.22 (s, C-8), 
127.63 (s, C-9), 125.10 (s, C-6), 124.82 (dd, 2JcF 32.5, 4Jcp 3.8, C-3'd), 112.18 (s, C-7), 
90.62 (dd, 2JcF43.4, 4JcP 7.3, C-4), 16.69 (s, CH3); m/z (EI) 219.0 (M+, 100%). 
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Chapter 11 
Experimental to Chapter 5 
N-( 3,5, 6-Trijluoro-pyridin-2-yl)-benzamidine, 38 
F "' F 0 n + 2 .x. F N"" F H2N NH.HCI 4 eq NaHC03, N Fn' 5 F MeCN H2 1 reflux, 270 h ._ ~ 2 "' • N N F 
38, 34% 
2,3,5,6-Tetrafluoropyridine (2.54 g, 16.8 mmol), benzamidine hydrochloride (5.26 g, 
33.6 mmol), and sodium hydrogen carbonate (5.64 g, 67.1 mmol) were stirred together 
in dry MeCN at 80 °C, under dry argon for 11 d. The mixture was evaporated, 50 mL 
water was added and the organic products extracted into CHC13 (3 x 40 mL). 
Evaporation of the solvent gave an off-white crude. Recrystallisation from MeCN gave 
N-(3,5,6-trijluoro-pyridin-2-yl)-benzamidine 38 (1.45 g, 34 %) as a pale yellow solid; 
mp 137-139 °C; (Found: C, 57.4; H, 3.1; N, 16.8. C12HsN3F3 requires: C, 57.4; H, 3.2; 
N, 16.7 %); Op -93.28 (IF, m, F-6), -127.05 (IF, dd, 3]pp 28.7, 4]pp 8.4, F-5), -144.99 
(IF, dd, 5JFF 24.3, 4JFF 8.4, F-3); OH 9.29, 6.16 (2H, br s, NH2), 7.90 (2H, m, H-3'), 7.49-
7.39 (4H, m, H-4, 2', 4'); lie 158.98 (s, C-7), 149.73 (ddd, 1Jcp 259.6, 2Jcp 5.6, 4JcF 2.2, 
C-6), 143.84 (m, C-2), 143.42 (ddd, 1JcF 236.9, 2JcF 15.9, 4JcF 3.4, C-5), 138.72 (ddd, 
1Jcp 256.5, 3Jcp 30.4, 4JcF 5.8, C-3), 136.38 (s, C-1'), 131.36 (s, C-4'), 128.79 (s, C-3'), 
127.15 (s, C-2'), 115.80 (ddd, 2Jcp 28.0, 2Jcp 19.2, 3Jcp 3.9, C-4); rn/z (EI) 251.1 (M', 
100 %), 232.1 (M+- 19, 80 %) 
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N-( 4-Bromo-3,5, 6-trijluoro-pyridin-2-yl) benzamidine 39 
Br Br 
F~F 
)L __ A + 
F N F 
4 eq NaHC03, n 
MeCN .,. N~ I '-"' F 
reflux, 210 h ~ "'6 N N F 
39,47% 
4-Bromo-2,3,5,6-tetrafluoropyridine (0.94 g, 4.1 mmol), benzamidine hydrochloride 
(1.26 g, 8.0 mmol), and sodium hydrogen carbonate (1.33 g, 15.9 mmol) were stirred 
together in dry acetonitrile at 80 °C, under dry argon. 19F NMR after 210 h showed no 
starting material remaining. The mixture was evaporated, 50 mL water was added and 
the organic products extracted into CHCI3 (3 x 40 mL). Evaporation of the solvent gave 
an light brown solid. Column chromatography (ethyl acetate:hexane, 1:1) on silica 
yielded N-(4-bromo-3,5,6-trijluoro-pyridin-2-yl) benzamidine 39 (0.64 g, 47 %) as an 
off white solid; mp 150-152 °C; (Found: C, 43.0; H, 2.3; N, 12.5. C12H1N3F3Br requires: 
C, 43.7; H, 2.1; N, 12.7 %); lip (DMSO-d6) -90.31 (lF, m, F-6), -124.04 (lF, dd, 3Jpp 
26.6, 4JFF 3.7, F-5), -142.85 (1F, dd, 5Jpp 26.4, 4Jpp 4.1, F-3); liH 8.19 (br s, NH2), 8.00 
(2H, m, H-2'), 7.55 (1H, m, H-4'), 7.50 (2H, m, H-3'); lie 159.43 (s, C-7), 147.22 (dm, 
1Jcp 253.0, C-6), 144.78 (m, C-2), 144.35 (dm, 1 JcF 233.1, C-5), 137.29 (dd, 1JcF 251.8, 
2JcF 33.0, C-3), 135.61 (s, C-1 '), 131.86 (s, C-4'), 128.94 (s, C-3'), 128.18 (s, C-2'), 
111.65 (m, C-4); rn/z (EI) 330.97 (M+, 58%), 328.98 (M+, 60 %), 312.0 (M+- F, 59%), 
310.0 (M+- F, 57%). 
4-Benzenesulfonyl-2,3,5,6-tetrajluoropyridine 40 
F~F JL .. ;l + PhS02Na 
F N F 
DMF 
130 °C 
40,62% 
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Pentafluoropyridine (5.07 g, 30 mmol) was added to a solution of phenylsulfinic acid 
(4.96 g, 30 mmol) in DMF (25 ml) under argon. After stirring the mixture at 130 °C for 
22 h the reaction mixture was left to cool and poured into water (250 ml). The solid 
which precipitated was filtered and the residue recrystallised from ethanol to yield 4-
benzenesuifony/-2,3,5,6-tetrajluoropyridine 40 (5.41 g, 62 %) as beige crystals; mp 145-
147 OC (Found: C, 45.3; H, 1.7; N, 4.8; c,,HsNF40zS requires: C, 45.3; H, 1.7; N, 4.8 
%); OF-86.19 (2F, m, F- 2), -137.47 (2F, m, F- 3); OH 8.12 (2H, m, H- 2'), 7.71 (1H, m, 
H- 4'), 7.65 (2H, m, H- 3'); Oc 144.36 (dm, 1JcF 256.0, C- 2), 139.41 (s, C- 1 '), 139.00 
(dm, 1JcF 263.2, C- 3), 135.93 (s, C-4'), 133.34 (m, C-4), 130.16 (s, C-3'), 128.74 (s, C-
2'); m/z (EI) 291.0 (M+, 66 %), 140.9 (S02Ph, 80 %), 76.9 (C6Hs, 100 %). 
7-Benzenesulfonyl-5, 6-dijluoro-2 -phenyl-JH-imidazo[ 4,5 -b] pyridine 41 
Q 
o"'s"o 
FnF + 
F N F 
40 
4 eq 
NaHC03 
MeCN 
41,36% 
4-Benzenesulfonyl-2,3,5,6-tetrafluoropyridine 40 (2.33 g, 8.0 mmol), benzamidine 
hydrochloride (2.51 g, 16.0 mmol) and sodium hydrogen carbonate (2.69 g, 32.0 mmol) 
were stirred together under argon in MeCN (300 ml) for 120 h. The reaction was poured 
into water (50 ml) and extracted into dichloromethane (4 x 30 ml). Drying (MgS04) and 
evaporation of the solvent gave a yellow solid. Recrystallisation from MeCN yielded 7-
benzenesuifonyl-5,6-difluoro-2-phenyl-JJJ-imidazo[4,5-b]pyridine 41 (1.1 g, 36 %) as a 
yellow powder; mp 241-245 °C; (Found: c. 58.3; H, 3.0; N, 11.6. c,sHilF2N302S 
requires: C, 58.2; H, 3.0; N, 11.3 %); OF (DMSO-d6) -91.33 (lF, d, 3JFF 27.9, F-5), -
147.73 (1F, m, F-6); OH 8.25 (2H, m, C-2'), 8.22 (2H, m, C-2"), 7.80 (lH, m, C-4'), 
7.70 (2H, m, C-3'), 7.61-7.58 (3H, m, C-3", 4"); Oc 156.42 (br m, C-2, C-4b), 147.92 
(dd, 1JcF 236.1, 2JcF 18.0, C-5), 139.99 (s, C-1 '), 138.06 (dd, 1JcF 259.6, 2JcF 31.1, C-6), 
135.13 (s, C-4'), 131.43 (s, C-4"), 129.70 (s, C-3'), 129.08 (s, C-3"), 128.63 (s, C-2'), 
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128.34 (s, C-2"), 127.52 (br s, C-1", C-7), 125.99 (br m, C-5b); mlz (Er+) 371.0 (M+, 
100 %). 
7-Benzenesulfonyl-5, 6-dijluoro-2 -methyl-1 H -imidazo[ 4,5-b] pyridine 42 
4 eq 
NaHC03 ,._ 
MeCN 
42,26% 
4-Benzenesulfonyl-2,3,5,6-tetrafluoropyridine 40 (1.46g, 5.0 mmol), acetamidine 
hydrochloride (0.95 g, 10.0 mmol) and sodium hydrogen carbonate (1.68 g, 20.0 mmol) 
were stirred together under argon in MeCN (200 ml) for 120 h. The reaction was poured 
onto water (50 ml) and extracted into dichloromethane (4 x 30 ml). Drying (MgS04) 
and evaporation of the solvent gave a yellow solid. Recrystallisation from MeCN 
yielded 7-benzenesulfonyl-5,6-dijluoro-2-methyl-1 H-imidazo[ 4,5-b ]pyridine 42 (0.40 g, 
26 %) as yellow crystals; mp 225-227 °C; (Found: C, 50.5; H, 3.0; N, 13.8. 
C 13H9F2N30 2S requires: C, 50.5; H, 2.9; N, 13.6 %); OF (DMSO-d,;) -93.18 (lF, d, 3hF 
28.2, C-5), -148.80 (IF, d, 3hF 27.5, C-6); 8H 13.14 (lH, br s, NH), 8.11 (2H, m, H-2'), 
7.77 (lH, m, H-4'), 7.68 (2H, m, H-3'); lie 159.44 (s, C-2), 147.80 (br m, C-4b), 147.05 
(dd, 1JcF 232.0, 2JcF 17.3, C-5), 139.53 (s, C-1 '), 136.94 (dd, 1JcF 257.7, 2JcF 32.5, C-6), 
135.34 (s, C-4'), 130.05 (s, C-3'), 127.71 (s, C-2'), 122.91 (m, C-7), 121.55 (br m, C-
Sb), 15.31 (s, CH3); m/z (EI) 309.0 (M+, 80 %), 76.9 (C6H5, 100 %). Crystals suitable 
for X-ray analysis were grown from MeOH. 
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3-Benzenesulfonyl-1,4-difluoro-6-methyl-dipyrido[ 1,2-a;4 ',3 '-d) imidazole, 43 and 4-
benzenesulfonyl-2,3-difluoro-6-methyl-dipyrido[ 1 ,2-a; 3 '2 '-d) imidazole, 44 
Q o_,8::-o FnF+ ~-~n 
F N F H2N N 
40 
Me 
,Q=N N~F 
4eq NaHC03, 
MeCN 
Reflux 
9 Jl&.~ 0 
F N ru 
7 
+ 
43,8% Me~ 
t--1 
+ N~F )l_J_ 
F N F 
3 
20 
' 9 
44,4% 
4-Benzenesulfonyl-2,3,5,6-tetrafluoropyridine 40 (1.46 g, 5.0 mmol), 2-amino-3-
picoline (1.19 g, 11.0 mmol) and sodium hydrogencarbonate (1.68 g, 20.0 mmol) were 
stirred together in dry MeCN (100 mL) at reflux temperature, under argon. After I week 
the reaction was evaporated to dryness, poured onto IM HCl solution (50 mL) and 
extracted into DCM (3 x 40 mL). Drying (MgS04) and evaporation of the solvent gave 
a yellow crude. Recrystallisation from MeCN gave 3-benzenesulfonyl-1,4-difluoro-6-
methyl-dipyrido[1,2-a;4',3'-d]imidazole 43 (0.14 g, 8 %) as planar yellow crystals; mp 
288-290 °C; (Found: C, 56.6; H, 3.0; N, ll.8. C11HIIF2N302S requires: C, 56.8; H, 3.1; 
N, 11.7 %); liF-76.61 (IF, d, 5JFF 30.9, F-1), -132.08 (IF, d, 5JFF 31.6, F-4); ()H 8.60 (lH, 
d, 3JHH 6.8, C-9), 8.15 (2H, m, C-2'), 7.62 (lH, m, C-7), 7.54 (3H, m, C-3', 4'), 7.11 
(IH, m, C-8), 2.74 (3H, s, CH3); mlz (ES+) 360.1 (M+ + H+, 100 %). Crystals suitable 
for X-ray analysis were grown from MeCN. 
Column chromatography (on silica, ethyl acetate: hexane, 2: 1) of the remaining material 
followed by recrystallisation from MeCN yielded 4-benzenesulfonyl-2,3-difluoro-6-
methyl-dipyrido[J,2-a;3'2'-d]imidazole 44 (0.08 g, 4 %) as a yellow solid; mp 242-244 
°C; (Found: C, 56.8; H, 3.1; N, 11.9. C11H 11 FzN302S requires: C, 56.8; H, 3.1; N, ll.7 
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%); Op-91.53 {IF, d, 3hF 24.8, F-2), -140.24 (IF, d, 3JFF 24.6, F-3); OH 8.42 (3H, m, C-
2', 4'), 7.64 (IH, m, C-9), 7.55 (2H, m, C-3'), 7.37 {IH, m, C-7), 6.93 (IH, m, C-8), 
2.71 (3H, s, CH3); Oc 151.21 (s, C-2a), 147.21 (dd, 1JcF 243.9, 2JcF 19.8, C-2), 141.44 
(dd, 1JcF 267.9, 2JcF. C-3), 140.66 (s, C-2'd), 134.62 (s, C-9), 133.90 (dm, 2JcF 15.2, C-
4), 131.29 (d, 4JcF 3.1, C-1 '), 130.24 (s, C-7), 129.26 (s, C-2'), 129.14 (s, C-3'), 128.99 
(s, C-6), 128.51 (m, C-3'd), 121.95 (s, C-4'), 112.87 (s, C-8), 17.02 (s, CH3); mlz (ES+) 
360.0 (M+ + W, 100 %). Crystals suitable for X-ray analysis were grown from CDCI3. 
N-( -4-Amino-5,8-dijluoro-2-p!zenyl-pyrido[ 3, 4-d] pyrimidin-6-yl )-benzamidine, 45 
CN 
F~F 
JL .. )_ + 
F N F 
4 eq 
NaHC03~ 
MeCN 
(') 
HfiN,-,,N~ 
F ""' N NH2 I 3d 
,... -"' 
N ' N ' F 
45,58% 
2,3,5,6-Tetrafluoro-4-pyridinecarbonitrile (0.88 g, 5.0 mmol), benzamidine 
hydrochloride (1.57 g, 10.0 mmol) and sodium hydrogen carbonate (1.68 g, 20.0 mmol) 
were stirred together under argon in MeCN (200 ml) for 170 h at 80 °C. The reaction 
mixture was treated with water (50 ml) and the organic products extracted into DCM (3 
x 40 ml). The organic phase was dried (MgS04) and the solvent removed under reduced 
pressure. Recrystallisation from MeCN of the crude material yielded N-( -4-amino-5,8-
dijluoro-2-p!zenyl-pyrido[3,4-d]pyrimidin-6-yl)-benzamidine 45 (1.09 g, 58 %) as a 
yellow solid; mp 215-216 °C; ([M + W] 377.1320. C20H1.F2N6 requires [M + H+] 
377.1321); Op (DMSO-~) -97.79 (d, 5JFF 28.0, F-8), -153.97 (d, 5JFF 29.3, F-5); OH 8.41 
(2H, m, H-2'), 8.21, 7.76, 7.38 (4H, br s, NH2), 8.11 (2H, m, H-2"), 7.55-7.47 (6H, m, 
H-3', 3", 4', 4"); llc 159.59 (s, C-2), 159.35 (m, C-4), 157.80 (s, C-9), 154.90 (dd, 2JcF 
12.8, 3JcF 3.7, C-6), 144.19 (dd, 1Jcp227.9, 4JcF 16.9, C-8), 140.25 (m, C-3d), 137.82 (s, 
C-1 '), 135.64 (s, C-1 "), 132.99 (dd, 1JcF 254.8, 4JcF 30.8, C-5), 130.87 (s, C-4"), 
130.42 (s, C-4'), 128.35 (s, C- 3'), 128.31 (s, C-3"), 127.80 (s, C-2'), 127.65 (s, C-2"), 
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110.99 (dd, 2JcF 8.3, 3JcF 3.6, C-4d); m/z (ES+) 377.1 (M+ + W, 100 %). Crystals 
suitable for X-ray analysis were grown from MeCN. 
N-( -4-amino-5,8-dijluoro-2 -methyl-pyrido[ 3,4-d] pyrimidin-6-y/ )-acetamidine, 46 
CN 
F~F 
)L~ + 
F N F 
4 eq 
NaHC03• 
MeCN 
HfiN , Nc}-Me 
..,... II 11 
F 4d N 
NH2 I """ 3d h .--; 
Me N ' N a F 
46, 16% 
2,3,5,6-Tetrafluoro-4-pyridinecarbonitrile (0.44 g, 2.5 mmol), acetamidine 
hydrochloride (0.47 g, 5.0 mmol) and sodium hydrogen carbonate (0.84 g, 10.0 mmol) 
were stirred together under argon in MeCN (100 ml) for 72 h at 80 °C. The reaction 
mixture was treated with water (100 ml) and the organic products extracted into DCM 
(3 x 100 ml). The organic phase was dried (MgS04) and the solvent removed under 
reduced pressure. The resulting crude was recrystallised from MeCN to give N-(-4-
amino-5,8-dijluoro-2-methyl-pyrido[3,4-d]pyrimidin-6-yl)-acetamidine 46 (0.10 g, 16 
%) as a yellow paper like solid; mp 224-228 °C; ([M + W] 253.1009. CwH10F2N6 
requires [M + W]153.1008); lip(DMSO-d6) -98.58 (d, 5Jpp28.12, C-8), -155.18 (d, 5Jpp 
27.88, C-5); liH 8.02, 7.17 (4H, br s, NH2), 2.41 (3H, s, C-10), 1.92 (3H;, s, C-11); lie 
163.69 (s, C-2), 160.61 (s, C-9), 158.92 (m, C-4), 154.29 (dd, 2JcF 12.9, 3JcF 3.0, C-6), 
143.52 (dd, 1JcF 226.2, 4JcF 15.6, C-8), 140.05 (m, C-3d), 132.30 (dd, 1JcF 254.9, 41cF 
30.7, C-5), 110.06 (dd, 2JcF 8.2, 3JCF3.2, C-4d), 25. 80 (s, C-11), 20.78 (s, C-10). 
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N-( -4-Cyano-3, 5, 6 trijluoro-pyridin-2yl-)-benzamidine, 47 and 5,6, 8-trijluoro-2-phenyl-
pyrido{3,4-d]pyrimidin-4-ylamine, 48 
CN 
F~F 
)L_~ 
F N F 
8 
4eq CN 
NaHC03 Nfl~F 
MeCN ,.if" 2)L_ A + I"" N 2 N 6 F 
~ 
1 
47,20% 
H;(;N ,,__NyO 
F 4d N 
"""' ' I " 
h 
F s N 8 F 
2,3,5,6-Tetrafluoro-4-pyridinecarbonitrile (0.44 g, 2.5 mmol), benzamidine 
hydrochloride (0.39 g, 2.5 mmol) and sodium hydrogen carbonate (0.42 g, 5.0 mmol) 
were stirred together under argon in MeCN (100 ml ) for I week at 80 °C. The reaction 
mixture was treated with water (50 ml) and extracted into dichloromethane (3 x 40 ml). 
The organic phase was dried (MgS04) and the solvent removed under reduced pressure 
to give an orange/red crude solid. Column chromatography on alumina (DCM:hexane 
3:2) gave N-(-4-cyano-3,5,6 trijluoro-pyridin-2yl-)-benzamidine 47 (0.14 g, 20 %) as a 
pale yellow solid; Op (DMSO-d6) -88.90 (dd, 3]pp 30.0, 5JFF 25.2, F-6), -123.03 (dd, 3JFF 
29.4, 4JFF 7.0, F-5), -144.10 (dd, 5JFF 25.0, 4JFF 6.5, F-3); OH 8.37 (2H, br s, NHz), 8.02 
(2H, m, H-2'), 7.58 (lH, m, H-4'), 7.51 (2H, m, H-3'); oc 159.44 (s, C-7), 148.53 (ddd, 
1JcF 268.0, 2JcF 7.5, 4JcF 3.2, C-6), 145.Dl (m, C-2), 143.39 (ddd, 1JcF 234.2, 2JcF 13.7, 
3JcF 3.9, C-5), 136.88 (dd, 1Jcp264.6, 3Jcp34.1, C-3), 134.60 (s, C-1'), 131.51 (s, C-4'), 
128.40 (s, C-3'), 127.75 (s, C-2'), 108.39 (m , C-8), 102.50 (m, C-4); m/z (EI+) 276.0 
(M+, 78 %), 257.0 (M+ - F, 100 %). Crystals suitable for X-ray analysis were grown 
fromMeCN. 
Recrystallisation of the remaining crude material from MeCN yielded 5,6,8-trijluoro-2-
phenyl-pyrido[3,4-d]pyrimidin-4-ylamine 48 (0.036 g, 5 %) as a yellow solid; mp 220-
223 °C; (Found; C 56.1; H, 2.5; N, 20.4. C13H7F3N4 requires; C, 56.5; H, 2.6; N, 20.3 
%); Op(DMSO-clG) -76.92 (dd, 3JFF 34.9, 4}pp 14.0, F-6), -100.11 (dd, 5JFF 21.7, 4}pp 13.8, 
F-8), -145.26 (dd, 3JFF 35.3, 5JFF 22.0, F-5); oH 8.67 and 7.9 (2H, br s, NH2), 8.40 (2H, 
m, H-2'), 7.54-7.48 (3H, m, H-3', 4'); lie 161.84 (s, C-2), 158.65 (d, 3JcF 3.4, C-4), 
149.93 (ddd, 11cF 253.8, 3JcF 10.7, 4JcF 2.0, C-8), 141.40 (ddd, 1JcF 236.5, 2JcF 18.6, 3JcF 
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13.5, C-6), 136.87 (ddd, 1Jcp259.6, 2JcF 27.5, 4JcF 7.1, C-5) 136.81 (S, C-1'), 134.76 
(dm, 2Jcp3l.4, C-3d), 13l.l9 (s, C-4'), 128.52 (s, C-3'), 128.10 (s, C-2'), ll3.41 (m, C-
4d); m/z (Er) 276 (M+, 100 %), 260 (M+-NH2, 49 %). Crystals suitable for X-ray 
analysis were grown from MeCN. 
N-( 4-Cyano-3,5, 6-t rijluoro-pyridin-2-yl )-acetamidine, 49 and 5, 6, 8-trijluoro-2-methyl-
pyrido[ 3,4-d] pyrimidin-4-ylamine, 50 
CN 
F~F 
)l_~ 
F N F 
8 
4eq CN 
NaHC03.,_ NrGfil ~ /
MeCN 7 1::-.... .....-:: + 
H3C/":: N ' N s F 
1 
49, 17% 50,8% 
2,3,5,6-Tetrafluoro-4-pyridinecarbonitrile (0.44 g, 2.5 mmol), acetamidine 
hydrochloride (0.24 g, 2.5 mmol) and sodium hydrogen carbonate (0.42 g, 5.0 mmol) 
were stirred together under argon in MeCN (100 ml) for 7 d. Evaporation under reduced 
pressure was followed by treatment with water (50 ml). Extraction of the organic 
products by DCM (3 x 40 ml), drying (MgS04), filtering and removal of solvent under 
reduced pressure gave a brown/black solid. Filtration of the crude material through 
alumina (DCM as eluant) yielded a yellow solid, N-(4-cyano-3,5,6-trijluoro-pyridin-2-
yl)-acetamidine 49 (0.09 g, 17 %); ([M + W] 215.0540. C8Bt,N.F3 requires [M + H+] 
215.0539); lip (DMSO-d6) -88.94 (dd, 3JFF 29.5, 5JFF 26.2, F-6), -124.26 (m, F-5), -
145.02 (dd, 5JFF 23.2, 4JFF 6.9, F-3); liH 8.02-7.76 (2H, br m, NH2), 2.04 (3H, s, CH3); lie 
163.35 (s, C-7), 147.91 (ddd, 1JcF 266.6, 2JcF 6.2, 4JcF 3.1, C-6), 144.61 (m , C-2), 
143.38 (ddd, 1JcF 232.1, 2JcF 13.1, 3JcF 3.3, C-5), 136.55 (dd, 1Jcp263.2, 3Jcp34.6, C-3), 
108.43 (m, C-8), 102.19 (m, C-4), 21.26 (s, CH3); rn/z (EI) 214.0 (W, 90 %), 197.0 (M+ 
- 17, 100 %). 
Washing the alumina with methanol followed by recrystallisation of the residue from 
MeCN yielded 5,6,8-trifluoro-2-methyl-pyrido[3,4-d]pyrimidin-4-ylamine 50 (0.04 g, 8 
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%) as an orange solid; ([M + W] 215.0541. C8Ht;N4F3 requires [M + W] 215.0545); lip 
(DMSO-d6) -77.42 (dd, 3Jpp35.1, 4Jpp 14.0, F-6), -100.78 (dd, 5Jpp22.1, 4Jpp 14.0, F-8),-
145.35 (dd, 3Jpp 35.0, 5Jpp 22.2, F-5); liH 8.56 (2H, br s, NH2), 2.46 (3H, s, CH3); lie 
166.42 (s, C-2), 158.18 (d, 3Jep3.4, C-4), 149.36 (ddd, 1JeF 252.4, 2JeF 11.0, 3Jep2.2, C-
6), 140.99 (ddd, 1Jep234.4, 3Jep 18.3, 4Jep 13.3, C-8), 136.74 (ddd, 1Jep258.6, 2JeF 27.0, 
4Jcp 7.1, C-5), 134.30 (dm, 2Jcp 28.3, C-3d), 112.78 (m, C-4d), 25.80 (s, CH3). 
2,3-Dijluoro-6-methyl-dipyrido[ 1 ,2-a,3 ',2 'd} imidazole-4-carbonitrile, 51 
CN 
F~F 
Jl.~ F N F 
4 NaHC03, 
MeCN 
Reflux, 
2 weeks 
51,52% 
2,3,5,6-Tetrafluoro-4-pyridinecarbonitrile (0.88 g, 5.0 mmol), 2-amino-3-picoline (1.08 
g, 10.0 mmol) and Sodium hydrogen carbonate (1.68 g, 20.0 mmol) were stirred 
together in MeCN at reflux temperature, under dry argon. After 2 weeks the reaction 
was cooled to room temperature and the solvent evaporated. The residue was 
redissolved in DCM and poured onto water (50 mL). Extraction of the organic products 
into DCM, followed by drying (MgS04) and evaporation of the solvent in vacuo left a 
brown crude. Column chromatography on silica (hexane: ethyl acetate, 1:1) yielded 2,3-
dijluoro-6-methyl-dipyrido[l,2-a,3',2'd]imidazole-4-carbonitrile 51 (0.63 g, 52%) as a 
yellow solid; mp 197-198 °C; (Found: C, 58.9; H, 2.4; N, 23.1. C 12llt;N4F2 requires: C, 
59.2; H, 2.5; N, 22.9 %); lip -91.96 (IF, d, 3Jpp 22.5, F-2), -135.23 (IF, d, 3Jpp 23.1, F-3); 
liH 8.53 (lH, d, 3JHH 6.9, H-9), 7.45 (lH, dm, 3JHH 6.9, H-7), 7.02 (m, H-8), 2.73 (3H, br 
s, CH3); lie 151.79 (s, C-2a), I46.35 (dd, 1JcF 245.5, 2JcF I7.3, C-2), 145.72 (dd, 1JCF 
268.5, 2JcF 31.6, C-3), 134.72 (d, 3JcF 2.9, C-2'd), 133.50 (m, C-3'd), 131.03 (s, C-7), 
128.94 (s, C-6), 122.31 (s, C-9), 113.28 (s, C-8), 109.9I (d, 3JcF 5,0, CN), 101.49 (dd, 
2Jcp 13.0, 3JcF 4.5, C-4), 17.03 (s, CH3); mlz (EI) 243.8 (M+, 100 %). 
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2-Diethylamino-3-f/uoro-6-methyl-dipyrido[ 1,2-a; 3 ',2 '-d]imidazole-4-carbonitri/e, 52 
N~F Met)_{_~ r N N F 
- 51 
-"5-'e'-'q'--H-'-N_E-::-t-"2 ,'-T_H_F,.,_ 
MW, 150 °C, 30 min 
~F Me N j___vl 11--<N IN N~ 
w ~ 
52, 17% 
2,3-difluoro-6-methyl-di pyrido[1,2-a,3' ,2' d]imidazole-4-carbonitrile (0.05 g, 0.20 
mmol) and diethylamine (0.07 g, 1.0 mmol) were stirred together in THF, under 
microwave heating, for 30 min at 150 °C. 19F NMR of the reaction mixture showed no 
starting material remaining and one major new resonance. The reaction was worked up 
and the dark orange crude purified by preparative HPLC to give 2-diethylamino-3-
f/uoro-6-methyl-dipyrido[ 1,2-a;3 ',2 · -d]imidazole-4-carbonitrile 52 (0.0 1 g, 17 %) as a 
yellow solid; Of -125.47 (s, F-3); oH 8.40 (1H, d, 3JHH 6.8, H-9), 7.22 (lH, dm, 3JHH 6.7, 
H-7), 6.83 (lH, m, H-8), 3.61 (4H, qd, 3JHH 6.9, 5JHF 1.7, CH2), 2.67 (3H, br s, CH3), 
1.28 (6H, t, 3JHH 6.9, CH2CH3); mlz (ES+) 298.1 (M+ + W, 100 %). 
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Experimental to Chapter 6 
6-B rttyl ami no-2, 4, 5 -I rich I o ro-ni cot inoni 1 ri I e, 53 
Cl 
CI~CN 
)t .. ~ Cl N Cl 
1.1 eqH
2
N) .,_ ~I:CcCN 
4 eq NaHCOa. N N Cl 
MeCN, reflux, 4 h H 
53, 13% 
Chapter 12 
A mixture of 2,4,5,6-tetrachloro-nicotinonitrile (1.21 g, 5.00 mmol), butylamine (0.40 g, 
5.50 mmol) and sodium hydrogen carbonate (1.68 g, 20.00 mmol) were refluxed 
together in MeCN (100 mL), under an atmosphere of dry argon, for 4 h. No starting 
material was observed by tic. The reaction was evaporated and poured onto water (100 
mL). Extraction of the organic products into DCM (4 x 30 mL), drying of the fractions 
(MgS04), and evaporation, gave an off-white solid. Column chromatography (silica, 
hexane: ethyl acetate, 10 : 1) gave 2 fractions. The major fraction (0.48 g, yellow solid) 
consisted of predominantly 1 compound (by 13C NMR). Recrystallisation from MeCN 
yielded 6-Butylamino-2,4,5-trichloro-nicotinonitrile 53 (0.18 g, 13 %) as an off-white 
solid; m.p. 137-141 °C; ([M + W] 278.0012. C10H 11 N3Cl3 requires [M + W] 278.0019); 
oH 5.77 (br s, NH), 3.53 (2H, m, CH2), 1.63 (2H, m, CHz), 1.41 (2H, m, CH2), 0.96 (3H, 
t, 3JHH 7.4, CH3); oc 155.07, 151.72, 143.67, 113.92, 112.10, 98.44, 42.09, 31.27, 20.10, 
13.85; m/z (EI) 280.9 (M+, 4 %; 37C1, 37Cl, 35Cl), 278.9 (M+, 8 %; 37Cl, 35Cl, 35Cl), 276.9 
(~. 8 %; 35Cl, 35Cl, 35Cl), 237.9 (M+- C3H7, 34 %; 37Cl, 37CI, 35Cl), 235.9 (M+- C3H7, 
100 %; 37Cl, 35Cl, 35Cl), 233.9 (M+- C3H7, 100 %; 35Cl, 35Cl, 35Cl). Crystals for X-ray 
analysis were grown from CDClJ. 
The minor fraction (0.17 g off-white solid), was also collected. NMR and MS data was 
consistent with the 4-substituted regioisomer of the major product. 
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N-( 3, 4, 6-Trich/oro-5-cyano-pyridin-2 -yl )-benzamidine, 54 
Cl 
CI~CN 
JL .. ~ Cl N Cl 
1
-2 H2N NH.HCI 
4 eq NaHC03, 
MeCN, reflux, 4 h 
Cl 
N~~~CN 
"·y_ __ ;l 
N N Cl 
54,36% 
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A mixture of 2,4,5,6-tetrachloro-nicotinonitrile (1.21 g, 5.00 mmol), benzamidine 
hydrochloride (0.86 g, 5.50 mmol) and sodium hydrogen carbonate (1.68 g, 20.00 
mmol) were refluxed together in MeCN, under an atmosphere of dry argon, for 4 h. No 
starting material was observed by tic. The reaction was evaporated and poured onto 
water (50 mL). The organic products were extracted into DCM (4 x 30 mL) and the 
fractions filtered to yield N-( 3,4,6-trichloro-5-cyano-pyridin-2-yl)-benzamidine 54 (0.59 
g, 36 %) as a yellow solid; m.p. 228-231 °C; (Found: C, 48.0; H, 2.1; N, 17.3. 
C13H7Cl3N4 requires: C, 48.0; H, 2.2; N, 17.2 %); oli 8.92, 8.71 (2H, br s, NHz), 8.06 
(2H, m, Ar-CH), 7.60 (IH, m, Ar-H), 7.53 (2H, m, Ar-CH); &c 160.85, 160.73, 148.59, 
144.24, 134.00, 132.06, 128.49, 127.99, 122.60, 133.76, 101.70; m/z (EI) 327.9 (M+, 30 
%; 37Cl, 37Cl, 35Cl), 325.9 (M•, 80 %; 37Cl, 35Cl, 35Cl), 323.9 (M+, 85 %; 35Cl, 35Cl, 
35Cl), 104.0 (PhCHN, 100 %), 77.0 (Ph, 95 %). 
2, 4,5, 6-Tetrajluoro-nicotinonitrile, 55 
Cl 
CI~CN 
J-.A Cl N Cl 
5.1 eq KF 
autoclave, 
320 °C, 22 h 
1:: F~-""CN jL_;L 
F N F 
55, 16% 
A stainless steel autoclave was charged with 2,4,5,6-tetrachloro-nicotinonitrile (40 g, 
0.17 mol) and flame-dried potassium fluoride (50 g, 0.86 mol). The autoclave was 
sealed and heated at 320 °C for 22 h after which time the reaction mixture was allowed 
to cool to 200 °C. The gaseous fluorinated products were removed under reduced 
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pressure and condensed in a Young's tap-equipped vessel. Distillation of this crude 
material yielded 2.4,5,6-tetrafluoro-nicotinonitri/e 55 (4.59 g, 16 %) as a colourless oil; 
b.p. ISO- 154 °C; (Found: C, 40.4; N, 15.9. C6F4N2 requires: C, 40.9; N, 15.9 %); op-
60.24 (IF, m), -72.26 (IF, m), -106.12 (IF, ddd, 3Jpp 24.3, 4Jpp 18.8, 4]pp 7.4, F-4), -
163.30 (IF, m, F-5); 8c 160.58 (dm, 1JcF 277.8, CF), 155.70 (dm, 1JcF 254.3, CF), 
152.79 (dm, 1Jcp 255.1, C-4), 133.21 (dm, 1JcF 264.4, C-5), 106.22 (d. 3JcF 5.5, CN), 
87.62 (dm, 2Jcp35.9, C-3); m/z (EI) 175.9 (M+, 100 %). 
Reaction with butylamine 
" 1.1 eq H2N) 
c 
\FXxCN FUCN FnCN I ,..., ... I ,..., + 
F N F 4 eq NaHC03, F N F N N F 
MeCN, reflux, 19 h H 55 3 2 
56 57 
A mixture of 2,4,5,6-tetrafluoro-nicotinonitrile 55 (0.88 g, 5.00 mmol), butylamine 
(0.40 g, 5.50 mmol) and sodium hydrogen carbonate (1.68 g, 20.00 mmol) were 
refluxed together in MeCN (100 mL), under an atmosphere of dry argon, for 19 h. No 
starting material was observed by 19F NMR. The reaction was evaporated and poured 
onto water (50 mL). Extraction of the organic products into DCM (3 x 50 mL), drying 
of the fractions (MgS04), and evaporation, gave a yellow solid. 19F NMR of the crude 
showed there to be two major products, 4-butylamino-2,5,6-trijluoro-nicotinonitrile 56 
( -73, -97 and -176 ppm) and 6-butylamino-2,4,5-trijluoro-nicotinonitrile 57 ( -70, -131, -
177 ppm), in a 3:2 ratio. No further purification was carried out. 
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5, 7,8-Trijluoro-2-pheny/-pyrido[ 4, 3-d] pyrimidin-4-ylamine 58 
1:: F~_.-CN 
J__;L 
F N F 
55 
1.1 eq2 
H2N NH.HCI 
---=----1· 
4 eq NaHC03, 
MeCN, RT, 70 h 
(j 
NIN 
F >~d I 4 · 
' I "" ,. NH2 
..< 
F 7 N 5 F 
58,60% 
A mixture of 55 (0.88 g, 5.00 mmol), benzamidine hydrochloride (0.86 g, 5.50 mmol) 
and sodium hydrogen carbonate (1.68 g, 20.00 mmol) were stirred together in MeCN, 
under an atmosphere of dry argon, for 70 h. No starting material was observed by 19F 
NMR. The reaction was evaporated and poured onto water (50 mL). The organic 
products were extracted into DCM (3 x 50 mL) and the fractions filtered to remove a 
yellow solid. Recrystallisation from MeCN gave 5, 7,8-trijluoro-2-phenyl-pyrido[4,3-
d]pyrimidin-4-ylamine 58 (0.84 g, 60 %) as a pale yellow solid; m.p. 195-198 °C; 
(Found: C, 56.4; H, 2.5; N, 20.3. C13H7F3N• requires: C, 56.5; H, 2.6; N, 20.3 %); or-
59.19 (IF, dd, 3Jrr 29.7, 4hr 11.3, F-7), -91.54 (dd, 5Jrr 19.1, 4Jrr 12.2, F-5), -161.31 
(dd, 3Jrr 29.6, 5Jpp 19.0, F-8); OH 8.82 (br s, NH), 8.42 (2H, m, H-2'), 7.92 (d, JHF 6.0, 
NH), 7.56 (lH, m, H-4'), 7.52 (2H, m, H-3'); oc 164.74 (s, C-2), 159.67 (d, 3Jcr 6.8, C-
4), 152.02 (ddd, 1Jcr250.1, 2Jcr16.8, 3Jcr2.6, C-7), 151.73 (m, C-4d), 147.96 (ddd, 1Jcr 
238.8, 3Jcr 19.0, 4Jcr15.2, C-5), 136.58 (s, Ar-C), 133.47 (ddd, 1Jcr253.8, 2Jcr23.0, 4Jcr 
8.1, C-8), 131.77 (s, Ar-CH), 128.69 (s, Ar-CH), 128.46 (s, Ar-CH), 97.15 (dd, 2Jcr 
27.4, 3Jcr3.7, C-3d); m/z (EI) 275.8 (M+, 100 %). 
5, 7,8-Trijluoro-2 -methyl-pyrido[ 4,3-d] pyrimidin-4-ylamine 59 
1:: F~CN 
~--~ F N F 
55 
Me 1.1eq):,. 
H2N NH.HCI 
4eq NaHC03, 
MeCN, RT, 48 h 
Me 
N~N 
F~ )L_).:•_ NH2 
F 7 N 5 F 
59,37% 
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A mixture of 55 (0.88 g, 5.00 mmol), acetamidine hydrochloride (0.52 g, 5.50 mmol) 
and sodium hydrogen carbonate (1.68 g, 20.00 mmol) were stirred together in MeCN, 
under an atmosphere of dry argon, for 48 h. The reaction was evaporated and poured 
onto water (50 mL). The organic products were extracted into DCM (3 x 40 mL), dried 
(MgS04) and evaporated to give a yellow solid (0.84 g). Recrystallisation from MeCN 
gave 5,7,8-trijluoro-2-met!zyl-pyrido[4,3-d]pyrimidin-4-ylamine 59 (0.40 g, 37 %) as a 
pale yellow solid; m.p. 217-219 °C; (Found: C, 44.8; H, 2.3; N, 26.2. C8HsF3N4 
requires: C, 44.9; H, 2.4; N, 26.2 %); OF-58.95 (IF, dd, 31FF30.2, 4hF 10.4, F-7), -91.76 
(dd, 5JFF 19.0, 4hF 12.2, F-5), -161.79 (dd, 3JFF 29.7, 5JFF 19.2, F-8); i5H 8.72 (IH, br s, 
NH), 7.82 (IH, br s, NH), 2.42 (3H, br s, CH3); i5c 170.32 (s, C-2), 159.81 (d, 3JcF 6.7, 
C-4), 152.57 (ddd, 1JcF250.4, 2JcF 16.8, 3JcF2.6, C-7), 151.96 (m, C-4d), 148.33 (ddd, 
1JcF 240.0, 3JcF 18.8, 4JcF 15.1, C-5), 135.53 (ddd, 1JcF 252.5, 2JcF 23.2, 4JcF 8.4, C-8), 
97.11 (dd, 2JcF 27.5, 3JcF 3.6, C-3d), 26.22 (s, CH3); m/z (EI) 213.9 (M+, 100 %). 
Crystals suitable for X-ray analysis were grown from MeCN. 
5, 7,8-Trijluoro-pyrido[ 4, 3-d] pyrimidin-4-ylamine 60 
2 
li' 1.1 eq N"""'N 
FnCN H ~ F ' I ' 2N NH.HCI 
-...::: NH2 I /- 'I 3d 4 eq NaHC03, /-F N F F ' N ' F MeCN, RT, 46 h 
55 60,20% 
A mixture of 55 (0.88 g, 5.00 mmol), formamidine hydrochloride (0.44 g, 5.50 mmol) 
and sodium hydrogen carbonate (1.68 g, 20.00 mmol) were stirred together in MeCN, 
under an atmosphere of dry argon, for 46 h. The reaction was evaporated and poured 
onto water (50 mL). The organic products were extracted into DCM (3 x 40 mL), dried 
(MgS04) and evaporated to give an off-white solid (0.92 g). Recrystallisation from 
MeCN gave 5,7,8-trijluoro -pyrido[4,3-d]pyrimidin-4-ylamine 60 (0.20 g, 20 %) as a 
white solid; m.p. 196-200 °C; (Found: C, 41.9; H, 1.4; N, 28.0. C7H3F3N4 requires: C, 
42.0; H, 1.5; N, 28.0 %); i5F(DMSO-d6) -58.26 (lF, dm, 3JFF 30.3, F-7), -91.22 (1F, dd, 
5JFF 18.8, 4JFF 12.1, F-5), -161.23 (lF, dd, 3JFF 30.3, 5JFF 18.8, F-8); i5H 8.86, 7.99 (br s, 
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NH), 8.58 (s, H-2); l:lc 160.53 (s, C-2), 159.34 (d, 3Jcp6.6, C-4), 151.85 (ddd, 1Jcr250.9, 
2Jcp 16.1, 3JcF 2.9, C-7), 150.79 (m, C-4d), 147.65 (ddd, 1 Jcr 239.1, 3Jcr 18.6, 4Jcr 15.1, 
C-5), 135.32 (ddd, 1JcF 253.4, 2Jcp22.3, 4JcF 8.5, C-8), 98.40 (dd, 2Jcp27.6, 3JcF 3.8, C-
3d); m/z (EI) 199.9 (M+, 100 %). 
Attempted Synthesis of 4,6,7-Trijluoro-1 H-pyrazolo[4,3-c]pyridine-3-ylamine 
li' F~CN jL_J_ 
F N F 
55 
_1c:_. 1c:_e:..:q'--'N-'-'2'---H-"-4 • ___ H-"2z_1 
4 eq NaHC03, 
MeCN, RT, 39 h 
Hydrazine hydrate (0.28 g, 5.50 mmol) was syringed into a stirring solution of 55 (0.88 
g, 5.00 mmol) and sodium hydrogen carbonate (1.68 g, 20.00 mmol) in MeCN (100 
mL), under an atmosphere, at room temperature. 19F NMR after 39 h showed three new 
major resonances. The reaction was evaporated and the crude poured onto water (50 
mL). The pH was adjusted to 2 and the organic products extracted into DCM (3 x 40 
mL). Drying (MgS04) and evaporation yielded a pale yellow solid (0.63 g). 
Recrystallisation from MeCN gave a yellow solid (0.58 g) corresponding to 61; Op 
(DMSO-~) -65.41 (lF, dd, 3JFF 20.4), -89.77 (1F, dd, 5Jpp21.4, 4JFF 11.3), -164.66 (lF, 
m, F-7); oH 10.64 (br s, NH), 2.03; oc 160.20, 158.11 (ddd, JcF 240.4, Jcp 18.8, JcF 2.0), 
149.47 (ddd, JcF 238.0, Jcp 20.5, Jcp 13.6), 146.73 (dm, JcF 10.6), 129.31 (ddd, Jcp 
246.5, JcF 28.1, JcF 5.4), 112.15 (d, JcF 5.2), 78.48 (ddd, Jcp 37.7, JcF 3.3, JcF 2.5), 
24.09, 18.17; m/z (EI) 228.0 (M+, 30 %), 187.1 (60 %), 144.9 (55%), 55.9 (100 %) 
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4,6, 7-Trijluoro-1 !1-pyrazo/o[ 4,3-c]pyridine-3-y/amine, 62 
" F~...-CN 
JL~ + F N F 
55 
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' HN-N 
F 3 \ 3 
'-':: 
7 I 4e 
/-
F ' N ' F 
62,9% 
55 (1.76 g, 10.00 mmol) and hydrazine hydrate (1.00 g, 20.00 mmol) were refluxed in 
ethanol (200 mL) for 5 h. 19F NMR showed there to be 3 main peaks and no starting 
material to be remaining. Water (50 mL) was added and the ethanol evaporated. The 
organic products were extracted into DCM (3 x 30 mL). Drying (MgS04) and 
evaporation gave a dark red solid. Recrystallisation from MeCN yielded 4,6, 7-
Trijluoro-JH-pyrazolo[4,3-c]pyridine-3-ylamine 62 (0.16 g, 9 %) as a pale red solid; 
m.p. 192 °C (decomposed); (Found: C, 38.5; H, 1.7; N, 29.8. C6H3N4F3 requires: C, 
38.3; H, 1.6; N, 29.8 %); Op (DMSO-d6) -72.11 (IF, dd, 3JFF 30.0, 4JFF 1l.l, F-6),-
104.37 (1F, dd, 5Jpp 19.0, 4Jpp 11.8, F-4), -170.25 (1F, dd, 3JFF 29.8, 5]pp 19.2, F-7); OH 
13.00 (lH, s, NH), 5.88 (2H, s, NH2); ilc 148.68 (d, 3Jcp 5.6, C-3), 147.24 (dd, 1JCF 
244.4, 2JcF 17.6, C-6), 144.79 (ddd, 1Jcp 229.5, 3Jcp 16.9, 4Jcp 14.5, C-4), 139.02 (m, C-
3c), 127.52 (ddd, 1JcF 248.7, 2JcF 29.4, 4JcF 8.0, C-7), 100.22 (d, 2Jcp 38.5, C-4c); m/z 
(EI) 188.0 (M+, 100 %). 
179 
